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1 Preface	  
This	  thesis	  is	  submitted	  as	  a	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  of	  the	  requirements	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  Ph.D.	  degree	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  Technical	  University	  of	  Denmark	  (DTU).	  The	  work	  was	  carried	  out	  in	  the	  Infection	  
Microbiology	  Group,	  Center	  for	  Systems	  Microbiology,	  Department	  	  of	  Systems	  Biology	  at	  
DTU	  under	  the	  supervision	  of	  Prof.	  Søren	  Molin.	  The	  work	  was	  performed	  from	  January	  2009	  
to	  March	  2012.	  This	  Ph.D.	  project	  was	  co-­‐financed	  by	  DTU	  and	  the	  Lundbeck	  Foundation.	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   scientific	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   Further	   I	  would	   like	   to	   thank	   Lars	   Jelsbak	   for	   a	   friendly	   attitude,	  
rewarding	   discussion	   and	   for	   showing	   an	   interest	   in	   my	   research.	   Thank	   you	   to	   Anders	  
Folkesson	  and	  Claus	  Sternberg	  too	  for	  good	  discussions	  and	  helpful	  advice.	  	  
	  
Of	  course	  also	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  you	  to	  all	  the	  other	  IMG	  Ph.D.	  students,	  previous	  and	  present.	  To	  
Lei	  Yang	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  partner	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   suggestions	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  Nicholas,	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  Martin	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  Maria,	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   friendly	  colleagues.	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   foreign	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2 Summary	  
Pseudomonas	   aeruginosa	   is	   an	   opportunistic	   pathogen	   capable	   of	   transition	   from	   an	  
environmental	   lifestyle	   to	   a	   host-­‐associated	   lifestyle,	   as	   exemplified	   in	   the	   life-­‐long	   airway	  
infection	   of	   cystic	   fibrosis	   (CF)	   patients.	   Long-­‐term	   infection	   is	   associated	   with	   extensive	  
genetic	  adaptation	  of	  P.	  aeruginosa	  towards	  the	  CF	  airway	  environment	  generating	  variants	  
with	   markedly	   altered	   phenotypes.	   Gaining	   insight	   into	   this	   adaptation	   process	   has	   great	  
clinical	   relevance	   but	   simultaneously	   has	   the	   potential	   to	   increase	   our	   understanding	   of	  
bacterial	   adaptation	   to	   a	  host	   environment.	   This	   has	  been	   the	   framework	  upon	  which	   this	  
thesis	  is	  based.	  	  
Early	  P.	  aeruginosa	  colonization	  of	  the	  CF	  airways	  is	  the	  period	  in	  which	  the	  outcome	  of	  
infection	   is	   determined,	   i.e.	   if	   the	   bacteria	   are	   eventually	   eradicated	   or	   persist.	   In	   three	  
patient	   cases	   the	  evolutionary	  events	   from	   initiation	  of	   infection	  were	  explored	   to	  unravel	  
the	   early	   adaptive	   processes	   possibly	   securing	   bacterial	   persistence.	   In	   this	   early	   stage,	  
clinical	   isolates	   displayed	   few	   adaptive	   events	   however	   these	   included	   phenotypes	   often	  
observed	   in	   late	   chronic	   infection	   isolates	   including	   the	  conversion	   to	  a	  mucoid	  phenotype	  
and	   increased	   antibiotic	   resistance.	   Detailed	   characterization	   of	   the	   mucoid	   phenotype	  
revealed	   profound	   pleiotropic	   effects	   such	   as	   reduction	   of	   virulence	   factors	   and	   the	   Rhl	  
quorum	   sensing	   system.	   Hence	   the	  mucoid	   phenotype	   in	   itself	   encompasses	  many	   of	   the	  
traits	  associated	  with	  chronic	  infection	  isolates.	  	  
In	  many	  CF	  patients	  intermittent	  colonization	  with	  P.	  aeruginosa	  is	  characterized	  by	  the	  
recurrent	   detection	   of	   the	   same	   genotype	   with	   several	   months	   apart.	   Comparing	   patient	  
sinus	  and	  lung	  isolates	   it	  was	  found	  that	  for	  some	  patients	  the	  paranasal	  sinuses	  constitute	  
an	   important	   niche	   for	   P.	   aeruginosa	   during	   intermittent	   colonization.	   In	   fact,	   evolution	  
within	   the	   sinus	   population	   gives	   rise	   to	   variants	   known	   to	   be	   adaptive	   to	   the	   CF	   lung	  
environment	   including	   mucoid,	   antibiotic	   resistant	   and	   small	   colony	   variants.	   The	   likely	  
downwards	  direction	  of	  migration	  between	  sinuses	  and	  lower	  airways	  at	  this	  stage	  suggests	  
that	  the	  paranasal	  sinus	  population	  in	  these	  patients	  has	  the	  potential	  for	  seeding	  the	  lungs	  
with	  pre-­‐adapted	  variants	  and	  thus	  increase	  the	  risk	  of	  progression	  to	  chronic	  lung	  infection.	  
Long-­‐term	  infection	  of	  P.	  aeruginosa	  in	  CF	  patients	  can	  be	  compared	  to	  the	  early	  stage	  
of	  host-­‐restriction	  adaptation.	  One	  example	  of	  CF	  long-­‐term	  infection	  is	  the	  dominant	  clone,	  
the	  DK2	  clone	  type,	  infecting	  CF	  patients	  at	  the	  Copenhagen	  CF	  clinic	  for	  more	  than	  35	  years.	  
Characterization	   of	   the	   genome	   evolution	   of	   DK2	   isolates	   during	   host-­‐adaptation	   revealed	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substantial	   genome	   reduction;	   in	   one	   isolate	   8	   %	   of	   the	   genome	   was	   deleted.	   Thus	   large	  
portions	  of	  the	  P.	  aeruginosa	  genome	  is	  dispensable	  for	  proliferation	  within	  the	  CF	  lung.	  The	  
deletions	   were	   mediated	   by	   illegitimate	   and	   homologous	   recombination	   but	   were	   not	  
insertion	   sequence	   (IS)	   element	   mediated	   as	   previously	   proposed	   for	   early	   stage	   host	  
adaptation.	  The	  putative	  entry	  of	  a	  prophage	  in	  one	  isolate	  was	  the	  only	  sign	  of	  DNA	  uptake	  
during	   infection	   revealing	   little	   importance	   of	   horizontal	   gene	   transfer	   (HGT)	   in	   the	  
adaptation	   towards	   the	   CF	   lung	   and	   further	   demonstrating	   the	   general	   signal	   of	   loss	   of	  
function	  compared	  to	  gain	  of	  function	  during	  adaptation	  to	  the	  CF	  lung.	  
The	  transition	  of	  P.	  aeruginosa	  from	  its	  natural	  aquatic	  and	  terrestrial	  habitats	  into	  the	  
very	  different	  CF	   lung	  environment	  containing	  multiple	  stresses	  usually	  not	  encountered	  by	  
the	   bacteria	   should	   pose	   a	   number	   of	   challenges.	   Yet,	   P.	   aeruginosa	   displays	   an	   inherent	  
capability	  for	  successful	  colonization	  of	  the	  CF	  lung	  with	  persistence	  seemingly	  mediated	  by	  
only	  a	  few	  adaptive	  events.	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3 Dansk	  resumé	  
Pseudomonas	   aeruginosa	   er	   en	   opportunistisk	   patogen	   som	   kan	   skifte	   fra	   naturen	   til	   en	  
værts-­‐associeret	   levevis,	  eksemplificeret	  ved	   livslang	   infektion	  af	   luftvejene	   i	   cystisk	   fibrose	  
(CF)	   patienter.	   Langvarig	   infektion	   er	   associeret	   med	   udstrakt	   genetisk	   adaptation	   af	   P.	  
aeruginosa	   til	   CF	   luftvejs-­‐miljøet,	   hvilket	   generer	   varianter	   med	   markant	   forandrede	  
fænotyper.	   At	   opnå	   indsigt	   i	   denne	   adaptations	   proces	   har	   stor	   klinisk	   relevans,	   men	  
ligeledes	   potentialet	   til	   at	   forøge	   vores	   forståelse	   af	   bakteriel	   adaptation	   til	   et	   værtsmiljø.	  
Dette	  er	  baggrunden	  for	  denne	  afhandling.	  
Den	  tidlige	  kolonisering	  med	  P.	  aeruginosa	  i	  CF	  luftvejene	  udgør	  den	  periode,	  som	  afgør	  
hvordan	  infektionen	  falder	  ud,	  dvs.	  udryddelse	  eller	  persistering.	  De	  evolutionære	  hændelser	  
i	  tre	  patienter	  blev	  undersøgt	  fra	  infektionens	  påbegyndelse,	  for	  at	  udrede	  de	  tidlige	  adaptive	  
processer	   som	   potentielt	   sikrer	   bakteriel	   persistering.	   De	   kliniske	   isolater	   udviste	   i	   dette	  
tidlige	   stadie	   få	   adaptive	   hændelser,	   til	   gengæld	   inkluderede	   disse,	   fænotyper	   ofte	  
observeret	  i	  isolater	  fra	  sen	  kronisk	  infektion,	  inklusive	  konvertering	  til	  en	  mukoid	  fænotype	  
samt	   forøget	   antibiotika	   resistens.	   En	   detaljeret	   karakterisering	   af	   den	  mukoide	   fænotype	  
afslørede	  omfangsrige	  pleiotropiske	  effekter,	   såsom	  reduktion	  af	  virulens	   faktorer	  samt	  Rhl	  
quorum	  sensing	  systemet.	  Følgelig	  omfatter	  den	  mukoide	  fænotype	  i	  sig	  selv	  adskillige	  af	  de	  
karaktertræk,	  som	  normalt	  er	  associeret	  med	  isolater	  fra	  kronisk	  infektion.	  
For	   mange	   CF	   patienter	   er	   intermitterende	   kolonisering	   med	   P.	   aeruginosa	  
karakteriseret	   ved	   gentagen	   detektering	   af	   den	   samme	   genotype,	   tidsmæssigt	   adskilt	   af	  
mange	  måneder.	  Sammenligning	  af	  bihule	  og	  lunge	  isolater	  afslørede,	  at	  bihulerne	  for	  visse	  
patienter	   udgør	   en	   vigtig	   niche	   for	   P.	   aeruginosa	   i	   løbet	   af	   intermitterende	   kolonisering.	  
Faktisk	   medfører	   evolution	   blandt	   bihule	   populationen	   dannelse	   af	   varianter	   kendt	   som	  
værende	   adaptive	   overfor	   CF	   lunge	  miljøet,	   inklusive	  mukoide,	   antibiotika	   resistente	   samt	  
små	   koloni-­‐varianter.	   Den	   sandsynlige	   nedadgående	  migrering	   fra	   bihuler	   til	   lunger	   i	   dette	  
infektionsstadie,	   antyder	   at	   bihule	   populationen	   i	   disse	   patienter	   potentielt	   kan	   tilføre	  
lungerne	  præ-­‐adapterede	  varianter	  og	  dermed	  forøge	  risikoen	  for	  udvikling	  af	  kronisk	  lunge	  
infektion.	  
Langvarig	   P.	   aeruginosa	   infektion	   i	   CF	   patienter	   kan	   sammenlignes	   med	   det	   tidlige	  
stadie	  af	  adaptation	  til	  bakteriel	   restriktion	  til	  et	  værtsmiljø.	  Den	  dominante	  klon,	  DK2	  klon	  
typen,	   med	   en	   infektions	   historik	   på	   mere	   end	   35	   år	   udgør	   et	   eksempel	   på	   langvarig	   CF	  
infektion.	   Karakterisering	   af	   evolutionen	   af	   genomet	   i	   DK2	   isolater	   i	   løbet	   af	   deres	   værts	  
	   x	  
adaptering	   afslørede	   betragtelig	   reducering	   af	   genomet;	   i	   et	   isolat	   var	   8	   %	   af	   genomet	  
forsvundet.	  Store	  bestanddele	  af	  P.	  aeruginosa	  genomet	  er	  dermed	  overflødigt	  med	  hensyn	  
til	   vækst	   i	   CF	   lungen.	   Deleterings	   mekanismen	   bestod	   af	   illegitim	   samt	   homolog	  
rekombination,	   men	   ikke	   af	   insertion	   sequence	   (IS)	   element	   rekombination	   som	   tidligere	  
foreslået	  for	  tidlig	  værts	  adaptation.	  Det	  eneste	  tegn	  på	  DNA	  optag	  under	  infektionen	  var	  et	  
potentielt	   optag	   af	   en	   pro-­‐fag	   i	   et	   enkelt	   isolat,	   hvilket	   påviser	   en	   begrænset	   betydning	   af	  
horisontal	   genoverførsel	   i	   adaptationen	   til	   CF	   lungemiljøet.	   Endvidere	   tjener	   det	   som	  
demonstration	   på	   den	   generelle	   observation	   af	   tab	   af	   funktion,	   modsat	   erhverv	   af	   ny	  
funktion	  i	  adaptationen	  til	  CF	  lungemiljøet	  for	  P.	  aeruginosa.	  
Overgangen	   fra	   dets	   naturlige	   habitat	   mod	   det	   særdeles	   anderledes	   CF	   lungemiljø	  
indeholdende	   adskillige	   stress	   påvirkninger	   som	   P.	   aeruginosa	   normalt	   ikke	   møder,	   må	  
formodes	  at	  præsentere	  væsentlige	  udfordringer	  for	  bakterien.	  Dog	  ses	  det	  at	  P.	  aeruginosa	  
udviser	  en	  immanent	  egnethed	  til	  succesfuld	  kolonisering	  af	  CF	  lungemiljøet,	  hvor	  persistens	  
umiddelbart	  kan	  opnås	  via	  ganske	  få	  adaptive	  hændelser.	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5 Introduction	  
5.1 Cystic	  fibrosis	  
Cystic	   fibrosis	   is	   the	   most	   common	   lethal	   autosomal	   recessive	   disease	   in	   Caucasian	  
populations	   affecting	   1	   in	   2500	   newborns.	   It	   is	   caused	   by	   mutations	   in	   the	   cystic	   fibrosis	  
transmembrane	  conductance	  regulator	  (CFTR)	  gene	  (Riordan	  et	  al.,	  1989)	  encoding	  a	  chloride	  
channel	  regulating	  the	  transport	  of	  ions	  and	  water	  in	  epithelial	  cells.	  The	  protein	  is	  expressed	  
in	   respiratory,	  gastrointestinal,	  hepatobiliary	  and	  reproductive	  systems	   (Lyczak	  et	  al.,	  2002)	  
and	  CFTR	  mutation	  consequently	  causes	  abnormalities	  in	  these	  organs	  such	  as	  poor	  nutrient	  
absorption,	  male	  infertility	  and	  airway	  infections,	  the	  latter	  causing	  a	  median	  age	  of	  survival	  
around	  37	  years	  for	  CF	  patients.	  The	  most	  frequent	  mutation	  (70-­‐80	  %	  of	  all	  CF	  patients)	  is	  an	  
in-­‐frame	   deletion	   at	   position	   508	   (ΔF508)	   which	   concurrently	   is	   one	   of	   the	   most	   severe	  
mutation	   types	   in	   terms	  of	   clinical	  manifestation	   (Koch	  and	  Hoiby,	  1993).	  A	  defective	  CFTR	  
channel	   leads	   to	   thick,	   sticky	   mucus	   caused	   by	   hyper-­‐absorption	   of	   Na+	   and	   Cl-­‐	   ions	   and	  
subsequent	  water	  uptake	  by	  osmosis	  (Figure	  1)	  (Rowe	  et	  al.,	  2005).	  	  
	  
Figure	  1:	  Model	  of	  airway	  epithelia.	  (A)	  Normal	  airway	  epithelia	  with	  hydrated	  mucus	  and	  
functional	   mucociliary	   clearance.	   (B)	   Dehydration	   of	   CF	   airway	   epithelia	   leads	   to	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malfunctional	   mucociliary	   clearance	   and	   (C)	   thick	   dehydrated	   mucus	   (Worlitzsch	   et	   al.,	  
2002).	  
	  
Thick	   mucus	   impairs	   the	   defense	   mechanism	   of	   mucociliary	   clearance	   of	   microbes	  
enabling	   these	   to	   establish	   lifelong	   infections	   in	   the	   lungs.	   This	   leads	   to	   excessive	  
inflammation	  and	  together	  these	  are	  the	  factors	  responsible	  for	  the	  morbidity	  and	  mortality	  
of	   cystic	   fibrosis	   disease.	   Microbes	   frequently	   isolated	   from	   CF	   patients	   include	   P.	  
aeruginosa,	  Staphylococcus	  aureus	  and	  Haemophilus	  influenza	  (Figure	  2).	  	  
	  
Figure	  2:	  Age	  specific	  prevalence	  of	  bacterial	  species	  in	  cystic	  fibrosis	  patients	  (Cystic	  
Fibrosis	  Foundation	  annual	  report	  2009).	  
	  
P.	   aeruginosa	   is	   the	  main	   pathogen	   of	   CF	   patients	   and	   infection	   is	   a	   poor	   prognostic	  
indicator	  and	  associated	  with	   lung	  function	  decline	  (Nixon	  et	  al.,	  2001;	  Li	  et	  al.,	  2005).	  One	  
reason	   is	   its	   capability	  of	  proliferation	   in	   the	  CF	   lung	   -­‐	  up	   to	  109	   cells	  per	  ml	   in	  CF	   sputum	  
samples	  are	  found.	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RESPIRATORY INFECTIONS
Goal 4:  People with CF, their families and CF health care professionals will be well-informed and active partners 
in reducing respiratory infections, particularly Pseudomonas aeruginosa (Pseudomonas) and Burkholderia 
cepacia (B. cepacia) complex.
!e best way for anyone to avoid germs is to:
 • Clean your hands often with soap and water or alcohol-based hand gels;
 • Use a tissue when coughing or sneezing, then clean your hands;
 • Avoid touching your eyes, nose or mouth to keep from spreading germs to yourself and others; and
 • If you are ill, stay away from others. 
Repeated lung infections are a concern for people with CF. Repeated infections and the in"amma-
tion from them damage the lungs. 
!is damage causes lung function (FEV1) to get worse. When the lungs are damaged, infections 
happen more often. !e next graph shows some of the germs that are found in the lungs of people 
with CF. Talk to your CF care center to learn more about how to avoid respiratory infections.
Information about CF germs (In"uenza, MRSA, B. cepacia, etc.) and Web casts (“Germs, Infection 
Control and People With CF”) a e available at www.c#.org/LivingWithCF/StayingHealthy. You 
can also watch “Put Your Hands Together” at www.cdc.gov/CDCTV/HandsTogether.
Age Specific Prevalence of Respiratory Organisms, 2009
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5.1.1 Cystic	  fibrosis	  lower	  airway	  environment	  
The	   cystic	   fibrosis	   lung	   environment	   comprises	   a	   complex	   heterogeneous	   environment	   for	  
microorganisms	   to	   adapt	   to.	   	   Apart	   from	   spatial	   heterogeneity	   it	   presents	   variation	   in	  
nutrients,	   oxygen	   concentration,	   immune	   system	   defences	   and	   antibiotics	   and	   the	  
considerable	  phenotypic	  diversity	  exhibited	  by	  P.	  aeruginosa	  CF	  clinical	   isolates	  (Govan	  and	  
Deretic,	  1996)	  provides	  a	  possible	  reflection	  of	  this	  heterogeneity.	  The	  lower	  airways	  can	  be	  
partitioned	   into	   two	   distinct	   compartments,	   the	   conductive	   zone	   and	   the	   respiratory	   zone	  
(Figure	  3).	  	  
	  
Figure	  3:	  The	  conductive	  and	  respiratory	  zones	  of	  the	  lungs	  (Høiby	  et	  al.,	  2010).	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found a prevalence of 54% [21]. P. aeruginosa, 
therefore, adapts to intensive antibiotic therapy 
by producing mucoid biofilms, and by becom-
ing mutators. In conclusion, P. aeruginosa 
adapts to intense antibiotic therapy by forming 
mucoid biofilms, and by conventional resist-
ance mechanisms, which act synergistically 
to allow P. aeruginosa to survives for decades 
despite the antibiotic therapy, while the lung 
tissue is gradually destroyed. 
Bacteriological & clinical consequences 
of the adaptability of P. aeruginosa 
biofilms in CF lungs
The P. aeruginosa PAO1 strain, which was orig-
inally isolated from a wound, was sequences 
by Stover et al. in 2000 [100]. It has 6.2 mil-
lion base pairs and 5570 genes, among which 
are a high proportion of regulatory, catabolic, 
transport, efflux and chemotaxis genes, which 
explains much of its adaptability [100]. When 
investigating clinical strains from chronic 
lung infection of CF patients, there are some 
obvious differences from the PAO1 strain, as 
described previously. CF strains are alginate 
producers, grow in biofilms in CF lungs, split-
off nonmucoid and small-colony-variant phe-
notypes, are often mutators, have accumulated 
mutations and have become auxotrophs. We 
have found that clinical CF strains in most 
patients persist [8], and grow much slower than 
PAO1; the mean generation time is two- to 
three-fold less than environmental isolates in 
laboratory media, and in vivo, in the lungs of 
CF patients, the generation time is 100–200 
min [57]. When such clinical strains have 
survived in CF lungs for 30 years, they may 
have experienced 78,840–157,680 divisions, 
during which time, niche specialists have 
evolved, which are well adapted to surviving 
in CF lungs, but may have less capability to 
survive elsewhere. Compared with the evolu-
tion of our own species, the genetic and phe-
notypic difference between PAO1 and CF P. 
aeruginosa strains may be comparable to the 
distance between Homo erectus and modern 
Homo sapiens. 
We have also found that the biofilm-form-
ing ability in vitro decreased when subsequent 
nonmucoid isolates were studied with the same 
clone of P. aeruginosa colonizing CF patients 
for many years [58]. This change was associated 
with a loss of motility and with decreased pro-
duction of virulence factors and QS molecules, 
and the isolates also became hypermutable [58]. 
This was not the case with mucoid isolates of 
the same clone [61]. These findings are in accord-
ance with the result of Smith et al., who studied 
a series of subsequent nonmucoid isolates during 
8 years of infection in a CF patient [101]. They 
found numerous genetic adaptations during 
the 8-year period. Sequencing of the genome of 
early and late mucoid, and nonmucoid isolates 
of P. aeruginosa from individual CF patients 
is, therefore, urgently needed to investigate 
the evolution of the P. aeruginosa genome in 
CF lungs during decades of chronic biofilm 
infection, which occurs despite the immune 
response and antibiotic therapy.
The clinical consequences of the impres-
sive evolutionary adaptation of P. aeruginosa 
in CF lungs have been illustrated by a clinical 
example. We examined explanted lungs from a 
42-year-old CF male who had chronic P. aeru-
ginosa infection for 28 years [9]. The patient 
developed a pronounced antibody response 
from the beginning of the infection in 1977 
and, at the same time, he started treatment 
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Figure 7. The conductive and respiratory zones of the lungs.
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The	   conductive	   zone	   constitutes	   about	   5	  %	   of	   the	   lung	   volume	   and	   includes	   trachea,	  
bronchi	   and	   terminal	   bronchioles.	   It	   contains	   cilia	   for	  mucociliary	   clearing	   and	   goblet	   cells	  
that	  together	  with	  submucosal	  glands	  are	  responsible	  for	  mucus	  production.	  It	  is	  possible	  to	  
reach	  high	  concentrations	  of	  antibiotics	  in	  the	  sputum	  of	  the	  conductive	  zone	  by	  nebulization	  
(Høiby	   et	   al.,	   2010).	   The	   respiratory	   zone	   constitutes	   95	   %	   of	   lung	   volume	   and	   contains	  
respiratory	  bronchioles	  and	  alveolar	  ducts	  but	  not	  cilia	  or	  mucus	  producing	  cells.	  Only	  a	  thin	  
barrier	   separates	   the	   blood	   from	   the	   air	   and	   intravenous	   antibiotic	   administration	   can	  
provide	  high	  concentrations	  in	  the	  tissue	  of	  the	  respiratory	  zone	  (Høiby	  et	  al.,	  2010).	  Aerobic	  
conditions	   are	   present	   in	   the	   respiratory	   zone	   unless	   mucus	   plugs	   restricts	   air	   passage	  
creating	  microaerobic	  conditions.	  	  
Microbial	   growth	   in	   the	   conductive	   zone	   is	   usually	   restricted	   to	   the	   thick	   mucus	  
containing	   gradients	   of	   oxygen	   ranging	   from	   aerobic	   through	   hypoxic	   to	   anaerobic	  
(Worlitzsch	   et	   al.,	   2002).	   The	   anaerobic	   condition	   affects	   the	   antibiotic	   efficacy	   negatively	  
and	  can	  sustain	  microbial	  growth	  through	  the	  presence	  of	  sufficient	  concentrations	  of	  nitrate	  
utilized	  by	  P.	  aeruginosa	   as	   an	  electron	  acceptor	   (Palmer	  et	   al.,	   2007).	   Importantly,	   the	  CF	  
lung	  is	  a	  nutrient	  rich	  environment	  with	  a	  nutritional	  composition	  of	  sputum	  containing	  high	  
concentrations	  of	   free	  amino	  acids	  as	  well	   as	   lactic	  acid	  and	  glucose	   (Barth	  and	  Pitt,	   1996;	  
Palmer	   et	   al.,	   2007).	   Due	   to	   the	   low	   water	   activity	   in	   CF	   mucus	   the	   bacteria	   will	   also	  
experience	   a	   high	   osmotic	   pressure.	   The	   immune	   defence	   in	   the	   lungs	   consists	   of	   non-­‐
inflammatory	  mechanisms	   such	   as	  mucociliary	   clearance,	   alveolar	  macrophages,	   defensins	  
and	   secretory	   IgA	   while	   the	   inflammatory	   mechanisms	   include	   polymorphonuclear	  
leukocytes	  (PMNs),	  IgG	  and	  complement	  (Chmiel	  and	  Davis,	  2003).	  Bacterial	  presence	  within	  
the	  CF	  lung	  leads	  to	  high	  levels	  of	  the	  inflammatory	  response	  consisting	  mainly	  of	  an	  influx	  of	  
PMNs	   (up	   to	   1,500	   times	   normal	   levels)	   releasing	   proteases	   and	   reactive	   oxygen	   species	  
(ROS)	  (Konstan	  et	  al.,	  1994).	  The	  release	  of	  these	  substances	  in	  turn	  leads	  to	  extensive	  tissue	  
damage,	  reduced	  lung	  function	  ultimately	  with	  a	  lethal	  outcome.	  Bacteria	  proliferating	  in	  the	  
CF	   lower	   airway	   environment	   consequently	   have	   to	   endure	   and	   adapt	   towards	   several	  
stresses,	  e.g.	  antibiotic,	  oxidative	  and	  osmotic	  stress.	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5.1.2 Environment	  of	  the	  cystic	  fibrosis	  paranasal	  sinuses	  
The	  respiratory	  system	  consists	  of	  both	  upper	  and	  lower	  airways.	  Since	  these	  are	  connected	  
any	  bacteria	  entering	  e.g.	  the	  lower	  airways	  could	  also	  potentially	  enter	  more	  distal	  parts	  of	  
the	  upper	  airways	  and	  not	  just	  the	  larynx	  and	  pharynx.	  For	  CF	  patients	  this	  is	  also	  the	  case	  as	  
a	   large	   percentage	   (36	  %	   in	   one	   study)	   are	   suffering	   from	   chronic	   sinusitis	   and	   symptoms	  
usually	  commence	  early	  in	  life	  (5-­‐14	  years)	  (Coste	  et	  al.,	  1995;	  Gysin	  et	  al.,	  2000;	  Wang	  et	  al.,	  
2005).	   The	  paranasal	   sinuses	   comprise	   several	   small	   air-­‐filled	   spaces	   surrounding	   the	  nasal	  
cavity	   and	   draining	   directly	   or	   indirectly	   into	   this.	   Their	   biological	   function	   includes	  weight	  
reduction	   of	   the	   skull	   and	   voice	   resonance	   and	   consist	   of	   the	   ethmodial,	   frontal,	  maxillary	  
and	  sphenoidal	  sinuses	  (Figure	  4).	  	  
	  
Figure	  4:	  Anatomical	  overview	  of	  the	  location	  of	  the	  paranasal	  sinuses	  (Dorland,	  2000).	  
	  
The	  sinus	  and	  lower	  airway	  environment	  is	  in	  many	  ways	  similar.	  Epithelial	  cells	  contain	  
the	  CFTR	  chloride	  channel	  and	  therefore	  similar	  effects	  of	  CFTR	  mutation	  is	  observed	  in	  both	  
environments.	   In	   addition	   they	   both	   contain	   the	   same	  mucous	  membrane	   lining	   with	   the	  
presence	   of	   cilia	   as	   well.	   Access	   of	   air	   to	   the	   CF	   paranasal	   sinuses	   can	   be	   restricted	   by	  
blockade	  of	   the	   sinus	  ostia	  and	   the	   sinuses	  are	  also	  easily	   filled	  with	   thickened	  mucus	  and	  
hypoxic	   or	   anaerobic	   conditions	   are	   known	   to	   exist	   on	   the	   mucosa	   (Aanaes	   et	   al.,	   2011).	  
Thus,	  invading	  bacteria	  will	  encounter	  and	  have	  to	  adapt	  to	  similar	  conditions	  however	  a	  few	  
important	  differences	  exist	  between	  the	  sinuses	  and	  lower	  airways.	  The	  immune	  response	  in	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the	  sinuses	  is	  less	  challenging	  and	  of	  a	  different	  character	  with	  lower	  abundance	  of	  PMNs	  but	  
higher	   levels	   of	   IgA	   (Johansen	   et	   al.,	   2009).	   Additionally	   the	   antibiotic	   load	   is	   lower	   in	   the	  
sinuses	  due	   to	  e.g.	  obstruction	  of	   sinus	  cavities.	  Taken	   together	   these	  characteristics	   lower	  
the	  protective	  barrier	  against	  e.g.	  P.	  aeruginosa	  colonization	  compared	  to	  the	  lower	  airways.	  	  
	  
5.1.3 P.	  aeruginosa	  infection	  progression	  in	  CF	  patients	  
The	  presence	  of	  P.	  aeruginosa	   in	   the	   lungs	  of	  CF	  patients	  usually	   follows	  a	  certain	  pattern.	  
Initially,	   after	   birth	   and	   a	   range	   of	   years	   thereafter,	   P.	   aeruginosa	   is	   not	   detected	   in	   lung	  
samples.	   	   Subsequently,	   upon	   the	   first	   isolation	   of	  P.	   aeruginosa	   from	   the	   lungs	   follows	   a	  
period	  of	  so-­‐called	  intermittent	  infection	  in	  which	  P.	  aeruginosa	  is	  only	  occasionally	  detected	  
in	   samples.	   This	  period	  will	   often	  be	  ensued	  by	   the	  period	  of	   chronic	   infection	   in	  which	  P.	  
aeruginosa	   persists	   in	   the	   lungs	   and	   is	   continuously	   detected	   (Koch,	   2002).	   In	   order	   to	  
distinguish	   these	   phases	   several	   definitions	   using	   different	   criteria	   have	   been	   suggested	  
(Ballmann	  et	  al.,	  1998;	  Lee	  et	  al.,	  2003;	  Proesmans	  et	  al.,	  2006;	  Pressler,	  2011).	  
One	   of	   the	  most	   widely	   used	   definitions	   is	   that	   originating	   from	   the	   Copenhagen	   CF	  
clinic.	  In	  this,	  the	  phase	  of	  intermittent	  colonization	  is	  defined	  as	  a	  culture	  of	  P.	  aeruginosa	  at	  
least	   once	   and	   the	   presence	   of	   normal	   levels	   of	   precipitating	   antibodies	   against	   P.	  
aeruginosa.	   The	   chronic	   infection	   phase	   is	   defined	   as	   the	   persistent	   presence	   of	   P.	  
aeruginosa	   for	  at	   least	  6	  consecutive	  months,	  or	   less	  when	  combined	  with	  the	  presence	  of	  
two	  or	  more	  P.	  aeruginosa	  precipitating	  antibodies	   (Hoiby	  et	  al.,	  1977;	  Pressler,	  2011).	  The	  
time	  point	  of	  the	  first	  acquisition	  (detection)	  of	  P.	  aeruginosa	  in	  CF	  patients	  is	  usually	  early	  in	  
life.	  This	  time	  point	  is	  quite	  variable	  and	  different	  studies	  have	  yielded	  different	  median	  ages,	  
some	  stating	  1-­‐2	  years	   (Demko	  et	  al.,	  1995;	  Burns	  et	  al.,	  2001;	  Li	  et	  al.,	  2005)	  while	  others	  
have	   found	   it	   to	   be	   7-­‐8	   years	   (Kerem	  et	   al.,	   1989;	  Maselli	   et	   al.,	   2003).	   Factors	   that	   could	  
influence	   these	   numbers	   are	   the	   frequency	   of	   sampling	   and	   possibly	   transmission	   from	  
patients	  already	  carrying	  P.	  aeruginosa	  through	  co-­‐localization	  at	  the	  same	  clinic	  (Hoiby	  and	  
Pedersen,	  1989).	  The	  duration	  of	  the	  period	  of	  intermittent	  colonization	  is	  also	  variable,	  one	  
reason	  being	  the	  differences	  in	  definitions	  from	  clinic	  to	  clinic	  but	  the	  frequency	  of	  sampling	  
can	  also	  be	  a	  limiting	  factor	  for	  accurate	  estimations.	  Furthermore	  the	  duration	  of	  this	  period	  
will	   be	   heavily	   influenced	   by	   the	   antibiotic	   treatment	   regime	   of	   the	   clinic	   (Johansen	   and	  
Hoiby,	  1992;	  Koch,	  2002).	  Aggressive	  antibiotic	   treatment	  can	  both	  end	  the	  period	  through	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eradication	  of	  the	  bacteria	  but	  can	  importantly	  postpone	  the	  transition	  to	  a	  chronic	  infection	  
(Koch,	   2002).	   At	   the	  Copenhagen	  CF	   center	   an	   aggressive	   antibiotic	   treatment	   approach	   is	  
followed	  during	   intermittent	   infection	  consisting	  of	  3	  weeks	  to	  3	  months	  of	   inhaled	  colistin	  
and	   oral	   ciprofloxacin.	   During	   chronic	   infection	   two-­‐week	   intravenous	   courses	   of	   e.g.	   a	  β-­‐
lactam	  and	  aminoglycoside	  every	  three	  months	  is	  initiated	  together	  with	  daily	  administering	  
of	  ciprofloxacin	  and	  colistin	  (Hoiby	  et	  al.,	  2005).	  
The	   genotypes	   of	   intermittent	   colonization	   isolates	   have	   been	   found	   to	   be	   highly	  
variable	   between	   patients	   and	   even	   within	   patients	   indicating	   that	   any	   P.	   aeruginosa	  
genotype	  has	  the	  potential	  for	  infection	  (Burns	  et	  al.,	  2001;	  Munck	  et	  al.,	  2001;	  Jelsbak	  et	  al.,	  
2007;	   Hansen	   et	   al.,	   2012).	   This	   observed	   level	   of	   genotype	   variation	   can	   however	   be	  
confounded	   by	   cross-­‐contamination	   of	   P.	   aeruginosa	   within	   the	   CF	   patient	   population	   by	  
patient-­‐to-­‐patient	   contact.	   As	   observed	   in	   the	   Copenhagen	   CF	   clinic	   for	   older	   patients	   this	  
can	  create	  dominant	  clone	  types	  since	  these	  are	  capable	  of	  outcompeting	  other	  invaders	  or	  
clone	  types	  already	  present	  in	  the	  patients	  (Jelsbak	  et	  al.,	  2007;	  Yang	  et	  al.,	  2011b)	  (Jelsbak,	  
Yang	   2011).	   The	   DK2	   clone	   type	   present	   in	   the	   Copenhagen	   CF	   clinic	   provides	   such	   an	  
example,	   infecting	   more	   than	   forty	   individuals	   over	   a	   period	   of	   35	   years	   (Rau	   et	   al.,	   in	  
preparation).	  
In	   several	   cases	   of	   intermittent	   colonization	   (approximately	   25	  %)	   a	   period	   of	   several	  
months	   without	   P.	   aeruginosa	   detection	   is	   followed	   by	   re-­‐colonization	   with	   the	   same	  
preceding	  genotype	  (Munck	  et	  al.,	  2001;	  Gibson	  et	  al.,	  2003;	  Doring	  et	  al.,	  2006;	  Hansen	  et	  
al.,	  2012).	  Considering	  the	  normal	  genotype	  diversity	  of	  colonization	  it	  indicates	  the	  presence	  
of	  a	  reservoir	  seeding	  the	  lungs	  of	  the	  patient	  having	  either	  an	  external	  environmental	  origin	  
or	   an	   internal	   origin	   e.g.	   the	   paranasal	   sinuses.	   An	   association	   between	   sinus	   and	   lower	  
airway	   colonization	   has	   also	   been	   established.	   Investigating	   this	   in	   young	   CF	   patients	  
(Muhlebach	  et	  al.,	  2006)	  found	  that	  phenotypically	  identical	  micro-­‐organisms,	  based	  on	  plate	  
assaying,	  were	  shared	  between	  sinuses	  and	  lower	  airways	  in	  12	  out	  of	  31	  patients,	  while	  10	  
of	  these	  also	  had	  identical	  genotypes	  based	  on	  Pulsed	  Field	  Gel	  Electrophoresis	  analysis.	  In	  a	  
larger	   study	   covering	  182	  patients	  of	   all	   ages,	   23	  of	   the	  24	  patients	   carrying	  P.	  aeruginosa	  
had	   identical	   genotypes	   in	   sinus	   and	   lower	   airways	   (Mainz	   et	   al.,	   2009).	   Although	   these	  
studies	   establish	   an	   association	   between	   sinus	   and	   lung	   colonization	   nothing	   is	   revealed	  
about	  any	  transfer	  between	  these	  two	  sites,	  let	  alone	  its	  direction.	  However	  a	  study	  on	  post	  
lung-­‐transplant	  CF	  patients	  showed	  a	  significant	  correlation	  between	  P.	  aeruginosa	  presence	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in	  the	  sinuses	  and	  in	  the	  transplanted	  lung	  as	  well	  as	  the	  reverse;	  absence	  of	  P.	  aeruginosa	  in	  
the	   sinuses	   was	   correlated	   with	   absence	   in	   the	   transplanted	   lung.	   Furthermore	   post-­‐
transplant	   sinus	   surgery	   was	   shown	   to	   decrease	   pneumonia	   (Holzmann	   et	   al.,	   2004).	  
Consequently	   several	   studies	   point	   towards	   the	   transfer	   of	   bacteria	   between	   the	   two	  
compartments.	  	  
This	   was	   finally	   confirmed	   by	   Hansen	   et	   al.	   (2012)	   finding	   not	   only	   a	   concordance	  
between	   P.	   aeruginosa	   genotypes	   of	   sinus	   and	   lung	   isolates	   of	   intermittently	   colonized	  
children	  but	  also	  distinct	  subpopulations	  in	  each	  side	  of	  the	  sinuses.	  The	  subsequent	  isolation	  
of	  phenotypically	  identical	  strains	  from	  the	  lungs	  provided	  strong	  indications	  of	  transfer.	  The	  
study	   further	   revealed	   that	   the	   likely	   directionality	   of	   transfer	   in	   this	   stage	   of	   infection	   is	  
downwards	  from	  sinuses	  to	   lungs	  and	  additionally	  that	  evolution	  of	  P.	  aeruginosa	  occurs	   in	  
the	   sinuses	   from	  which	  mucoid,	   small	   colony	   variants	   and	   antibiotic	   resistant	   clones	  were	  
isolated.	  Thus	  the	  sinuses	  of	  intermittently	  CF	  patients	  can	  constitute	  a	  reservoir	  of	  variants	  
pre-­‐adapted	   to	   the	   CF	   lung	   environment	   revealing	   that	   infection	   of	   the	   paranasal	   sinuses	  
could	  easily	  be	  a	  risk	  factor	  for	  development	  of	  chronic	  lung	  infection.	  
	  
5.2 Pseudomonas	  aeruginosa	  
Pseudomonas	   aeruginosa	   is	   a	   rod-­‐shaped	   Gram-­‐negative	   bacterium	   displaying	   a	   high	  
metabolic	  diversity.	  It	  is	  thought	  to	  be	  ubiquitous	  in	  nature	  colonizing	  aquatic	  and	  terrestrial	  
habitats.	   Even	   though	   it	   is	   a	   successful	   environmental	   bacterium	   it	   is	   in	   addition	   an	  
opportunistic	  pathogen	  capable	  of	  infecting	  amoeba,	  plants	  and	  animals	  (Rahme	  et	  al.,	  2000;	  
Pukatzki	   et	   al.,	   2002).	   Human	   infection	   is	   generally	   restricted	   to	   immuno-­‐compromised	  
individuals	  causing	  systemic	  infections	  in	  burn	  patients,	  cancer	  and	  HIV	  patients,	  respiratory	  
system	   infections	   including	   cystic	   fibrosis	   patients	   (Spencer,	   1996;	   Brennan	   and	   Geddes,	  
2002;	   Sadikot	   et	   al.,	   2005;	   Church	  et	   al.,	   2006).	   It	   is	   capable	  of	   survival	   and	   growth	   in	   low	  
nutrient	  environments	  and	   is	  known	  to	  persist	   in	  moist	  environments	  and	  water	   reservoirs	  
such	  as	  bathrooms,	  sinks	  and	  kitchens	  providing	  opportunity	  for	  human	  contact.	  It	  is	  motile	  
through	  the	  action	  of	  a	   flagellum	  and	  pili	  while	  having	  an	  optimum	  growth	  temperature	  of	  
37°	  but	  capable	  of	  survival	  up	  to	  42°.	  The	  genome	  is	  one	  of	  the	  largest	  among	  bacteria	  being	  
5.5-­‐7.0	   Mbp	   with	   so	   far	   five	   assembled	   genomes	   (Stover	   et	   al.,	   2000;	   Lee	   et	   al.,	   2006;	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Winstanley	   et	   al.,	   2009;	   Roy	   et	   al.,	   2010;	   Rau	   et	   al.,	   2012)	   having	   a	   high	   proportion	   of	  
regulatory	  genes	  likely	  reflecting	  its	  versatility.	  	  
	  
5.2.1 Virulence	  factors	  	  
Reflecting	   its	   potential	   as	   an	   opportunistic	   pathogen,	   P.	   aeruginosa	   has	   the	   potential	   to	  
produce	  a	  multitude	  of	  virulence	   factors	   some	  of	  which	  are	   secreted	  while	  others	  are	  cell-­‐
associated	  (Figure	  5).	  
	  
Figure	  5:	  Pseudomonas	  aeruginosa	  virulence	  factors	  
Secreted	   virulence	   factors	   include	   siderophores,	   pyocyanin,	   proteases,	   hydrogen	  
cyanide	  and	  rhamnolipids.	  The	  two	  siderophores,	  pyoverdin	  and	  pyochelin,	  are	  produced	  and	  
secreted	  during	   iron-­‐limited	  conditions	  and	  taken	  up	  through	  specific	  cell-­‐surface	  receptors	  
(Beare	  et	  al.,	  2003).	  They	  can	  favourable	  compete	  with	  human	  transferrin	  for	  iron.	  Pyocyanin	  
is	  a	  redox-­‐active	  blue	  pigment	  with	  antimicrobial	  activity	  that	  upon	  reaction	  with	  oxygen	  can	  
produce	  superoxide	  and	  hydrogen	  peroxide	  inhibiting	  mammalian	  cell	  respiration	  (Wilson	  et	  
al.,	   1987).	   The	   functions	   of	   rhamnolipids	   are	   multifaceted.	   Their	   amphiphilic	   nature,	  
mediated	  by	  its	  structure	  containing	  rhamnose	  and	  a	  fatty	  acid	  residue,	  provides	  detergent-­‐
like	  properties	  used	  for	  e.g.	  swarming	  motility.	  They	  are	  believed	  to	  dissolve	  lung	  surfactant	  
phospholipids	   and	   protect	   against	   PMNs	   (Liu,	   1974;	   Kohler	   et	   al.,	   2000;	   Van	  Gennip	   et	   al.,	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base pairs of P. aeruginosa PAO1 containing 5570 open reading frames (Stover et al. 2000). P. 
aeruginosa is an environmental bacterium often found in soil and water habitats but also capable 
of infecting higher organisms such as plants and animals (Wolfgang et al. 2003a; Stover et al. 
2000). It is an important opportunistic pathogen in humans, capable of infecting health-
compromised patients and causes urinary tract infections, respiratory system infections, systemic 
infections in burn patients as well as being the major cause of morbidity and mortality in cystic 
fibrosis patients (Spencer 1996; Church et al. 2006; Brennan and Geddes 2002). P. aeruginosa 
possesses many properties involved in infection, e.g. motility by flagella and type IV pili, secretion 
of virulence factors and antibiotic resistance mechanisms. 
 
Virulence factors 
Pseudomonas aeruginosa is capable of producing a multitude of virulence factors, e.g. pyocyanin, 
siderophores, rhamnolipids, hydrogen cyanide, secretion systems and proteases, see Figure 1. 
Pyocyanin (1-hydroxy-5-methyl-phenazine) is a redox active blue pigment having antibiotic 
properties. It can expose host cells to oxidative stress by reacting with oxygen and producing 
superoxide and hydrogen peroxide (Muller 2002). It has also been found to inhibit mammalian cell 
respiration and disrupt the beating of human cilia (Wilson et al. 1987). The two siderophores, 
pyoverdin and pyochelin, are produced by P. aeruginosa under iron limiting conditions and are 
capable of competing with human transferrin for iron. After chelating iron the secreted 
siderophores are taken up by specific cell-surface receptors (Beare et al. 2003). Hydrogen cyanide 
can block cytochrome oxidase leading to inhibition of mitochondrial respiration and has been 
shown to mediate Caenorhabditis elegans killing (Gallagher and Manoil 2001). 
 
Figure 1: Overview of virulence factors in P. aeruginosa. Figure from (Van Delden and Iglewski 1998). 
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2009).	   Hydrogen	   cyanide,	   for	   which	   P.	   aeruginosa	   has	   inherent	   resistance	  mechanisms,	   is	  
known	  to	  cause	  inhibition	  of	  mitochondrial	  respiration	  and	  is	  a	  key	  factor	  in	  Caenorhabditis	  
elegans	  killing	  (Gallagher	  and	  Manoil,	  2001).	  In	  addition	  to	  these	  secreted	  virulence	  factors	  P.	  
aeruginosa	   expresses	   the	   Type	   III	   secretion	   system	   involved	   in	   the	   secretion	   of	   cytotoxic	  
effector	  proteins	  (ExoS,	  ExoT,	  ExoU	  and	  ExoY)	  into	  the	  cytoplasm	  of	  eukaryotic	  cells	  (Hauser	  
et	  al.,	  2002).	  Cell-­‐associated	  virulence	  factors	  include	  flagella,	  type	  IV	  pili	  and	  LPS.	  Apart	  from	  
twitching	  motility,	   pili	   are	   involved	   in	   the	   attachment	  of	  P.	   aeruginosa	   to	   both	   abiotic	   and	  
biotic	  surfaces	   (de	  Bentzmann	  et	  al.,	  1996)	  while	   flagella	  responsible	   for	  swimming	  motility	  
are	   highly	   immunogenic	   (Mizel	   et	   al.,	   2003).	   The	   endotoxin	   LPS	   consists	   of	   lipid	   A,	   core	  
oligosaccharide	  and	  repeated	  O-­‐linked	  polysaccharide	  of	  either	  A-­‐band	  or	  B-­‐band	  form.	  The	  
B-­‐band	  is	  variable	  between	  the	  different	  O-­‐band	  serotypes	  and	  is	  required	  for	  P.	  aeruginosa	  
virulence	  (Cryz	  et	  al.,	  1984;	  Rocchetta	  et	  al.,	  1999).	  	  
	  
5.2.2 Antibiotic	  resistance	  
A	  high	   intrinsic	  tolerance	  to	  many	  antibiotics	   is	  characteristic	  of	  P.	  aeruginosa	  due	  to	  e.g.	  a	  
vast	  array	  of	  efflux	  pumps,	  and	  especially	  a	  potential	  for	  development	  of	  increased	  resistance	  
through	   mutation	   affecting	   the	   expression	   of	   these.	   Usually	   the	   mutations	   are	   located	   in	  
their	   respective	   regulator	  genes	   (Masuda	  et	  al.,	  1996;	  Vogne	  et	  al.,	  2004;	  Rau	  et	  al.,	   2010)	  
(Vogne	  2004,	  Masuda	  1996,	  Rau	  2010).	  Other	  mechanisms	  include	  enzymatic	  degradation	  of	  
the	  antibiotic	  or	  modification	  of	  its	  target.	  Five	  families	  of	  efflux	  pumps,	  most	  of	  those	  in	  P.	  
aeruginosa	   are	   of	   the	   Resistance-­‐Nodulation-­‐Division	   (RND)	   family	   of	   which	   it	   has	   12	  
different	   members.	   These	   three-­‐component	   systems	   differ	   in	   substrate	   spectrum	   and	  
antibiotic	   class	   affinity	   with	   some	   overlap	   between	   them.	   The	   system	   of	   MexAB-­‐OprM	  
encompasses	   a	   broad	   substrate	   spectrum	  and	   is	   strongly	   associated	  with	   the	  high	   intrinsic	  
resistance	  of	  P.	  aeruginosa	   (Poole	  et	  al.,	  1993)	  while	  MexXY-­‐OprM	   is	   involved	   in	   resistance	  
towards	  aminoglycosides	  (Aires	  et	  al.,	  1999).	  A	  third	  system,	  MexCD-­‐OprJ	  is	  especially	  active	  
against	  fluoroquinolones	  (Jalal	  et	  al.,	  2000).	  	  
In	  addition	  P.	  aeruginosa	  contains	  a	  chromosomally	  encoded	  gene	  ampC	  that	  confers	  β-­‐
lactam	   resistance	   and	   mutation	   of	   its	   regulator	   genes	   are	   known	   to	   cause	   high-­‐level	  
resistance	   (Campbell	   et	   al.,	   1997;	   Juan	   et	   al.,	   2005).	   The	   third	   mechanism	   of	   target	  
modification	  is	  observed	  in	  the	  resistance	  towards	  cationic	  antimicrobial	  peptides.	  Resistance	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towards	   these	   can	   be	   increased	   by	   mechanism	   of	   lipid	   A	   modification	   through	   the	   up-­‐
regulation	  of	  the	  arn	  operon	  (Moskowitz	  et	  al.,	  2004).	  	  
	  
5.2.3 Quorum	  sensing	  
Bacterial	  quorum	  sensing	   is	  a	  means	  of	  communication	  between	  cells	  by	  the	  mechanism	  of	  
signal	  molecule	   secretion	   and	   detection.	   Usually,	   upon	   reaching	   a	   critical	   concentration	   of	  
autoinducer	   molecule	   in	   the	   surrounding	   environment	   a	   signal	   molecule	   sensor	   molecule	  
activates	   the	   corresponding	   quorum	   sensing	   (QS]	   regulon.	   Pseudomonas	   aeruginosa	  
possesses	  three	  QS	  systems,	  the	  Las,	  Rhl	  and	  PQS	  systems.	  The	  Las	  and	  Rhl	  systems	  consists	  
of	   the	   autoinducer	   molecules	   3-­‐oxo-­‐C12-­‐HSL	   (Las)	   and	   C4-­‐HSL	   (Rhl)	   and	   their	   cognate	  
sensors,	  LasR	  and	  RhlR	  (Figure	  6).	  	  	  
	  
	  
Figure	  6:	  The	  Las	  and	  Rhl	  quorum	  sensing	  system.	  Included	  are	  the	  response	  regulators,	  
LasR	  and	  RhlR,	  and	  their	  respective	  signal	  molecules.	  Upon	  signal	  molecule	  binding	  the	  
response	  regulator	  activates	  transcription	  of	  target	  genes	  (Jimenez	  et	  al.,	  2012).	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The	  QS	   regulatory	   network	   in	  P.	   aeruginosa	   is	   fairly	   complex	   involving	  multiple	   other	  
regulatory	  proteins	  but	   in	  general	   the	  QS	  systems	  are	  organized	  hierarchically	  with	   the	  Las	  
system	  capable	  of	  regulating	  the	  Rhl	  system	  while	  the	  PQS	  system	  can	  be	  regulated	  by	  both	  
(de	   Kievit	   and	   Iglewski,	   2000;	   Deziel	   et	   al.,	   2004;	   Schuster	   and	   Greenberg,	   2006).	   The	   P.	  
aeruginosa	  QS	   systems	  are	  key	   regulators	  of	   virulence	   factors.	  The	  Las	   system	   is	   known	   to	  
regulate	   several	   proteases	  and	  be	   important	   for	  biofilm	   formation	   (Gambello	   and	   Iglewski,	  
1991;	  Toder	  et	  al.,	  1991)	  while	  numerous	  virulence	  factors	  are	  regulated	  by	  the	  Rhl	  system,	  
e.g.	   rhamnolipid,	   proteases,	   hydrogen	   cyanide,	   pyocyanin	   and	   siderophores	   (Brint	   and	  
Ohman,	  1995;	  Latifi	  et	  al.,	  1995;	  Diggle	  et	  al.,	  2002).	  Consequently,	  the	  QS	  systems	  are	  global	  
regulators	  of	  several	  functions	  normally	  related	  to	  pathogenesis.	  
	  
5.2.4 The	  mucoid	  phenotype	  
Another	   characteristic	   of	   P.	   aeruginosa	   is	   its	   potential	   for	   excessive	   production	   of	   the	  
polysaccharide	  alginate	  by	  mutation,	  as	   is	  often	  seen	   in	   infection	  of	  CF	  patients	   (Deretic	  et	  
al.,	   1995;	   Govan	   and	   Deretic,	   1996;	   Li	   et	   al.,	   2005;	   Rau	   et	   al.,	   2010;	   Yang	   et	   al.,	   2011b).	  
Alginate	   is	   a	   negatively	   charged	   linear	   copolymer	   of	   partially	   O-­‐acetylated	   β-­‐1,4-­‐linked	   D-­‐
mannuronic	  acid	  and	   its	  C5	  epimer,	  α-­‐L-­‐guluronic	  acid	  (Linker	  and	  Jones,	  1966)	  synthesized	  
by	   the	   12	   gene	   alginate	   operon	   (algD	   –	   algA)	   and	   a	   13th	   gene	   algC	   also	   involved	   in	  
rhamnolipid	   biosynthesis.	   The	   precursor	   for	   alginate	   biosynthesis	   is	   fructose	   6-­‐phosphate	  
which	  is	  converted	  into	  GDP-­‐mannuronic	  acid	  that	  is	  polymerized	  and	  further	  processed	  into	  
the	   two	   constituent	   sugar	   residues	   while	   being	   transported	   across	   the	   cell	   membrane	  
(Ramsey	  and	  Wozniak,	  2005)	  (Figure	  7).	  
	  
Synthesis	   is	   regulated	   mainly	   through	   the	   algD	   promoter	   which	   is	   under	   heavy	  
regulation	  of	  several	  regulators,	  e.g.	  AlgT	  (AlgU,	  σ22),	  AlgR,	  AlgB,	  RpoN	  and	  AmrZ	  (Govan	  and	  
Deretic,	  1996;	  Baynham	  et	  al.,	  1999;	  Boucher	  et	  al.,	  2000).	  The	  alternative	  sigma	  factor	  AlgT	  
is	  the	  key	  regulator	  during	  conversion	  to	  the	  mucoid	  phenotype	  and	  its	  corresponding	  gene	  is	  
located	  in	  the	  algT	  operon	  consisting	  of	  algT	  and	  mucABCD	  genes	  (Figure	  8).	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Figure	  7:	  Overview	  of	  alginate	  biosynthesis	  in	  P.	  aeruginosa.	  Colored	  and	  lettered	  objects	  
indicate	  alginate	  biosynthesis	  enzymes.	  O.M.	  and	  I.M.	  correspond	  to	  outer	  and	  inner	  
membrane	  respectively	  (Ramsey	  and	  Wozniak,	  2005).	  
	  
The	  algT	  operon	  is	  autoregulated	  by	  AlgT	  while	  the	  Muc	  proteins	  all	  function	  as	  negative	  
regulators	  of	  AlgT	  and	  alginate	  production	  to	  varying	  extent	  (Boucher	  et	  al.,	  1996;	  Boucher	  et	  
al.,	  1997b;	  Rowen	  and	  Deretic,	  2000).	  MucA	  is	  the	  primary	  negative	  regulator	  and	  mutation	  
of	   the	   gene	   is	   also	   the	  most	   frequent	   cause	   of	   conversion	   to	   the	  mucoid	   phenotype	   in	   CF	  
isolates	   (Govan	   and	  Deretic,	   1996;	   Ciofu	   et	   al.,	   2008)	   although	  mucB	   and	  mucD	  mutations	  
were	  also	   identified	   (Boucher	  et	  al.,	  1997a).	  Mutation	   in	  numerous	  positions	   in	  mucA	  have	  
been	   observed	   although	   certain	   mutated	   alleles	   are	   predominant	   especially	   ΔG430	   and	  
T349C	  constituting	  mutational	  hotspots	  (Bragonzi	  et	  al.,	  2006;	  Ciofu	  et	  al.,	  2008).	  MucA	  is	  the	  
corresponding	   anti-­‐sigma	   factor	   of	   AlgT	   and	   normally	   binds	   and	   sequesters	   AlgT	   at	   the	  
cytoplasmic	   membrane	   hindering	   its	   transcription	   initiation	   (Schurr	   et	   al.,	   1996).	   Upon	  
mutation	   MucA	   is	   cleaved	   from	   the	   membrane	   by	   AlgW	   and	   MucP	   and	   subsequently	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AlgK in order to protect the growing alginate polymer from
degradation by alginate lyase (AlgL) (Jain and Ohman,
1998). Recent evidence suggests that AlgX may be part
of this periplasmic scaffold (Robles-Price et al., 2004).
The role of alginate lyase is not clear, although there is
evidence that alginate is rapidly degraded and varies in
size in mucoid strains that hyperexpress AlgL, lending
support to the hypothesis that alginate lyase might provide
short oligomers that could prime the polymerization reac-
tion (Boyd and Chakrabarty, 1994; Monday and Schiller,
1996). After epimerization, some of the mannuronate res-
idues are acetylated at the O2 and/or O3 positions by the
algF, algJ and algI gene products, which might form a
complex in the membrane that serves as a reaction centre
for O-acetylation (Franklin and Ohman, 2002). The donor
of the acetyl group to AlgI is currently unknown. After O-
acetylation, the copolymer is transported out of the cell
through the outer membrane protein AlgE (Rehm and
Valla, 1997).
Recent structural studies have shed light on the enzy-
matic complexity behind the synthesis of GDP-
mannuronic acid. The algC gene encodes an enzyme with
phosphomannomutase (PMM) and phosphoglucomutase
(PGM) activities, and PMM/PGM catalyses the reversible
conversion of mannose 6-phosphate to mannose 1-
phosphate during alginate biosynthesis (Fig. 2). Interest-
mucB algN Homologous to RseB 
in E. coli
Periplasmic protein that negatively 
regulates AlgT; inactivation leads to 
alginate production
 Goldberg et al. (1993); 
Martin et al. (1993c)
mucC algM Hypothesized inner membrane protein; 
might act synergistically with MucA and 
MucB to  negatively regulate AlgT (AlgU)
Boucher et al. (1997b); 
Mathee et al. (1997)
mucD algY Homologous to serine 
protease DegP (HtrA)
Negatively regulates AlgT by removing 
activating factors (i.e. denatured proteins)
Boucher et al. (1996)
rpoN ntrA, s54 Negative regulator of algD transcription in 
mucA22 background; responsible for 
algD transcription in muc23 background;
responsible for algC transcription
Boucher et al. (2000)
Gene or
protein
Additional
name(s) Structure and/or homology Function Reference(s)
Table 1. cont.
O.M.
E
G
GG M
Alginate
AcAc
M
8 44
G
K
GDP
M
I
J F
X
L
I.M.
Periplasm
-C-CH3
O
Acetyl-Donor (?)
Mannose
6-phosphate
Fructose
6-phosphate
A C
Cytosol GDP-mannuronic acid
GDP-mannose
A D
Mannose
1-phosphate
Fig. 2. Model for the biosynthesis and assem-
bly of alginate in P. aeruginosa. The illustration 
shown is a summary of recently published data 
concerning the localization of alginate biosyn-
thetic enzymes within the cell (Franklin and 
Ohman, 2002; Gimmestad et al., 2003; Robles-
Price et al., 2004). Letters A–X and numbers 8 
and 44 indicate alginate biosynthetic enzymes 
(A for AlgA, etc.). I.M. and O.M. represent inner 
and outer membrane respectively. The letters G 
and M are for guluronate or mannuronate 
respectively. ‘Ac’ stands for an acetyl group. 
Portions of this figure have been reproduced 
with permission from the following sources: 
Franklin and Ohman (2002); Gimmestad et al. 
(2003); copyright American Society for 
Microbiology.
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degraded	   by	   ClpXP	   liberating	   AlgT	   activating	   algT	   operon	   transcription	   causing	   further	  
synthesis	  of	  de-­‐regulated	  AlgT	  (Qiu	  et	  al.,	  2007;	  Qiu	  et	  al.,	  2008).	  
	  
	  
Figure	  8:	  AlgT	  regulation	  of	  the	  alginate	  biosynthesis	  operon	  and	  downstream	  
regulators.	  AlgT	  can	  activate	  transcription	  of	  a	  number	  of	  genes,	  e.g.	  the	  algD	  operon,	  algC,	  
algR,	  algB	  while	  being	  regulated	  by	  proteins	  such	  as	  MucA,	  MucB,	  AlgW.	  Arrows	  indicate	  
positive	  regulation	  while	  blunt-­‐ended	  lines	  indicate	  negative	  regulation	  (Sautter	  et	  al.,	  
2012).	  
	  
De-­‐regulating	   AlgT	   has	   profound	   pleiotropic	   effects	   on	   the	   cell	   as	   its	   regulon	   is	  
extensive.	  This	   is	   largely	  helped	  by	   its	  direct	   regulation	  of	   several	   regulatory	  genes	   such	  as	  
algR,	  algB	  and	  amrZ	  (Goldberg	  and	  Dahnke,	  1992;	  Wozniak	  and	  Ohman,	  1994;	  Wozniak	  et	  al.,	  
2003).	  The	  most	  renowned	  effect	  of	  AlgT	  activation	  is	  the	  increased	  transcription	  of	  the	  algD	  
promoter	   leading	   to	   alginate	   overproduction	   however	   recently	   it	   was	   evidenced	   by	  
transcriptome	   and	   phenotype	   analysis	   that	   the	   AlgT	   regulon	   also	   includes	   genes	   encoding	  
virulence	  factors,	  the	  Rhl	  quorum	  sensing	  system,	  motility	  and	  possibly	  osmotic	  stress	  (Rau	  et	  
al.,	   2010).	   Examining	   a	  mucoid	   clinical	   isolate,	  mucA	  mutation	  was	   shown	   to	   cause	   down-­‐
regulation	   of	   pyoverdin,	   hydrogen	   cyanide,	   rhamnolipid,	   the	   Type	   III	   secretion	   system,	  
flagella	   and	   pili	   while	   putative	   osmotic	   stress	   genes	   were	   up-­‐regulated	   (Rau	   et	   al.,	   2010).	  	  
Although	   a	   previous	   transcriptome	   study	   (Firoved	   and	   Deretic,	   2003)	   on	   the	   pleiotropic	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effects	   of	  mucA	   mutation	   yielded	   different	   results,	   the	   above	   is	   corroborated	   by	   several	  
experimental	  findings	  (Garrett	  et	  al.,	  1999;	  Lizewski	  et	  al.,	  2004;	  Wu	  et	  al.,	  2004b;	  Tart	  et	  al.,	  
2006;	  Morici	  et	  al.,	  2007;	  Jones	  et	  al.,	  2010).	  	  
Apart	   from	   the	   direct	   regulation	   by	   AlgT	   as	   observed	   for	   the	   alginate	   biosynthesis	  
operon	   and	   several	   regulatory	   proteins	   most	   of	   the	   pleiotropic	   effects	   are	   likely	   indirect	  
through	  e.g.	  AlgR,	  AlgB	  and	  AmrZ.	  AlgR	  is	  e.g.	  known	  to	  have	  binding	  sites	  upstream	  of	  rhlI,	  
part	  of	   the	   rhl	  QS	   system	  by	  which	  many	  of	   the	  mentioned	  virulence	   factors	  are	   regulated	  
(Morici	   et	   al.,	   2007).	   AlgT	   has	   high	   homology	   to	   σE	   of	   Escherichia	   coli	   and	   Salmonella	  
Typhimurium	   (DeVries	   and	   Ohman,	   1994)	   a	   sigma	   factor	   known	   to	   be	   important	   for	  
pathogenesis	   and	   various	   environmental	   stresses	   (Rowley	   et	   al.,	   2006).	   For	   persistent	   P.	  
aeruginosa	   infection	   of	   CF	   patients	   this	   is	   especially	   true.	   The	   linkage	   of	   virulence	   factors,	  
quorum	   sensing,	   oxidative	   stress	   response	   and	   possibly	   osmotic	   stress	   response	   to	   one	  
regulon	  explains	  why	  this	  regulon	  is	  so	  frequently	  targeted	  for	  activation	  in	  the	  CF	  lung.	  
	  
5.3 The	  P.	  aeruginosa	  genome	  –	  a	  dynamic	  genome	  
The	   genome	   of	   P.	   aeruginosa	   as	   a	   species	   is	   best	   described	   as	   a	   mosaic	   genome	   with	   a	  
conserved	   core	   present	   in	   all	  P.	   aeruginosa	   strains	   and	   an	   accessory	   genome	   consisting	   of	  
strain-­‐specific	  elements	   from	  other	   species	  or	  genera.	  These	  elements	  are	  dispersed	   in	   the	  
genome	  at	  a	  limited	  number	  of	  loci,	  often	  described	  as	  regions	  of	  genomic	  plasticity	  (Mathee	  
et	  al.,	  2008;	  Klockgether	  et	  al.,	  2011).	  	  
	  
5.3.1 The	  accessory	  genome	  
The	   accessory	   genome	   of	   P.	   aeruginosa	   consists	   of	   different	   element	   types,	   such	   as	  
integrative	   conjugative	   elements	   (ICEs),	   replacement	   islands,	   prophages	   and	   transposons.	  
The	   group	   of	   ICEs	   are	   self-­‐transmissible	   genomic	   islands	   transferred	   between	   strains	   by	  
conjugation	  while	  integration	  into	  the	  recipient	  genome	  is	  phage	  integrase	  mediated	  (Burrus	  
et	  al.,	  2002).	  These	  elements	  can	   further	  exist	  as	  circular	  extra-­‐chromosomal	  elements	  and	  
are	   composed	   of	   a	   conserved	   backbone	   and	   individual	   cargo	   genes	   (Wurdemann	   and	  
Tummler,	  2007).	  Sizes	  range	  between	  81	  to	  108	  kbp	  (Kung	  et	  al.,	  2010).	  One	  family	  of	   ICEs	  
are	   the	   pKLC102-­‐related	   family	   comprising	   a	   highly	   prevalent	   family	   among	   P.	   aeruginosa	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strains	   (Klockgether	  et	  al.,	  2011).	  Apart	   from	  pKLC102	  these	   include	  e.g.	  PAPI-­‐1	  and	  PAGI-­‐5	  
conferring	  pathogenic	  traits	  (Figure	  9)	  (He	  et	  al.,	  2004;	  Battle	  et	  al.,	  2009).	  	  
	  
	  
Figure	   9:	   Comparison	   of	   three	   ICEs	   belonging	   to	   the	   pKLC102	   family.	   The	   ICEs	   share	  
modules	  involved	  in	  different	  processes,	  e.g.	  integration	  (I),	  maintenance	  (M)	  and	  transfer	  
(T).	  Grey	  lines	  indicate	  similar	  sequence	  (Kung	  et	  al.,	  2010).	  	  
	  
Genes	   encoding	   several	   virulence	   factors,	   i.e.	   LPS	   O-­‐antigen,	   pyoverdine,	   pili	   and	  
flagella,	   are	   termed	   replacement	   islands	   as	   these	   loci	   have	  been	  horizontally	   acquired	   and	  
display	   high	   sequence	   diversity	   between	   P.	   aeruginosa	   strains	   (Smith	   et	   al.,	   2006).	   The	  
evolutionary	  rationale	  behind	  the	  high	  diversity	   is	   likely	  related	  to	  the	  insurance	  hypothesis	  
for	  the	  general	  P.	  aeruginosa	  population	  to	  evade	  host	  immune	  systems	  and	  to	  resist	  phage	  
predation.	   It	   is	  believed	   that	  most	  P.	  aeruginosa	   strains	  can	  be	   lysogenized	  by	  at	   least	  one	  
temperate	  phage,	  of	  which	   there	  exists	  more	   than	  sixty	  members	  capable	  of	  P.	  aeruginosa	  
infection	   (Akhverdian	   et	   al.,	   1984;	   Kung	   et	   al.,	   2010).	   Prophages	   can	   bestow	   the	   recipient	  
organism	  with	  beneficial	  functions,	  e.g.	  prophage	  D3	  causes	  sero-­‐conversion	  of	  the	  recipient	  
by	  O-­‐antigen	  alteration,	  putatively	  providing	  advantageous	  in	  a	  host	  setting	  (Vaca-­‐Pacheco	  et	  
al.,	   1999;	   Newton	   et	   al.,	   2001).	   Likewise	  P.	   aeruginosa	   transposons	   can	   provide	   beneficial	  
functions,	   among	   these	   the	   insertion	   of	   antibiotic	   resistance	   cassettes	   (Kung	   et	   al.,	   2010).	  
Consequently,	   accessory	  elements	  play	  pivotal	   roles	   for	   the	  adaptation	  of	  P.	  aeruginosa	   to	  
existing	  habitats	  but	  are	  equally	   important	   for	  niche	  expansion.	   In	  CF	   infection	   their	   role	   is	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less	   explored	   however	   some	   findings	   have	   revealed	   their	   importance.	   The	   sequenced	   CF	  
isolate	  P.	  aeruginosa	  LESB58	  carries	  several	  prophage	  clusters	  and	  genomic	  islands	  of	  which	  
genes	   from	   four	  prophage	   regions	  and	  one	  genomic	   island	  conferred	   increased	   fitness	   in	  a	  
chronic	  rat	  lung	  infection	  model	  (Winstanley	  et	  al.,	  2009).	  	  
	  
5.3.2 Genetic	  adaptation	  during	  CF	  infection	  
Pseudomonas	  aeruginosa	  is	  thought	  to	  be	  ubiquitous	  to	  aquatic	  and	  terrestrial	  environments	  
and	   is	   therefore	   highly	   adapted	   to	   life	   in	   these	   environments.	   Even	   though	   its	   versatility	  
allows	  it	  to	  be	  an	  opportunistic	  pathogen	  capable	  of	  causing	  a	  range	  of	  human	  infections	  it	  is	  
not	  a	  host	  environment	  specialist.	  Consequently,	  a	  host	  associated	   life	  style	  spanning	  up	  to	  
several	  years	  would	  be	  expected	  to	  be	  associated	  with	  genetic	  adaptation	  towards	  becoming	  
a	   specialist	   in	   the	   host	   environment.	   Before	   the	   advent	   of	   readily	   accessible	   genome	  
sequencing,	   phenotypic	   studies	   of	   P.	   aeruginosa	   CF	   isolates	   also	   revealed	   a	   multitude	   of	  
changes	   at	   the	   phenotypic	   level	   during	   infection	   and	   in	   recent	   years	   whole	   genome	  
sequencing	   of	   CF	   isolates	   have	   provided	   a	   more	   comprehensive	   overview	   of	   the	   level	   of	  
genetic	   adaptation	   occurring	   in	   the	   transition	   from	   an	   environmental	   life	   style	   to	   host	  
association.	   In	   order	   to	   understand	   this	   process	   it	   is	   important	   to	   be	   aware	   of	   what	   the	  
adaptation	   is	   towards,	   i.e.	   the	   immune	   response,	   extensive	   antibiotic	   administrations	   in	  
addition	   to	   a	   different	   nutritional	   composition	   and	   much	   adaptation	   would	   therefore	   be	  
expected	  to	  be	  directed	  towards	  these	  components.	  	  
Some	   of	   the	   earliest	   observations	   of	   adaptation	   are	   the	   frequent	   loss	   of	   virulence	  
factors.	   Although	   these	   have	   great	   importance	   for	   enabling	   acute	   infections	   the	   reverse	  
seems	  to	  be	  the	  case	  for	  proliferation	  in	  the	  CF	  lung.	  Indeed,	  in	  this	  environment	  they	  seem	  
to	   be	   selected	   against.	   This	   concerns	   especially	   the	   trait	   of	   motility	   mediated	   by	   loss	   of	  
function	   of	   pilin	   and	   flagellar	   systems	   (Mahenthiralingam	   et	   al.,	   1994;	   Yang	   et	   al.,	   2011a),	  
alteration	  of	  LPS	  by	  loss	  of	  B	  band	  O-­‐antigen	  (Goldberg	  and	  Pler,	  1996)	  as	  well	  as	  the	  loss	  of	  
virulence	  factors	  such	  as	  proteases,	  phenazines,	  pyocins,	  siderophores	  and	  Type	  III	  secretion	  
systems	  (Luzar	  and	  Montie,	  1985;	  Jain	  et	  al.,	  2004;	  Hogardt	  et	  al.,	  2007;	  Yang	  et	  al.,	  2011a).	  
Often	  this	  is	  mediated	  by	  inactivation	  of	  QS	  systems	  especially	  by	  lasR	  mutation	  (Smith	  et	  al.,	  
2006)	  which	  additionally	  provides	  a	  growth	  advantage	  on	  certain	  amino	  acids	  (D'Argenio	  et	  
al.,	  2007).	  The	  external	  nature	  of	  the	  virulence	  factors	  renders	  them	  highly	  immunogenic	  and	  
their	   loss	  was	  therefore	  proposed	  as	  an	  adaptation	  mechanism	  for	   immune	  system	  evasion	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(Nguyen	   and	   Singh,	   2006).	   Another	   mechanism	   of	   this,	   is	   the	   excessive	   production	   of	  
alginate,	   a	   hallmark	   of	   CF	   lung	   adaptation.	   Alginate	   overproduction	   can	   confer	   increased	  
protection	   against	   the	   immune	   system	   in	   several	   ways:	   By	   masking	   complement	   and	  
antibodies	   on	   the	   bacterial	   cell	   surface	   thereby	   preventing	   their	   subsequent	   phagocytosis,	  
avoiding	  non-­‐opsonic	  phagocytosis	  by	  neutrophils	  and	  macrophages	  and	  by	  functioning	  as	  an	  
efficient	  scavenger	  of	   reactive	  oxygen	   intermediates	  released	  by	  PMNs	  (Cabral	  et	  al.,	  1987;	  
Govan	  and	  Deretic,	  1996;	  Mathee	  et	  al.,	  1999).	  	  
The	   selective	   pressure	   from	   frequent	   antibiotic	   administration	   is	   reflected	   in	   the	  
increased	  antibiotic	  resistance	  observed	  in	  persisting	  CF	  isolates.	  These	  mechanisms	  include	  
the	  mutational	  overexpression	  of	  efflux	  pumps	  such	  as	  MexXY	  for	  aminoglycoside	  resistance	  
(Vogne	  et	  al.,	  2004),	  MexCD-­‐OprJ	  for	  fluoroquinolone	  resistance	  (Jalal	  et	  al.,	  2000;	  Jeannot	  et	  
al.,	  2008)	  or	  altered	  lipid	  A	  composition	  for	  cationic	  antimicrobial	  peptide	  resistance	  (Ernst	  et	  
al.,	  1999;	  Moskowitz	  et	  al.,	  2004),	  gyrase	  mutations	  for	  fluoroquinolone	  resistance	  (Kureishi	  
et	   al.,	   1994;	   Yang	   et	   al.,	   2011b)	   and	   increased	   ampC	   expression	   for	   β-­‐lactam	   resistance	  
(Giwercman	   et	   al.,	   1990).	  Most	   frequently	   the	  molecular	  mechanism	   facilitating	   increased	  
resistance	  is	  by	  regulator	  mutations,	  a	  common	  theme	  in	  P.	  aeruginosa	  adaptation	  to	  the	  CF	  
lung.	   Increased	   resistance	   towards	   the	   different	   classes	   of	   antibiotics	   administered	   to	   CF	  
patients	   is	   part	   of	   the	   inherent	   genetic	   potential	   of	   P.	   aeruginosa	   and	   one	   of	   the	   major	  
reasons	  it	  is	  the	  main	  cause	  of	  morbidity	  and	  mortality	  for	  CF	  patients.	  Most	  other	  organisms	  
do	   not	   possess	   a	   comparable	   resistance	   repertoire	   and	   indeed	   before	   commencing	   an	  
aggressive	   antibiotic	   treatment	   strategy	   the	   main	   pathogen	   of	   CF	   patients	   was	  
Staphylococcus	  aureus.	  	  
Pseudomonas	  aeruginosa	   infection	  of	  CF	  patients	   is	  also	  associated	  with	  development	  
of	   the	   so-­‐called	   small	   colony	   variant	   (SCV)	  phenotype	   characterized	  by	   an	   increased	  ability	  
for	  biofilm	  formation,	  an	  important	  trait	  in	  CF	  infection	  (Høiby	  et	  al.,	  2010).	  As	  implied	  by	  the	  
name	   these	   variants	   have	   a	   certain	   (small)	   colony	  morphology	   and	   have	   been	   found	   for	   a	  
multitude	   of	   species	   isolated	   from	   various	   infections	   (Proctor	   et	   al.,	   2006).	   Unlike	   some	  
species,	  this	  term	  comprises	  a	  somewhat	  heterogeneous	  collection	  of	  characteristics	  among	  
P.	   aeruginosa	   isolates.	   Consistent	   characteristics	   include	   an	   autoaggregative	   behaviour	  
coupled	   with	   increased	   biofilm	   formation	   (Haussler,	   2004)	   while	   increased	   motility	   by	  
hyperpiliation	  and	  increased	  antibiotic	  resistance	  are	  frequent	  as	  well	  (Haussler	  et	  al.,	  2003;	  
Starkey	  et	  al.,	  2009).	  The	  molecular	  mechanism	  is	  thought	  to	  occur	  via	  overexpression	  of	  cup	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genes	   encoding	   fimbrial	   adhesin	   leading	   to	   autoaggregation	   (Vallet	   et	   al.,	   2001)	   while	  
overexpression	  of	  pel	  and	  psl	  polysaccharides	  have	  been	  implicated	  in	  the	  biofilm	  formation	  
of	  the	  special	  rugose	  SCV	  variant	  (Figure	  10)	  (Starkey	  et	  al.,	  2009).	  	  
	  
	  
Figure	  10:	  Example	  of	  auto-­‐aggregation	  and	  subsequent	  clumping	  of	  a	  rugose	  SCV	  on	  the	  
left.	  The	  reaming	  tubes	  are	  rugose	  SCV	  psl	  gene	  mutants	  and	  consequently	  less	  aggregative	  
(Starkey	  et	  al.,	  2009).	  
	  
The	  presence	  of	  SCVs	  are	  correlated	  with	  poor	  lung	  function	  (Haussler	  et	  al.,	  1999)	  and	  
their	   presence	   is	   likely	   due	   to	   increased	   biofilm	   formation	   capability	   providing	   protection	  
towards	  the	  immune	  system	  and	  antibiotics.	  	  
Compared	   to	   aquatic	   or	   terrestrial	   environments	   the	   CF	   lung	   provides	   abundant	  
nutrients.	   High	   concentrations	   of	   free	   amino	   acids,	   glucose	   and	   lactic	   acid	   have	   been	  
reported	  although	  amino	  acids	  were	  preferentially	   catabolized	  over	   lactic	   acid	   and	  glucose	  
(Barth	  and	  Pitt,	  1996;	  Palmer	  et	  al.,	  2007).	  The	  significance	  of	  amino	  acid	  catabolism	  in	  the	  CF	  
lung	   is	  also	  demonstrated	  by	  amino	  acid	  auxotrophy	  among	  clinical	   isolates	   (Thomas	  et	  al.,	  
2000)	  and	  the	  up-­‐regulation	  of	  the	  atu	  operon	  mediating	  an	  increased	  growth	  rate	  on	  leucine	  
and	   likely	   other	   branched	   chain	   amino	   acids.	   In	   addition	   up-­‐regulation	   of	   the	   glyoxylate	  
shunt,	  observed	  in	  several	  clinical	  isolates	  (Lindsey	  et	  al.,	  2008;	  Yang	  et	  al.,	  2011a),	  seems	  to	  
be	   adaptive,	   possibly	   by	   mediating	   increased	   hydrogen	   cyanide	   production	   (Hagins	   et	   al.,	  
2009).	   Although	   metabolic	   adaptation	   ought	   to	   be	   important	   when	   entering	   a	   new	  
environment	  knowledge	  on	   this	   area	  of	  P.	  aeruginosa	   adaptation	   to	   the	  CF	   lung	   is	   limited.	  
One	   explanation	   is	   that	  most	   studies	   have	   focused	   on	   the	   two	  major	   selective	   forces,	   the	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immune	   system	   and	   antibiotics,	   and	   studies	   focused	   on	  metabolic	   adaptation	   solely	   could	  
provide	   more	   clues.	   Yet,	   increased	   growth	   rate	   is	   unlikely	   to	   be	   a	   key	   parameter	   in	   the	  
adaptation	  since	  clinical	   isolates	  are	  commonly	  observed	  to	  have	  decreased	   in	  vitro	  growth	  
rates	  (Head	  and	  Yu,	  2004;	  Yang	  et	  al.,	  2008)	  a	  likely	  secondary	  effect	  of	  adaptation	  towards	  
e.g.	  the	  immune	  system	  and	  antibiotics.	  	  Consequently,	  any	  metabolic	  changes	  observed	  for	  
CF	   isolates	  need	  not	  confer	  advantages	   in	  nutrient	  utilization	  but	  could	  also	  be	  selected	  by	  
providing	  improved	  tolerance	  towards	  the	  other	  stress	  factors	  present	  in	  the	  CF	  lung.	  
One	   frequently	   evolved	   trait	   of	   CF	   lung	   isolates	   is	   the	   trait	   of	   hypermutability.	  
Considering	  the	  major	  divergent	  selection	  pressures	  existing	  in	  the	  CF	  lung	  and	  the	  extensive	  
genetic	  adaptation	  the	  persisting	  bacteria	  are	  subject	  to,	  this	  finding	  might	  not	  be	  surprising.	  
The	   mechanism	   of	   increased	   mutation	   rate	   is	   most	   frequently	   by	   inactivation	   of	   the	  
mismatch	   repair	   (MMR)	   system	   conferring	   100-­‐1000	   fold	   increases	   in	   mutation	   rates	  
(Hogardt	   and	   Heesemann,	   2012)	   while	   inactivation	   of	   the	   guanine	   8-­‐oxo-­‐2-­‐deoxyguanine	  
(GO)	   system	   confers	   a	   weak	   mutator	   phenotype	   and	   is	   only	   occasionally	   observed	  
(Mandsberg	  et	  al.,	  2009;	  Ciofu	  et	  al.,	  2010).	  Mutators	  have	  been	  associated	  with	  an	  increased	  
rate	  of	  especially	  antibiotic	  resistance	  generation	  but	  also	  faster	  generation	  of	  other	  types	  of	  
adaptive	  mutations	  (Oliver	  et	  al.,	  2000;	  Hogardt	  et	  al.,	  2007;	  Mena	  et	  al.,	  2008).	  Apart	  from	  
the	  effect	  of	  selection	  pressures	  mutator	  phenotypes	  are	  also	  believed	  to	  arise	  through	  the	  
oxidative	  stress	  conditions	  present	  in	  the	  CF	  lung	  by	  the	  liberation	  of	  reactive	  oxygen	  species	  
by	  PMNs	  (Ciofu	  et	  al.,	  2005).	  
	  
5.3.3 Evolutionary	  dynamics	  of	  infecting	  lineages	  
Global	  phenotypic	  and	  genetic	  analyses	  on	  clonal	  longitudinal	  isolates	  have	  provided	  valuable	  
insight	   into	   the	   dynamics	   of	   evolution	   during	   CF	   lung	   infection.	   Transcriptional	   analysis	   of	  
longitudinal	  isolates	  of	  three	  infecting	  lineages	  found	  evidence	  of	  parallel	  evolution	  between	  
these	  as	  24	  genes	  were	  differentially	  expressed	   in	   the	  same	  direction	   in	   the	   three	   lineages	  
while	   parallelism	  of	   gene	   expression	  between	   any	   two	   lineages	  was	   86	   genes	   (Huse	   et	   al.,	  
2010).	  The	  majority	  of	  total	  differential	  gene	  expression	  (684	  genes)	  was	  however	  dissimilar	  
(Figure	  11)	  and	  although	  many	  phenotypes	  are	  frequent	  among	  CF	  isolates,	  vast	  evolutionary	  
diversity	   is	  also	  seems	  to	  be	  present	  when	  comparing	  the	  results	  of	  other	  global	  studies	  on	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CF	  isolate	  evolution	  (Smith	  et	  al.,	  2006;	  Hoboth	  et	  al.,	  2009;	  Rau	  et	  al.,	  2010;	  Cramer	  et	  al.,	  
2011;	  Yang	  et	  al.,	  2011b).	  
	  
	  
Figure	  11:	  Common	  and	  distinct	  gene	  expression	  changes	  between	  three	  CF	  lineages,	  A,	  B	  
and	  Cb.	  +	  and	  –	  indicate	  up	  or	  downregulation	  respectively	  (Huse	  et	  al.,	  2010).	  
	  
One	  generally	  interesting	  aspect	  of	  P.	  aeruginosa	  CF	  infection	  is	  the	  temporal	  dynamics	  
of	   the	   rate	  of	   evolution.	  Mutation	   rates	   can	  provide	  accurate	  measurements	  of	   this	   at	   the	  
genome	  level	  however	  what	   is	  at	   least	  equally	   interesting	   is	  the	  rate	  on	  a	  phenotypic	   level.	  
Analyzing	   transcriptome	   and	   global	   catabolic	   function	   over	   time	   of	   a	   long-­‐term	   infecting	  
lineage,	  the	  DK2	  clone,	  revealed	  that	  the	  most	  substantial	  phenotypic	  changes	  occur	  initially	  
(a	  few	  years)	  with	  limited	  phenotypic	  change	  thereafter	  (Yang	  et	  al.,	  2011b).	  Conversely,	  the	  
rate	  of	  genomic	  evolution	  of	  the	  DK2	  clone,	  based	  on	  single	  nucleotide	  polymorphism	  (SNP)	  
analysis,	   remained	   quite	   constant	   and	   approximated	   linearity	   during	   infection.	   The	   limited	  
phenotypic	   change	   was	   a	   likely	   effect	   of	   negative	   selection,	   based	   on	   the	   ratio	   of	  
synonymous	  to	  non-­‐synonymous	  substitutions,	  observed	  in	  the	  later	  stages	  but	  not	  initially.	  
Consequently,	   genetic	   drift	   was	   the	   main	   mechanism	   of	   evolution	   in	   the	   later	   stage	  
correlating	  well	  with	  the	  observed	  limited	  phenotypic	  change.	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5.3.4 Horizontal	  gene	  transfer	  
Niche	   adaptation	   for	   P.	   aeruginosa	   can	   be	   facilitated	   by	   mechanism	   of	   HGT	   by	   acquiring	  
accessory	  elements	  enhancing	  fitness	  in	  vacant	  niches.	  A	  sequenced	  P.	  aeruginosa	  strain	  e.g.	  
contained	  a	  genomic	  island	  encoding	  enzymes	  for	  the	  degradation	  of	  terpenoids	  produced	  by	  
trees	   likely	  conferring	   increased	  fitness	   in	  a	  very	  specific	  niche	  (Mathee	  2008).	  Additionally,	  
accessory	  elements	  of	  P.	  aeruginosa	  are	  known	  to	  confer	   increased	  resistance	  towards	  e.g.	  
heavy	   metals	   (Aguilar-­‐Barajas	   et	   al.,	   2010).	   Likely	   these	   processes	   contribute	   to	   the	   high	  
versatility	   observed	   for	   P.	   aeruginosa,	   its	   proliferation	   in	   diverse	   habitats	   and	   ubiquitous	  
presence	  in	  the	  environment	  however	  their	  relevance	  for	  P.	  aeruginosa	  adaptation	  to	  the	  CF	  
lung	  has	  been	  less	  studied.	  
	  	  
One	   likely	  mechanism	  of	  HGT	  within	   the	  CF	   lung	  would	  be	   spread	  of	   genetic	  material	  
between	  microbes	  through	  transduction.	  Phages	  can	  exert	  significant	   influence	  on	  bacterial	  
communities	   through	   e.g.	   spread	   of	   fitness	   enhancing	   genetic	   elements	   or	   through	  
predation,	   also	   known	   as	   top-­‐down	   control	   (Rodriguez-­‐Valera	   et	   al.,	   2009).	   Systematic	  
studies	  of	  phage	   influence	  and	  presence	   in	   the	  CF	   lung	  are	   limited	  although	   recent	   studies	  
have	   shed	  more	   light	  on	   this	   subject.	  One	   study	   found	   that	   the	  CF	   lung	   contains	   an	  active	  
phage	  population	  with	  a	  slightly	   lower	  diversity	  in	  CF	  patients	  compared	  to	  non-­‐CF	  patients	  
(Willner	   et	   al.,	   2009).	   The	   phage	   community	   of	   CF	   patients	   was	   enriched	   for	   sequence	  
involved	   in	   especially	   carbohydrate	   and	   amino	   acid	  metabolism,	   alginate	   biosynthesis	   and	  
virulence	   factors	   leading	   to	   suggestions	   of	   phages	   participating	   in	   the	   microbial	  
diversification	   in	   the	   CF	   lung	   (Willner	   and	   Furlan,	   2010).	   Investigating	   the	   spatial	  
heterogeneity	  of	  phage	  in	  explant	  lungs	  and	  post-­‐mortem	  acquired	  lungs	  from	  two	  patients	  
further	   revealed	   phage	   sequence	   encoding	   the	   SCV	   phenotype	   and	   antibiotic	   resistance	   in	  
post-­‐mortem	   lungs.	   However,	   explanted	   lungs	   contained	   no	   bacteriophages	   in	   the	   highly	  
diseased	   regions	   of	   the	   lungs	   indicating	   escape	   from	   phage	   predation	   by	   the	   microbial	  
population	  here	   (Willner	  et	  al.,	  2012).	  As	  CF	  patients	   from	  Willner	  et	  al.	   (2009)	  had	  severe	  
airway	   obstruction,	   indicating	   severe	   chronic	   infection,	   infection	   stage	   differences	   do	   not	  
seem	   to	   influence	   the	   observed	  differences	   in	   diversity.	   Escape	   from	  phage	  predation	  was	  
further	   indicated	   in	   the	   evolution	   of	   the	   DK2	   lineage	   over	   35	   years	   in	   several	   patients,	  
without	   the	   apparent	   detection	   of	   any	   prophage	   entry	   (one	   putative	   entry	   was	   detected)	  
(Rau	   et	   al.,	   in	   preparation).	   Consequently,	   the	   importance	   of	   HGT	   for	   P.	   aeruginosa	  
adaptation	  to	  the	  CF	  lung	  seems	  limited	  as	  acquisition	  of	  novel	  DNA	  in	  the	  highly	  successful	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DK2	   lineage	   was	   non-­‐existent	   or	   at	   least	   very	   limited	   during	   CF	   infection	   (Rau	   et	   al.,	   in	  
preparation).	  The	  intrinsic	  potential	  for	  increased	  fitness	  towards	  the	  stresses	  of	  the	  CF	  lung	  
could	   explain	   the	   apparent	   insignificance	   of	   HGT	   adaptation	   in	   this	   niche	   or	   could	   be	   a	  
reflection	   of	   e.g.	   the	   lack	   of	   external	   beneficial	   DNA	   or	   increased	   P.	   aeruginosa	   phage	  
resistance.	  
Two	   processes	   of	   bacterium-­‐phage	   co-­‐evolution	   are	   known	   to	   occur,	   fluctuating	  
selection	  and	  the	  arms	  race	  process	  (Figure	  12).	  	  
	  
	  
Figure	  12:	  Model	  of	  fluctuating	  selection	  during	  bacterium-­‐phage	  co-­‐evolution.	  An	  increase	  
of	  a	  certain	  bacterial	  genotype	  is	  followed	  by	  an	  increase	  of	  a	  phage	  genotype	  particularly	  
effective	  at	  predating	  the	  bacterial	  genotype,	  which	  is	  subsequently	  killed	  giving	  rise	  to	  a	  
new	  bacterial	  genotype	  (Willner	  and	  Furlan,	  2010).	  	  
	  
Arms	   race	   is	   characterized	   by	   increased	   phage	   infectivity	   and	   increased	   bacterial	  
resistance	  over	  time	  while	  fluctuating	  selection	  is	  characterized	  by	  fluctuation	  in	  the	  fitness	  
of	   different	   bacterial	   or	   phage	   genotypes,	   e.g.	   bacteria	   are	   more	   resistant	   to	   the	  
contemporary	   phage	   genotype	   than	   to	   previous	   or	   future	   phage	   genotypes.	   The	   apparent	  
lack	  of	  phage	  predation	  in	  explant	  lungs	  observed	  by	  Willner	  et	  al.	  (2012)	  indicates	  an	  arms	  
race	   process	   in	   this	   specific	   scenario.	   Increased	   bacterial	   resistance	   in	   an	   arms	   race	  
theoretically	   leads	   to	   increased	  costs	  while	  costs	   in	   fluctuating	  selection	  should	  be	  smaller.	  
Actual	   fitness	   costs	   seem	   to	   depend	   on	   condition	   as	   any	   increase	   in	   resistance	   in	   a	   soil	  
environment	   came	   at	   a	   relatively	   high	   cost	   leading	   to	   fluctuating	   selection	   (Gomez	   and	  
Buckling,	   2011)	   while	   no	   cost	   was	   observed	   in	   nutrient-­‐rich	   laboratory	  media	   enabling	   an	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abundance of its phage predators, leading 
to increased killing of the successful host 
(the “winner”).28 This allows another 
host population to rise in abundance and 
continue the cycle, and also maintains 
less dominant hosts in the community.28 
“Kill-the-Winner” dynamics have been 
shown to operate at the strain level in 
aquatic environments, thus maintaining 
a dynamic equilibrium where hosts do 
not change at the species level.29 Similar 
dynamics might be expected to operate 
in the CF airway where a small number 
of species are thought to dominate, and 
intra-species diversity is high.30
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as a se ond significant mechanism of top-
d wn control.26,27 PMNs nd clincally 
administered antibiotics can be thought 
of as analogues to protozoan grazers in the 
CF airway. By providing genes which aid 
in biofilm formation, antibiotic resistance, 
and avoidance of PMNs as seen in the CF 
phage core metabolic profile, phage could 
ensure exclusive access to their susceptible 
hosts. Microbes are also subject to nutri-
ent limitations (i.e., bottom-up controls), 
and adaptations which allow escape from 
phage predation may incur a metabolic 
cost or force microbes into novel meta-
bolic states. For example, bacteria may 
downregulate or even abolish expression 
of specific cell surface receptors leading 
to a decrease in phage adsorption. The 
intended ligand of the receptor may be a 
specific carbon source or other nutrient, 
thus in gaining phage resistance, bacteria 
may shift their metabolic profiles.
The results of the original study and 
the core CF phage metabolic profile 
presented here indicate the importance 
of phage-encoded functional genes in 
microbial adaptations to the CF air-
way. Phage metabolisms reflect essen-
tial host metabolisms and suggests that 
phage drive microbial diversification 
through lateral gene transfer and preda-
tion as observed in other environments. 
However, the nature of phage-host inter-
actions remains largely unknown. Phage 
and microbes in natural systems often 
follow an oscillatory “Kill-the-Winner” 
model (Fig. 2). In this model, an increase 
in abundance of a host population is fol-
lowed by a corresponding increase in the 
access ry genome.13-18 This acc ssory 
genome contains genes for antibiotic resis-
tance s well s novel functions allowing 
rapid and efficient adaptation to growth 
in the respiratory tract, many of which are 
encoded in labile prophage elements.13-15,18 
Antibiotics induce prophage in S. aureus 
and most likely in other microbes, and 
may heighten the ability of phage to act 
as major agents of gene flow in CF micro-
bial infections.15,19 Phage also have been 
shown to modulate phenotypic differ-
ences in P. aeruginosa colonies and asso-
ciated biofilms, leading to the emergence 
of highly virulent small colony variants.20 
Comparison of the CF phage metabolic 
profile with the P. aeruginosa core metabo-
lism supports these previous findings. Our 
results suggest that CF-associated phage 
carry a critical set of functions derived 
from core host genes, while also providing 
an additional set of functions which hosts 
can incorporate through lateral gene trans-
fer, thus leading to host diversification.
Phage can also drive host diver-
sity and control microbial populations 
through predation.21 Top-down control 
of microbes by phage has been demon-
strated in aquatic and terrestrial environ-
ments, but the role of indigenous phage in 
controlling microbial populations in the 
CF lung is unknown.22,23 The exopoly-
saccharide layer surrounding microbial 
biofilms in the CF airway has been sug-
gested as a significant barrier to phage 
infection, however, phage have adapted 
mechanisms to decrease polysaccharide 
viscosity, allowing for predation.24,25 In 
marine systems, protozoan grazing serves 
Figure 2. Kill-the-Winner dynamics in phage-host systems. An increase in host population (Host 
1) is followed by an increase in the population of its corresponding phage predator (Phage 1), 
resulting in th  most abundant host being killed by its phage. This leaves a vacancy for a new host 
to become highly abundant (Host 2), and this new dominant host will subsequently be killed by 
its predator (Phage 2). These pairs continue to oscillate over time, with phage-host pairs blooming 
independently f om each other.
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arms	   race	   in	   this	   condition	   (Brockhurst	   et	   al.,	   2007).	   The	  nutrient	   rich	   conditions	   in	   the	  CF	  
lung	  might	  therefore	  facilitate	  the	  possibility	  of	  an	  arms	  race	  between	  P.	  aeruginosa	  and	  the	  
resident	   phage	   population.	  Many	   phage	   receptors,	   e.g.	   flagella,	   pili	   and	   LPS	   are	   altered	   or	  
reduced	   during	   infection	   while	   the	   mucoid	   phenotype	   was	   selected	   upon	   co-­‐evolution	   of	  
Pseudomonas	   fluorescence	   and	   phage	   phi2	   (Scanlan	   and	   Buckling,	   2011).	   Consequently,	  
these	  phenotypes	  might	  be	  adaptive	  towards	  evasion	  of	  both	  the	  immune	  system	  and	  phage	  
predation.	  
	  
5.4 Bacterial	  host-­‐restriction	  adaptation	  
Long-­‐term	  adaptation	  of	  P.	   aeruginosa	   to	   the	  CF	   lung	   frequently	   produces	   variants	   lacking	  
e.g.	   motility,	   virulence	   factors,	   QS	   functionality	   in	   addition	   to	   slow	   growth	   and	  
overproduction	   of	   alginate.	   These	   variants	   should	   possess	   inferior	   fitness	   in	   the	   natural	  
aquatic	   and	   terrestrial	   environments.	  Hence,	   highly	   adapted	   variants	   can	   be	   considered	   as	  
host	   restricted,	   i.e.	   their	   main	   habitat	   has	   been	   restricted	   to	   the	   host	   environment.	  
Consequently,	  P.	  aeruginosa	  infection	  in	  the	  CF	  lung	  constitutes	  an	  example	  of	  the	  very	  early	  
stage	  of	  host-­‐restriction	  adaptation.	  Several	  more	  advanced-­‐stage	  examples	  of	  adaptation	  to	  
host	   restriction	   exist	   among	   strictly	   host-­‐associated	   bacteria	   such	   as	   Burkholderia	   mallei,	  
Mycobacterium	   leprae,	   and	   Rickettsia	   and	   Buchnera	   species	   (Andersson	   et	   al.,	   1998;	  
Shigenobu	   et	   al.,	   2000;	   Gomez-­‐Valero	   et	   al.,	   2007;	   Song	   et	   al.,	   2010).	   Investigating	   the	  
mechanisms	  and	  dynamics	  of	  genome	  changes	  during	  such	  adaptation	  is	  usually	  carried	  out	  
by	   comparison	   of	   present-­‐day	   isolates	   to	   distant	   theoretical	   ancestors	   providing	   limited	  
resolution	  of	  events	  during	  adaptation,	  however	  certain	  characteristics	  are	  observed	  among	  
strains	   at	  different	   stages	  of	  host	   adaptation	   including	   changes	   in	   genome	   size,	   number	  of	  
pseudogenes	  and	  quantity	  of	  selfish	  genetic	  elements	  (Figure	  13).	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Figure	  13:	  Genome	  characteristics	  in	  different	  stages	  of	  host-­‐restriction	  adaptation	  
(Ochman	  and	  Davalos,	  2006).	  
	  	  	  
The	  reduction	  of	  genome	  size	   is	  a	  continuous	  process	  occurring	   in	  both	  early	  and	   late	  
stages.	   Two	   general	   mechanisms	   are	   responsible	   for	   the	   observed	   nucleotide	   loss:	   Large	  
deletions	  in	  addition	  to	  gene	  inactivation	  followed	  by	  gradual	  erosion	  of	  the	  inactivated	  gene	  
(Moran	  and	  Plague,	  2004).	  The	   latter	  was	  proposed	  to	  be	  the	  main	  mechanism	  in	  the	  early	  
stage	  of	  adaptation	  based	  on	  comparison	  of	  Buchnera	  APS,	  Mycobacterium	   leprae,	  Shigella	  
flexneri	  and	  Salmonella	  Typhi	  to	  theoretical	  ancestors	  (Silva	  et	  al.,	  2001;	  Dagan	  et	  al.,	  2006).	  
However	  analyzing	  the	  same	  Buchnera	  genome	  researchers	  reached	  the	  conclusion	  that	  the	  
main	   mechanism	   of	   genome	   reduction	   in	   the	   early	   stage	   was	   through	   large	   deletions	   of	  
contiguous	  sequence	  (Moran	  and	  Mira,	  2001).	  Several	  other	  studies	  have	  supported	  this	  to	  
be	  a	  prominent	  feature	  of	  the	  early	  stage	  adaptation,	  e.g.	  adaptation	  of	  P.	  aeruginosa	  to	  the	  
cystic	  fibrosis	   lung	  revealed	  substantial	  genome	  reduction	  (up	  to	  8	  %	  in	  one	  lineage)	  during	  
infection	   mediated	   by	   the	   loss	   of	   large	   regions	   of	   contiguous	   sequence	   (Rau	   et	   al.,	   in	  
preparation).	  Roughly	  double	  the	  amount	  of	  sequence	  was	  deleted	  compared	  to	  the	  quantity	  
be inactivated and deleted. Population-level
processes operate on all genomes, and their
effects are even observed in the functional re-
gions of the human genome (9). Thus, orga-
nisms with small population sizes are more
prone to gene decay and loss, even for genes
that are usually considered beneficial. This is
the case for pathogens, which typically require
only small inocula to infect each new host,
resulting in a reduction in the effective size of
their populations.
The impact of these factors is evident from
the contents and organization of sequenced bac-
terial genomes. When com-
pared with their free-living
relatives, facultative bacterial
pathogens are seen to harbor
substantial numbers of pseu-
dogenes (5, 10) and a popu-
lation structure that promotes
the maintenance of delete-
rious mutations (1, 11, 12).
Such pathogens represent an
intermediate stage of genome
erosion relative to the obli-
gately host-associated line-
ages, whose genomes are
highly reduced, having un-
dergone massive inactivation
and loss of nonessential
genes (Fig. 1). When consid-
ering all bacterial genomes,
there appears to be a set of
only 50 to 100 genes that are
universally maintained. The
losses observed in degraded
and reduced genomes in-
clude not only those genes
that are clearly superfluous
but also many that are ben-
eficial but not essential, such
as those involved in DNA
repair (2, 13, 14).
Redundant Regions in
Bacterial Genomes
Some fraction of genes in
each bacterial genome will
not be functional because
of ongoing mutational and
population-level processes.
Most genome annotations
carry in them the implicit as-
sumption that all predicted coding DNA se-
quences (CDSs) confer some (although often
unspecified, hypothetical, or putative) function
(15–18), but the crit cal task of identifying in-
activated genes has been largely ignored.
To understand the functional status of a ge-
nome, we need to recognize the pseudogenes
within it. Unfortunately, there are inconsist-
encies in the methods by which pseudogenes
are defined (19, 20). Hence, the assignment of
pseudogenes must be based on some a priori
assumptions about the spectrum of alterations
in a gene that will abolish the function of
its encoded protein. For example, genes in
adenine þ thymine (A þ T)–rich genomes are
often shorter than their homologs in other ge-
nomes, owing to their propensity toward mu-
tations that form stop codons (21, 22). Such
truncations cannot automatically be taken to
reflect a global inactivation of genes. Wherev-
er possible, predicted pseudogenes should also
be appraised in light of the physiological
features of the cell. For example, the bacterial
pathogen Yersinia pestis, unlike its sister taxon
Y. pseudotuberculosis, requires exogenous me-
t ionine and phenylala in for growth because
it contains disabled versions of the metB and
pheA genes (4, 20).
Finding Pseudogenes
The availability of genome sequences from
closely related organisms has considerably al-
tered the way that genes are recognized and
annotated, but just how useful and accurate
are genome annotations for the downstream
analyses of microbial systems? Their reliabil-
ity can be best assessed in E. coli K-12,
which, owing to its long history as an ex-
perimental organism, has the highest propor-
tion of genes for which functions have been
determined directly (23–25). Furthermore,
many genomic features first discovered in
E. coli (such as gene and operon structure,
occurrence of mobile elements, mutational
patterns, and rates of gene exchange and ac-
quisition) subsequently have been found to be
characteristic of other bacterial groups.
Early molecular genetic analyses gave little
indication that E. coli, or any other bacterial
genome, might harbor substantial numbers of
nonfunctional genes. The
original annotation of the
E. coli K-12 reported only
a single pseudogene among
its 4288 coding regions.
Because this genome is ex-
pected to possess all of the
hallmarks of free-living bac-
teria (Fig. 1), we set out to
identify the inactivated and
nonfunctional portion of the
E. coli K-12 genome and to
assess the number and au-
thenticity of pseudogenes
predicted by several analyt-
ical approaches.
Genes and Proteins with
Structural Alterations
We searched the annotated
genome of E. coli K-12
(26) for genes that differed
substantially in length from
their homologs in the ge-
nome sequences of close
relatives (i.e., enteropatho-
genic E. coli EDL933, uro-
pathogenic E. coli CFT073,
and Shigella flexneri 2a,
which is more closely re-
lated to K-12 than either of
the other two E. coli strains).
As a consequence, more
than 160 putative coding
regions in E. coli K-12 were
predicted to be pseudogenes
(27, 28). Contained within
intergenic regions, there were
47 additional pseudogenes
that were not recognized as
such in the original annotation.
Although the criteria for distinguishing
pseudogenes differ among studies, the overall
ationale is the same: The predicted protein
must be altered to a degree that abolishes its
function. Such thresholds should derive from
the known size and organization of functional
domains within proteins, the observed length
variation within individual gene families con-
served across bacteria, and available informa-
tion on experimentally disrupted proteins. In
general, we classed as pseudogenes those cases
Obligate symbiont
or pathogen
Recent or facultative
pathogenFree-living
Genome size
Number of pseudogenes
Incidence of LGT
Selfish genetic elements
Genome organization
Effective population size
Large
(5-10 MB)
Few
Frequent
Few
Stable or unstable
Large
Intermediate
(2-5 MB)
Many
Frequent to rare
Common
Unstable
Small
Small
(0.5-1.5 MB)
Rare
Rare to none
Rare
Stable
Small
Pseudogenes
Transposable elements
LGT
Fig. 1. Trends in the size and contents of bacterial genomes. Upon classifying bacteria
according to their degree of association or dependence on a eukaryotic host, several
general features emerge (8). Because of their relatively large population sizes, selection
operates most effectively in free-living species—i.e., those that replicate in the
environment independently of a host. Because selection is effective in removing
deleterious sequences, these species usually possess large genomes containing relatively
few pseudogenes (red) or mobile genetic elements (yellow). In recently derived
pathogens, the availability of host-supplied nutrients combined with decreases in
eff ctive population sizes llows for the accumulation f pseudoge es and of
transposable elements. In long-term host-dependent species, the ongoing mutational
bias toward deletions has removed all superfluous sequences, resulting in a highly
reduced genome containing few, if any, pseudogenes or transposable elements. LGT,
lateral gene transfer.
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of	  gene	  sequence	  affected	  by	  pseudogene	  formation	  (Rau,	  unpublished).	  Early	  stage	  in	  vitro	  
experimental	  reductive	  evolution	  further	  showed	  the	  loss	  of	  large	  blocks	  of	  sequence,	  up	  to	  
200	  kbp	  (Nilsson	  et	  al.,	  2005).	  The	  alternate	  conclusions	  reached	  by	  Dagan	  et	  al.	  (2006)	  and	  
Silva	   and	   Mira	   (2001)	   could	   be	   affected	   by	   low	   resolution	   and	   the	   choice	   of	   analysis	  
approach.	   Nonetheless,	   both	   the	   extent	   of	   reductive	   evolution	   and	   the	   proportion	   of	  
pseudogene	   formation	   versus	   large	  deletions	   is	   likely	   to	  be	   influenced	  by	   the	  potential	   for	  
nucleotide	  loss	  of	  the	  host-­‐adapting	  strains	  yielding	  different	  ratios.	  Another	  feature	  of	  early	  
adaptation	   to	   host-­‐restriction	   is	   the	   proliferation	   of	   IS	   elements	   as	   exemplified	   by	   an	  
increased	  density	  of	  these	  in	  the	  genomes	  of	  bacteria	  with	  a	  recent	  obligate	  host-­‐association	  
(Figure	  14).	  	  
	  
	  
Figure	  14:	  Density	  of	  IS	  elements	  in	  the	  genomes	  of	  bacteria	  with	  either	  a	  free-­‐living	  (grey),	  
recent	  host-­‐restriced	  (red)	  or	  ancient	  host-­‐restriced	  (black)	  lifestyle	  (Moran	  and	  Plague,	  
2004).	  
	  
The	   mechanism	   of	   deletion	   can	   be	   through	   either	   illegitimate	   or	   homologous	  
recombination.	  In	  the	  early	  stage	  adaptation	  of	  Burkholderia	  mallei,	  Bordetella	  parapertussis	  
and	  Bordetella	   pertussis	   an	   association	   between	   end-­‐regions	   of	   deletions	   and	   IS	   elements	  
strongly	   indicated	   that	   the	   deletion	   mechanism	   occurred	   through	   IS	   element	   mediated	  
homologous	   recombination	   (Parkhill	   et	   al.,	   2003;	   Song	   et	   al.,	   2010).	   This	  was	   the	   case	   for	  
most	   deletion	   end-­‐regions.	   However	   in	   the	   very	   early	   stage	   of	   adaptation	   towards	   host-­‐
restriction	   as	   exemplified	   by	   infection	   of	   CF	   patients	   with	   the	   P.	   aeruginosa	   DK2	   clone,	  
stages and that become restricted to living in hosts. First,
losing the ability to live in the environment results in a
much smaller effective population size, decreasing the
efficiency of purifying selection and resulting in the
inactivation of beneficial genes through genetic drift
[31]. Second, living only in hosts reduces the intensity
of purifying selection on many genes, which may be
superfluous in the nutrient-rich environment provided
by host tissues (e.g. see [8,32!]). This second explanation
might provide the reason for loss of some genes, i.e. those
with functions that might be replaced by uptake of host
metabolites. However, among the genes that are elimi-
nated from small genomes, many have fun tions involved
in central informational processes of the cell, such as
DNA repair. In these cases, gene inactivations are likely
to represent slightly deleterious mutations. The overall
consequence is that many more mutations that disrupt
gene function can persist in host-restricted bacteria.
The spread of mobile genetic elements is governed by
opposing forces: their tendency to increase as ‘selfish
genes’ versus selection against their spread, which acts
either against genotypes with transpositions that destroy
the function of particular genes or in favor of general
genomic mechanisms that suppress transposition [33].
The explanation put forward for IS proliferation in
host-restricted bacteria hinges on the proposal that the
reduced effective population size lowers the efficiency by
which purifying selection maintains genes [23!!]. In other
words, the transition to a small population size shifts the
balance of forces that govern IS numbers, causing more
transpositions to become fixed by genetic drift.
In addition, host restriction may limit opportunities for
the horizontal transmission of elements. In eukaryotes
that lose sexual reproduction, mobile elements are pre-
dicted to decrease in frequency and ultimately to be
eliminated because they lack the potential to move into
new genetic backgrounds [34]; similarly, in bacteria that
never exchange DNA with other bacteria, no new IS
elements enter the genome. In strictly asexual genomes,
existing elements either will lead to extinction of the host
Genomic changes following host restriction in bacteria Moran and Plague 629
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deletion	  of	  up	  to	  8	  %	  of	  the	  genome	  occurred	  without	  any	  involvement	  of	  IS	  elements	  (Rau	  
et	   al.,	   in	   preparation).	   One	   reason	  was	   the	   low	   proliferation	   of	   IS	   elements	   keeping	   a	   low	  
density	   of	   these	   throughout	   infection	   and	   consequently	   also	   low	  potential	   for	   IS	  mediated	  
deletions.	   Yet,	   the	   findings	   demonstrate	   that	   a	   significant	   portion	   of	   the	   genome	   can	   be	  
deleted	  without	   IS	   element	   involvement.	   The	   time	   scales	   between	   these	   studies	   are	   quite	  
different	   (35	   years	   for	   P.	   aeruginosa	   infection	   vs.	   1-­‐3	   million	   years)	   likely	   affecting	   the	  
outcomes	  and	  given	  more	  time,	  IS	  element	  mediated	  deletions	  might	  occur	  in	  the	  infecting	  P.	  
aeruginosa	  strains.	   In	  fact,	   IS	  mediated	  inversions	  have	  been	  observed	  in	  CF	   isolates	  before	  
(Kresse	  et	  al.,	  2003;	  Kresse	  et	  al.,	  2006).	  The	  IS	  element	  copy	  numbers	  within	  these	  isolates	  
were	  also	  higher,	  14	  to	  25	  copies,	  indicating	  a	  higher	  proliferation	  rate	  of	  the	  elements.	  The	  
mechanisms	   of	   deletion	   observed	   by	   Rau	   et	   al.,	   (in	   preparation)	   instead	   consisted	   of	  
illegitimate	  recombination	  and	  non-­‐IS	  element	  mediated	  homologous	  recombination	  as	  also	  
found	   during	   in	   vitro	   reductive	   evolution	   (Nilsson	   et	   al.,	   2005).	   Hence	   these	   could	   be	   the	  
main	  deletion	  mechanisms	   in	  the	  beginning	  of	  host-­‐restriction	  adaptation.	  A	  predominance	  
towards	   illegitimate	   recombination	  was	   present	   in	   both	   studies	   likely	   reflecting	   the	   higher	  
density	  of	  such	  regions	  within	  the	  genome.	  	  
	  
Although	   not	   observed	   in	   the	   DK2	   clone	   adaptation	   to	   the	   CF	   lung,	   host-­‐restriction	  
adaptation	   can	   occur	   by	   HGT	   albeit	   at	   a	   lower	   frequency	   compared	   to	   free-­‐living	   bacteria	  
(Toft	   and	   Andersson,	   2010).	   Examples	   include	   the	   uptake	   of	   genes	   encoding	   secretion	  
systems	  and	  eukaryotic-­‐like	  proteins	   likely	   transferred	  by	  means	  of	  phage	  as	   the	  genes	  are	  
located	  next	  to	  prophage	  sequence	  (Wu	  et	  al.,	  2004a;	  Berglund	  et	  al.,	  2009).	  
	  
As	   mentioned	   host-­‐restriction	   adaptation	   displays	   certain	   characteristics	   such	   as	  
changes	   in	   genome	   size,	   number	  of	  pseudogenes	  and	  quantity	  of	   selfish	   genetic	   elements.	  
There	   are	   a	   number	   of	   probable	   reasons	   to	   the	   observed	   characteristics	   during	   host-­‐
restriction	   adaptation.	   One	   is	   the	   potential	   small	   population	   sizes	   leading	   to	   decreased	  
efficiency	   of	   purifying	   selection	   and	   thus	   fixation	   of	   deletions	   and	   IS	   element	   insertions	  
through	  genetic	  drift.	   Inactivation	  of	  otherwise	  beneficial	  genes	  might	  occur	  in	  this	  process.	  
Likewise	   loss	   of	   superfluous	   genes	   such	   as	   certain	  metabolic	   genes	   in	   a	   nutrient-­‐rich	   host	  
environment	  can	  be	  caused	  by	  reduced	   intensity	  of	  purifying	  selection,	   i.e.	  many	  genes	  are	  
not	   selected	   for	   (Moran	   and	   Plague,	   2004).	   Both	   processes	   should	   be	   present	   during	   P.	  
aeruginosa	  adaptation	  to	  the	  CF	  lung.	  The	  P.	  aeruginosa	  population	  in	  the	  CF	  lung	  is	  not	  very	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small	  however	  it	  is	  likely	  subject	  to	  severe	  bottlenecks	  especially	  during	  antibiotic	  treatment,	  
creating	  the	  foundation	  for	  genetic	  drift.	  Likewise	  numerous	  P.	  aeruginosa	  genes	  should	  be	  
neutral	   and	   some	   even	   deleterious	   in	   the	   CF	   environment	   creating	   further	   potential	   for	  
reductive	  evolution.	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6 Concluding	  remarks	  
The	  study	  of	  Pseudomonas	  aeruginosa	  adaptation	  to	  the	  cystic	  fibrosis	   lung	  has	  great	  merit	  
both	   from	   a	   clinical	   and	   an	   evolutionary	   point	   of	   view.	   Knowledge	   on	   the	   process	   of	  
adaptation	   can	  be	  of	   great	  benefit	  by	  providing	  novel	   targets	   for	   treatment	  of	   infection	  as	  
well	  as	  uncovering	  the	  dynamics	  of	  in	  vivo	  microbial	  adaptation	  towards	  a	  markedly	  different	  
environment.	  In	  this	  work	  one	  focus	  has	  been	  the	  early	  stage	  of	  P.	  aeruginosa	  colonization	  of	  
CF	   airways	   as	   this	   stage	   is	   deciding	   for	   the	   persistence	   of	  P.	   aeruginosa.	   Three	   cases	   of	  P.	  
aeruginosa	   survival	   in	   the	   CF	   airways	   for	   more	   than	   two	   years	   revealed	   very	   different	  
evolutionary	   trajectories	   for	   early	   stage	   adaptation.	   One	   persisting	   lineage	   displayed	  
adaptation	  mainly	  by	  modification	  of	  the	  expression	  of	  a	  global	  regulatory	  network	  while	  in	  
another	  a	   few	  adaptations	  with	   small	   impact	  on	   the	  global	  phenotype	  were	  observed.	   The	  
lineages	   are	   consequently	   climbing	   different	   peaks	   of	   the	   fitness	   landscape	   and	   further	  
reveal	  that	  a	  specific	  sequence	  of	  events	  is	  not	  necessary	  to	  achieve	  sufficient	  fitness	  towards	  
the	  CF	  lung	  for	  persistence.	  What	  seems	  necessary	  however,	  is	  increased	  fitness	  towards	  the	  
selective	   pressures	   of	   the	   CF	   lung	   as	   the	   third	   lineage,	   displaying	   no	   signs	   of	   adaptation,	  
eventually	  was	  eradicated.	  	  
The	   sinuses	   were	   shown	   to	   be	   the	   likely	   habitat	   of	   P.	   aeruginosa	   during	   the	   specific	  
pattern	   of	   recurrent	   intermittent	   infection	   observed	   in	   some	   CF	   patients.	   Interestingly,	  
before	   the	   onset	   of	   chronic	   lung	   infection,	   the	   sinus	   environment	   selected	   for	   the	  mucoid	  
phenotype,	   SCVs	   and	   antibiotic	   resistance	   i.e.	   variants	   pre-­‐adapted	   to	   the	   CF	   lung	  
environment.	   Consequently	   P.	   aeruginosa	   sinusitis	   can	   provide	   increased	   opportunity	   for	  
persistence	   in	   the	  host.	  Targeting	   sinusitis	  by	   focusing	  on	   improved	  antibiotic	   treatment	  of	  
the	  sinuses	  during	   intermittent	  colonization	  could	  potentially	   lower	  the	  risk	   for	  progression	  
to	   a	   chronic	   lung	   infection.	   The	   direction	   of	   transfer	   between	   upper	   and	   lower	   airways	   in	  
intermittent	  colonization	  appears	  to	  be	  mainly	  downward	  however	  the	  dynamics	  of	  transfer	  
could	  potentially	   change	  during	   infection.	  After	  establishment	  of	   chronic	   infection	   the	   lung	  
population	   would	   be	   expected	   to	   exceed	   the	   sinus	   population	   in	   quantity	   and	   should	  
therefore	   present	   a	   higher	   potential	   for	   acquiring	   adaptive	  mutations.	   Consequently	   there	  
could	  be	  a	  change	  in	  the	  direction	  of	  transfer	  over	  time.	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The	  adaptation	  of	  P.	  aeruginosa	  towards	  the	  CF	  lung	  can	  be	  viewed	  as	  the	  initial	  stage	  
of	  host-­‐restriction	  adaptation.	  The	  observation	  of	  substantial	  reductive	  evolution	  in	  the	  DK2	  
clone	  supports	  this	  notion.	  In	  the	  shift	  from	  one	  environment	  to	  another	  many	  functions	  are	  
rendered	  redundant	  and	  are	  therefore	  prone	  to	  be	   lost	  by	  genetic	  drift.	  The	  overall	   sign	  of	  
negative	   selection	   during	   evolution	   of	   the	   DK2	   lineage	   (Yang	   et	   al.,	   2011b)	   confirms	   that	  
genetic	  drift	  plays	  a	  fundamental	  part	   in	  re-­‐shaping	  the	  genome	  and	  many	  of	  the	  observed	  
deletions	   could	   therefore	   be	   attributed	   to	   this.	   Since	   the	  P.	   aeruginosa	   lung	   population	   is	  
likely	   to	   encounter	   bottlenecks	   during	   e.g.	   antibiotic	   treatment	   evolution	   by	   genetic	   drift	  
should	   not	   be	   unexpected.	   However	   some	   deletions	   could	   also	   occur	   through	   positive	  
selection,	  e.g.	  the	  deletions	  containing	  hpc	  genes.	  The	  deletion	  of	  large	  contiguous	  genomic	  
regions	   carries	   with	   it	   the	   likelihood	   of	   simultaneous	   removal	   of	   beneficial	   genes.	  
Consequently	   the	  P.	  aeruginosa	   lung	  population	  could	  be	  subject	   to	   the	  effects	  of	  Muller’s	  
ratchet	   by	   accumulating	   such	   slightly	   deleterious	   mutations	   over	   time.	   Unlike	   previous	  
reports,	  the	  mechanism	  of	  deletion	  in	  the	  early	  stage	  of	  host	  adaptation	  was	  not	  IS	  element	  
mediated	   but	   occurred	   through	   homologous	   and	   illegitimate	   recombination.	   The	  
involvement	  of	   IS	  elements	   in	  genome	  reduction	  will	  depend	  on	  their	  genomic	  density	  and	  
therefore	   ultimately	   their	   proliferation	   rate	   within	   the	   genome.	   Thus,	   their	   involvement	  
could	  vary	  substantially	  between	  host	  adapting	  strains.	  	  
Only	   limited	  uptake	  of	   novel	  DNA,	   if	   any	   at	   all,	  was	  observed	  within	   the	  DK2	   lineage,	  
possibly	   as	   a	   consequence	   of	   a	   lack	   of	   external	   beneficial	   DNA	   or	   decreased	   capability	   for	  
DNA	  uptake.	  Typical	  phage	  receptors	  such	  as	  pili,	   flagella	  and	  LPS	  are	  reduced	  or	  altered	   in	  
the	   DK2	   lineage	   suggesting	   increased	   phage	   resistance.	   Possibly	   these	   phenotypes	   are	  
adaptive	  towards	  evasion	  of	  both	  the	  immune	  system	  and	  phage	  predation.	  The	  limited	  DNA	  
uptake	   emphasizes	   a	   general	   aspect	   of	   P.	   aeruginosa	   adaptation	   to	   the	   CF	   lung,	   i.e.	   a	  
preponderance	  towards	  reduction	  of	  function	  compared	  to	  gain	  of	  function.	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Summary
Pseudomonas aeruginosa is an opportunistic patho-
gen ubiquitous to the natural environment but with
the capability of moving to the host environment.
Long-term infection of the airways of cystic fibrosis
patients is associated with extensive genetic adapta-
tion of P. aeruginosa, and we have studied cases of
the initial stages of infection in order to characterize
the early adaptive processes in the colonizing bacte-
ria. A combination of global gene expression analysis
and phenotypic characterization of longitudinal iso-
lates from cystic fibrosis patients revealed well-
known characteristics such as conversion to a
mucoid phenotype by mucA mutation and increased
antibiotic resistance by nfxB mutation. Additionally,
upregulation of the atu operon leading to enhanced
growth on leucine provides a possible example of
metabolic optimization. A detailed investigation of the
mucoid phenotype uncovered profound pleiotropic
effects on gene expression including reduction of
virulence factors and the Rhl quorum sensing
system. Accordingly, mucoid isolates displayed a
general reduction of virulence in the Caenorhabditis
elegans infection model, altogether suggesting that
the adaptive success of the mucoid variant extends
beyond the benefits of alginate overproduction. In the
overall perspective the global phenotype of the
adapted variants appears to place them on paths in
direction of fully adapted strains residing in long-term
chronically infected patients.
Introduction
The bacterium Pseudomonas aeruginosa is a microor-
ganism that is usually found both in aquatic and terrestrial
environments. Like other Pseudomonads it is a versatile
species with an extended metabolic repertoire allowing it
to occupy many different niches. Its genome, one of the
largest in the bacterial world with close to 6000 genes,
displays the versatility of the organism with its multiple
metabolic pathway genes, and the extraordinary large
number of regulatory genes (more than 500) suggests
that P. aeruginosa has a great competitive capacity to
move between different types of environments (Stover
et al., 2000). The diversity of gene regulatory activities in
the organism ensures adaptation to new environmental
conditions. Another reason why P. aeruginosa has
attracted considerable interest is connected to its capacity
to cause infections in plants, animals and humans
(Spencer, 1996; Wolfgang et al., 2003). These infections
are associated with the genomic content of a large
number of virulence genes, which are important elements
in most cases of infections.
One of the best studied human infections caused by P.
aeruginosa is airway infections in patients suffering from
the genetic disorder cystic fibrosis (CF). Because of a
severely reduced mechanical clearing of the airway
mucus in these patients they acquire multiple infections of
various bacteria and fungi, and a major cause of morbidity
and mortality is chronic infection of P. aeruginosa in the
lungs (Koch and Hoiby, 1993; Govan and Deretic, 1996).
Most patients acquire P. aeruginosa early in their lives and
initial colonization is typically caused by environmental
strains displaying all the wild-type phenotypes associated
with this species (Johansen and Hoiby, 1992; Burns et al.,
2001; Koch, 2002). Because the majority of children in
a given clinical setting carry unique genotypes of
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P. aeruginosa it also seems clear that colonization in most
cases is a separate event (Burns et al., 2001; Jelsbak
et al., 2007). In many cases the original colonization pro-
ceeds into a chronic infection (or alternatively other clones
may later establish chronic infections), without any possi-
bility of eradication (Koch, 2002; Jelsbak et al., 2007).
During infection the bacteria have to adapt to the new
environment comprising the host immune response, anti-
biotics and a different substrate composition. It is com-
monly observed that the bacteria gradually loose the
function of many genes normally associated with bacterial
pathogenicity (Smith et al., 2006; Jelsbak et al., 2007);
however, in a chronic infection scenario this does not per
se imply a reduction in virulence but likely rather an alter-
ation of virulence (Bragonzi et al., 2009).
Genetic and phenotypic investigations of P. aerugi-
nosa isolates from chronically infected patients have
shown that among the many specific traits developing in
the bacteria during infection, the mucoid phenotype
caused by excessive production of the extracellular
polysaccharide alginate is occurring with high frequency
(Pedersen, 1992; Martin et al., 1993; Govan and Deretic,
1996). Conversion to a mucoid phenotype is caused by
mutations in regulatory genes, mainly in various posi-
tions of the mucA gene encoding the anti-sigma factor
MucA (Boucher et al., 1997). Binding between MucA and
AlgU, the corresponding sigma protein (homologous to
the sigma E factor of Escherichia coli) prevents AlgU
from acting as a necessary initiation factor required for
transcription of the alg operon (encoding the enzymes
required for alginate synthesis) (Govan and Deretic,
1996; Boucher et al., 1997; Rowen and Deretic, 2000).
Mutations disabling the activity of MucA lead to activa-
tion of AlgU, and the resulting elevated transcription of
the alg operon leads to alginate overproduction (Rowen
and Deretic, 2000). In the CF airways overproduction of
alginate has been associated with increased tolerance to
the host immune defense (Cabral et al., 1987; Govan
and Deretic, 1996; Mathee et al., 1999) and additionally
described as a protective extracellular matrix in connec-
tion with biofilm development in the infected airways
(Høiby et al., 2001; Yang et al., 2008). It is thus
assumed that the major impact of the mucA mutations
on the infection success of the bacteria is connected to
the alginate production.
Pseudomonas aeruginosa in its wild-type configuration
is naturally resistant to many antibiotics, and if con-
fronted with antimicrobial agents it will in many cases be
able to develop tolerance to increased levels of the com-
pounds (Hancock, 1997; Hancock and Speert, 2000).
This capacity to resist antimicrobial treatment is most
likely an important reason why P. aeruginosa has
become the dominant airway infection problem for CF
patients as antibiotic therapy was introduced to these
patients. Before antibiotic treatment patients died very
young from infections of indigenous pathogens such as
Staphylococcus aureus and Haemophilus influenza. The
medical success leading to extended life spans of CF
patients is coupled to antibiotic treatments with com-
pounds towards which P. aeruginosa is not inherently
resistant (Høiby et al., 2005; Hansen et al., 2008).
Because antibiotics are used to combat the infections as
soon as P. aeruginosa has been diagnosed, it means
that persistent colonization and subsequent chronic
infection will eventually be associated with development
of resistance.
Some of the most common phenotypic traits reported
for P. aeruginosa isolates from chronically infected CF
patients (‘the chronic infection phenotype’) include slow
growth, auxotrophy, alginate overproduction (mucoidy),
antibiotic resistance and loss of virulence factors and
motility (Mahenthiralingam et al., 1994; Barth and Pitt,
1996; Bagge et al., 2002; Lee et al., 2005; Smith et al.,
2006; Jelsbak et al., 2007; Ciofu et al., 2008). Because
these phenotypic characteristics have been observed in
many different clinical settings it is highly likely that such
a phenotypic profile is an end-point result of parallel evo-
lution of the bacteria in many CF patients colonized by
many different bacterial genotypes. The actual evolution-
ary trajectories towards this common phenotypic profile,
however, could be quite different in different clinics,
patients and colonizing genotypes. In three cases
described here the colonizing bacteria are all at the begin-
ning of their colonization history, they all constitute persis-
tent colonization (present for thousands of generations),
and none of them have at the present time reached the
typical ‘chronic infection phenotype’. The question
addressed here is: in each of these three cases – do the
bacteria show indications of being on a direct path
towards the ‘chronic infection phenotype’, and if so what is
the mechanism behind this?
Results
From the environment to colonization of human airways
We have collected isolates from the majority of CF chil-
dren infected with P. aeruginosa associated with the
Copenhagen CF clinic during a 4.5 year period (2005–
2009). In total 45 CF children were followed from first
isolate of P. aeruginosa (or very early in their colonization
history). In this communication we distinguish between
cases of cured and persistent colonization of the patient
airways (cf. Experimental procedures for definitions), and
at the conclusion of the study a large group of patients (20
patients) had been cured (one or several times) of P.
aeruginosa after a period of treatment with antibiotics, and
for 13 patients status was still unknown because of recent
1644 M. H. Rau et al.
© 2010 Society for Applied Microbiology and Blackwell Publishing Ltd, Environmental Microbiology, 12, 1643–1658
colonization within the last 12 months. These cases are
not examined further here. Another large group of 13
patients comprises cases of recurrent colonization where
the bacteria are not present in airway samples for a period
of time (often several months) and then suddenly reap-
pear with the same genotype (to be published). Based
mainly on duration of bacterial persistence and frequency
of isolation it is from this group of persistent clones we
have chosen three cases for further characterization of
the bacterial genotypes and phenotypes and for evolu-
tionary changes over time.
The experimental approach has been to combine tran-
scriptional profiling using standardized Affymetrix DNA
arrays with phenotypic characterization. The DNA array
experiments have been performed under standardized
conditions in laboratory media (cf. Experimental proce-
dures), and the results of these provide information about
impacts of genetic changes on expression of specific
genes, when comparing data sets from isolates harvested
from the patients at different time points. Because the
Affymetrix gene chips mainly cover the genes present in
reference strains of P. aeruginosa such as PAO1, PA14
and PAK, the obtained data only cover expression of
genes in the core genome. Parallel phenotypic investiga-
tions have been employed to verify the transcription
analysis, and to bring about information that may indicate
which mutational events may be responsible for the
observed changes of gene expression and corresponding
phenotype. Gene sequencing was employed in some
cases to confirm such mutational events.
Characterization of a transiently colonizing strain of
P. aeruginosa
Patient B6 was initially colonized by a strain of P. aerugi-
nosa that persisted for 2 years after which it was no
longer isolated from patient samples. The sample time
line is shown in Fig. 1. B6-0 is the first isolate of P.
aeruginosa in this patient and most likely represents the
original environmental strain initiating colonization, while
B6-4 is the latest isolate of this particular genotype in
the patient. It is not known if this first colonizing clone
was removed by the medical treatment, by competition
from a new genotype that emerged in the patient
airways (Fig. 1), or both. Colony morphology appear-
ance of the two isolates was identical and like that nor-
mally observed for wild-type isolates, indicating an
environmental origin. The cells are fully motile in agree-
ment with a general wild-type phenotype. Transcriptional
profiling was performed through isolation of RNA from
cultures growing exponentially in Luria–Broth (LB)
medium and harvested at an OD600 of 0.5 followed by
analysis using Affymetrix Gene Chips for P. aeruginosa.
Global gene expression comparison of isolates B6-0 and
B6-4 shows that only six genes had P-values below
0.05, all in the range of a twofold downregulation. Four
of these are PA4582-PA4585 of which PA4585 (rtcA) is
involved in RNA processing. These results suggest that
only a small number of genetic changes occurred during
the 2 years of colonization of this particular P. aerugi-
nosa clone.
Fig. 1. Time line of P. aeruginosa infection in
patients B6, B12 and B38. Black boxes
indicate P. aeruginosa-positive samples while
stars, for patient B6, indicate samples
containing a new genotype only. Unlike
patient B6, only one genotype was detected
in patients B12 and B38. Arrows indicate
sample isolates chosen for DNA microarray
analysis. Sample numbers are not completely
consecutive as not all P. aeruginosa-positive
samples were available for analysis.
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Characterization of a persisting non-mucoid strain of
P. aeruginosa
In patient B12 a specific clone of P. aeruginosa has per-
sisted for more than 4 years and is still isolated from the
patient. The isolate B12-0 does not represent the first
acquisition for this patient, as P. aeruginosa was identified
in a sample from the patient 4 months prior to sample B12-0.
Although we have no stored isolate from this 4 month
period it is quite likely that the P. aeruginosa clone was the
same as the one described in the subsequent collected
samples. DNA microarray analysis was performed on iso-
lates from three samples: B12-0, B12-4 (isolated after 2
years and 10 months) and B12-7 (isolated after 3 and 8
months) (cf. Fig. 1). Gene expression changes are shown
in Table 1 and in contrast to the lack of changes observed
for the B6 isolates, the analysis of the B12 isolates
showed that several genes and operons display changed
expression levels in the later isolates compared with
the first one. These changed expression levels include
upregulation of the MexCD-OprJ multidrug efflux system
involved in resistance towards, e.g. fluoroquinolones
(Jalal et al., 2000; Jeannot et al., 2008). In agreement with
this it was found that the MIC of ciprofloxacin, with which
the patient was treated, increased 15-fold from a wild-type
level of 0.19 to 3 mg ml-1. The underlying genetic basis is
a 13 bp (D329–341) frameshift deletion in the MexCD-OprJ
operon repressor, nfxB, present in isolate B12-7. The atu
operon, also upregulated, is involved in the catabolism of
the acyclic monoterpene citronellol, but also partly involved
in catabolism of leucine (Aguilar et al., 2006), which may be
an important nutrient in the airway mucus. Growth on
leucine as carbon source was accordingly significantly
improved for isolate B12-7 (doubling time of 4.1 h,
SD = 0.4) compared with isolate B12-4 (doubling time of
9.1 h, SD = 0.4). A frame-shift deletion (DA326) in atuR
in B12-7 could explain this. Several genes showed moder-
ately changed expression, among which were genes
encoding type III secretion proteins (downregulation).
Because isolate B12-0 presumably had a 4 month period
of colonization and adaptation prior to the sampling time,
some other changes in expression relative to the original
environmental colonizer could have occurred during
this period. In fact, gene expression in B12-0 in comparison
with the reference strain PAO1 revealed up to 10-fold
downregulation of wbp genes involved in O-antigen syn-
thesis as well as up to 17-fold downregulation of pil and
fim genes involved in motility, in agreement with the finding
that B12 isolates are twitching motility deficient.
Characterization of a persisting mucoid strain of
P. aeruginosa
Pseudomonas aeruginosa colonization in patient B38
occurred after a 10 year period of time without P. aerugi-
nosa. The time line of this new infection in B38 is dis-
played in Fig. 1. The initial colonizing strain was wild-type
non-mucoid (same phenotype as for isolates from B6 and
B12) but rapidly converted to an alginate overproducing
mucoid phenotype. In sample B38-2 five different clonal
mucoid lineages could be identified by differences in the
respective mucA sequences (Table 2). The five mucoid
lineages displayed some phenotypic diversity and could in
part also be distinguished based on the plate colony mor-
photypes of in vitro generated non-mucoid revertants. For
the sequenced isolates each colony morphology type
matched a specific lineage.
Sequencing the mucA gene in isolates from later
samples indicated that only the type A lineage carrying the
T349C mucA allele was continuously present in the
patient airways. Investigating colony morphologies of 70
isolates from sample B38-6 revealed that all displayed the
morphotype associated with isolates carrying the T349C
mucA allele. Thus it is strongly indicated that the type A
mucoid lineage has dominated the P. aeruginosa popula-
tion from sample B38-6 and onwards and most likely is
the only persisting mucoid lineage. Consequently, isolates
of the type A mucoid lineage were chosen for transcrip-
tome analysis that included strains B38-1NM, B38-6A-M,
B38-2A-M and B38-2A-NM*, an isogenic non-mucoid
strain having a PA14 wild-type mucA allele. The latter
strain was generated in vitro by allelic replacement, cf.
Experimental procedures. Inter-strain gene expression
comparison enables not only the determination of tempo-
ral changes in gene expression between isolates from
samples 1, 2 and 6, but also documents that changes
between isolates from sample 1 and 2 are related or
unrelated to the mucA mutation.
Gene expression in B38-1-NM was considered to be a
wild-type reference data set. In B38-2A-M 761 genes had
significantly changed expression relative to B38-1-NM
with a P-value cut-off of 0.05 and fold change above 2.
Most of the gene expression changes were also observed
when comparing the isogenic strains B38-2A-M and B38-
2A-NM* (668 with a fold change above 2) showing that the
genetic basis for most gene expression changes found in
B38-2A-M is the mucA mutation. A comparison between
strains B38-1NM and B38-2A-NM* disclosed fewer and
smaller gene expression changes as only 75 genes
showed changed expression (P-value below 0.05 and fold
change above 2), while only one gene was significantly
changed above twofold in expression in strain B38-6A-M
relative to strain B38-2A-M. Selected differentially
expressed genes from isolates from samples 1, 2 and 6
are shown in Table 3.
It is evident that most changes in gene expression
shown in Table 3 are caused by the mucA mutation, and
as expected expression of both mucA and algU were
upregulated in the mucoid strain as was expression of the
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Table 1. All gene expression changes between isolates B12-0 and B12-7.a
Locus ID and gene name Description Fold change
Antibiotic resistance
PA4597 oprJ Multidrug efflux outer membrane protein OprJ precursor 25
PA4598 mexD Multidrug efflux transporter MexD 53
PA4599 mexC Multidrug efflux membrane fusion protein MexC precursor 86
PA4600 nfxB Transcriptional regulator NfxB 12
Type III secretion
PA1694 pscQ Translocation protein in type III secretion -2
PA1699 Conserved hypothetical protein in type III secretion -2
PA1700 Conserved hypothetical protein in type III secretion -2
PA1707 pcrH Regulatory protein PcrH -2
PA1708 popB Translocator protein PopB -3
PA1709 popD Translocator outer membrane protein PopD precursor -2
PA1714 exsD ExsD -2
PA1715 pscB Type III export apparatus protein -3
PA1718 pscE Type III export protein PscE -3
PA3841 exoS Exoenzyme S -2
Citronellol/leucine catabolism
PA2885 atuRb Putative repressor of atu genes 3
PA2886 atuAb Protein with apparent function in citronellol catabolism 15
PA2887 atuBb Putative dehydrogenase involved in catabolism of citronellol 12
PA2888 atuCb Geranyl-CoA carboxylase, b-subunit 23
PA2889 atuDb Putative citronellyl-CoA dehydrogenase, citronellol catabolism 18
PA2890 atuEb Putative isohexenylglutaconyl-CoA hydratase 10
PA2891 atuFb Geranyl-CoA carboxylase, a-subunit (biotin-containing) 3
PA2892 atuGb GCase, a-subunit (biotin-containing) 8
PA2893 atuHb Putative very long-chain acyl-CoA synthetase 2
Exopolysaccharide production
PA2232 pslB Probable phosphomannose isomerase -4
PA2233 pslC Probable glycosyl transferase -3
PA2234 pslD PslD -2
PA2235 pslE Hypothetical protein -3
PA2236 pslF Hypothetical protein -3
PA2237 pslG Probable glycosyl hydrolase -3
LPS modification
PA3552 arnB ArnB -5
PA3553 arnC ArnC -3
PA3554 arnA ArnA -3
PA3556 arnT ArnT -2
PA3558 arnF ArnF -3
Other
PA0085 Conserved hypothetical protein 2
PA0612 ptrBb Repressor, PtrB -2
PA0637b Conserved hypothetical protein -2
PA0644b Hypothetical protein -3
PA0646b hypothetical protein 2
PA1535 Probable acyl-CoA dehydrogenase 4
PA1559 Hypothetical protein -4
PA1560 Hypothetical protein -5
PA2193 hcnAb Hydrogen cyanide synthase HcnA -2
PA2199b Probable dehydrogenase -3
PA2204b Hypothetical protein -10
PA2639 nuoDb NADH dehydrogenase -2
PA2655 Hypothetical protein 2
PA3115 fimV Motility protein FimV 2
PA3439 folX d-Erythro-7,8-dihydroneopterin triphosphate epimerase -5
PA3470b Hypothetical protein -2
PA3559 Probable nucleotide sugar dehydrogenase -2
PA3842 Probable chaperone -2
PA3981b Conserved hypothetical protein -3
PA4354b Chemotactic transducer PctC -2
PA4596 Probable transcriptional regulator 2
PA4601 morAb Motility regulator 3
PA4773 Hypothetical protein -3
PA4776 pmrA PmrA: two-component regulator system response regulator -2
PA5298b Xanthine phosphoribosyltransferase -3
Pae_AF241171cds21b Probable two-component system -4
Pae_tRNA_His_fb tRNA, histidine -2
Pae_tRNA_Lys_fb tRNA, lysine -2
Pae_tRNA_Met_sb tRNA, methionine -3
ig_3874653_3873835b Intergenic region 3
a. Gene expression changes are displayed as discrete fold changes, converted from log (2) fold changes. Negative values correspond to
downwards fold change.
b. Gene expression change present between isolates B12-4 and B12-7, i.e. likely an effect of mutations occurring between these samples.
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AlgU controlled regulators algR and algB. Among the
observed changes in gene expression in the mucA isolate
it was striking that expression of several virulence factor
genes was downregulated in the mucoid strain suggesting
reduced production of phenazines involved in pyocyanin
synthesis, hydrogen cyanide, rhamnolipids, type III and
type VI secretion proteins, motility factors, chemotaxis
proteins and Rhl quorum sensing proteins. These down-
regulations may not be a direct regulatory effect of AlgU,
but rather indirect, as several well-known quorum sensing
and virulence factor regulatory genes were also differen-
tially expressed. Other pleiotropic effects of the mucA
mutation include the expression upregulation of the genes
osmC and osmE induced by osmotic stress in E. coli
(Gutierrez and Devedjian, 1991; Gutierrez et al., 1995),
and a number of genes shown to be part of the osmotic
stress response of PA14 encoding hypothetical proteins
or proteins putatively involved in the synthesis of the
osmo-protectant N-acetyl glutaminyl glutamine amide
(NAGGN) (Aspedon et al., 2006).
Because the most pronounced phenotypic effect of
mucA mutations is the constitutive high-level production
of extracellular alginate, it was important to clarify the
direct and indirect consequences of the synthesis of this
polymer. Therefore a B38-A2-M algD mutant strain was
constructed, cf. Experimental procedures. The resulting
strain produces no alginate, is still mucA deficient and
expresses wild-type AlgU. As shown in the transcriptome
analysis (Table 3) most of the gene expression changes
that could be specifically associated with alginate over-
production are related to metabolism, e.g. downregulation
of lactate and glycerol metabolism genes. Otherwise the
gene expression profiles of B38-2A-M and the algD
mutant strain are quite similar (correlation coefficient
factor of 0.95), especially concerning the virulence
factors.
Some of the differentially regulated genes unrelated to
the mucA mutation include the operon (PA3186-PA3190)
involved in transport of glucose, fructose, glycerol and
mannitol (Wylie and Worobec, 1995) in addition to an
operon involved in glutamate and aspartate transport and
metabolism, both of which are upregulated. The only dif-
ferentially expressed gene with a fold change above 2
when comparing isolates B38-2A-M and B38-6A-M is the
mexX gene (2.6-fold), while a fold change of 1.7 is present
for mexY. These genes encode part of the MexXY OprM
efflux pump system involved in antibiotic resistance
towards aminoglycosides, e.g. tobramycin (Aires et al.,
1999; Islam et al., 2009). However the fold changes were
low and assessing the MIC of tobramycin revealed only a
minor increase in MIC from 0.75 for B38-2A-M to 1.5 for
B38-6A-M.
Phenotypic consequences of mucA mutations
The gene expression data presented here suggest that
the mucoid phenotype is associated with reduced viru-
lence caused by the regulatory consequences of the
mucA mutation. Because reduced virulence is one of the
characteristics of P. aeruginosa isolates from chronically
infected patients it was important to determine if the
changed gene expression pattern related to the virulence
genes was indeed correlated with a reduced virulence
phenotype of mucA strains. Additionally, the generality of
a possible reduction of virulence because of mucA muta-
tions should be assessed in different strain pairs of P.
aeruginosa, as clinical mucoid isolates have different
genomes and carry different specific mucA mutations that
could express different associated phenotypes. Thus the
phenotypic analysis described in the following is both a
control of the transcription analysis described in the pre-
vious section and an expanded investigation of the pleiot-
ropy of mucA mutations.
Comparative analysis of mucoid and non-mucoid
strains of P. aeruginosa can only be carried out reliably
from isogenic pairs of strains. For the B38 isolates allelic
replacements of the mutated mucA gene in B38-2A-M
with a wild-type allele resulted in non-mucoid B38-2A-
NM*, and a replacement of the wild-type algD gene with a
mutant algD allele in B38-2A-M resulted in non-mucoid
B38-2A-M algD. Similar allelic replacements were con-
structed for four other different mucoid strains isolated
during early infection of CF children, and for the non-
mucoid reference strain PAO1 an isogenic mucoid mucA
strain, PDO300, was employed. The mucA genes of the
mucoid variants of these pairs harbour different muta-
tions. The resulting isogenic mucoid/non-mucoid pairs of
strains were analysed phenotypically as described below.
The suggested reduced virulence of mucA mutant
strains was confirmed by phenotypic characterization of
the strains. Overall virulence activities of the relevant
strains were assessed using the Caenorhabditis elegans
worm killing assay. It was previously shown that P. aerugi-
nosa isolates from chronically infected patients do not kill
the worms, whereas isolates from the environment or from
early stages of infection in CF children efficiently killed the
worms. The comparison between non-mucoid, mucA
mucoid and non-mucoid mucA, algD strains showed that
Table 2. mucA mutations of the five different mucoid lineages
present in sample B38-2.
Strain mucA mutation
B38-2A-M T349C
B38-2B-M T382C
B38-2C-M C insert 251
B38-2D-M DGA478–479
B38-2E-M DG430
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Table 3. Selected gene expression changes between B38 non-mucoid and mucoid strains.a,b
Locus ID and gene name Description
B38-1-NM vs.
B38-2A-NM*
B38-1-NM vs.
B38-2A-M
B38-2A-NM* vs.
B38-2A-M
B38-2A-NM* vs.
B38-2A-M algD
Alginate regulation and biosynthesis
PA0762 algU Sigma factor 3 3 3
PA0763 mucA Anti-sigma factor 3 3 3
PA5261 algR Alginate biosynthesis regulatory protein 5 4 4
PA5483 algB Two-component response regulator 3 3 2
PA3540 algD GDP-mannose 6-dehydrogenase 181 180
Virulence factors
PA2386 pvdA L-ornithine N5-oxygenase -2 3 6 9
PA2396 pvdF Pyoverdine synthetase F > 4 9
PA2426 pvdS Sigma factor 6 5
PA1905 phzG2 Probable pyridoxamine 5′-phosphate oxidase > -3 -6 -6
PA4211 phzB1 Probable phenazine biosynthesis protein > -4 -6 -6
PA4217 phzS Flavin-containing monooxygenase > -5 -7 -7
PA2193 hcnA Hydrogen cyanide synthase -20 -24 -27
PA2194 hcnB Hydrogen cyanide synthase > -5 -6 -5
PA2195 hcnC Hydrogen cyanide synthase -4 -6 -5
PA3479 rhlA Rhamnosyltransferase chain A -5 -5 -5
PA4228 pchD Pyochelin biosynthesis protein -7 -5 -5
PA4230 pchB Salicylate biosynthesis protein -17 -10 -9
PA4229 pchC Pyochelin biosynthetic protein -7 -6 -5
Secretion systems
PA1713 exsA Transcriptional regulator type III secretion > -4 -7 -5
PA1718 pscE Type III export protein > -12 -18 -27
PA1719 pscF Type III export protein > -4 -6 -7
PA0083 Type VI secretion -2 -27 -13 -5
PA0084 Type VI secretion < -18 -11 -3
PA0085 HcpI, secreted protein < -28 -17 -6
Regulation
PA0652 vfr Quorum sensing regulator < -2 -2 -2
PA0905 rsmA Regulator of secondary metabolites and
quorum sensing
2 > >
PA1003 mvfR Quorum sensing regulator < -2 -2
PA3385 amrZ Alginate and motility regulator Z 2 2 2
PA4856 retS Regulator of virulence factors and type
III and VI secretion
-2 < <
Quorum sensing
PA3476 rhlI Auto-inducer synthesis protein RhlI -4 -4 -3
PA3477 rhlR Rhl quorum sensing regulator -2 -3 -2
Motility
PA1078 flgC Flagellar basal-body rod protein -17 -17 -21
PA1092 fliC Flagellin type B -48 -44 -59
PA1094 fliD Flagellar capping protein -23 -21 -23
PA5042 pilO Type 4 fimbrial biogenesis protein -5 -5 -4
PA5043 pilN Type 4 fimbrial biogenesis protein -5 -4 -3
PA5044 pilM Type 4 fimbrial biogenesis protein -7 -6 -5
Osmotic stress
PA0059 osmC Osmotically inducible protein > 11 7 10
PA4876 osmE Osmotically inducible lipoprotein 9 7 6
PA1323 Putative osmotic stress response 2 11 5 4
PA1324 Putative osmotic stress response > 7 4 4
PA2146 Putative osmotic stress response 8 8 11
PA3459 Putative osmotic stress response 8 7 5
PA3460 Putative osmotic stress response > 10 8 5
PA3461 Putative osmotic stress response 5 5 5
PA4880 Putative osmotic stress response 2 12 6 3
Metabolism
PA3584 glpD Glycerol-3-phosphate dehydrogenase -16 -20 -12
PA4770 lldP L-lactate permease 2 -11 -23
Carbohydrate transport
PA3186 oprB Glucose/carbohydrate outer membrane porin 3 3 > <
PA3187 Probable ATP binding component of ABC
transporter
7 8 <
PA3188 Probable permease of ABC sugar transporter 8 12 > <
PA3189 Probable permease of ABC sugar transporter 5 9 >
PA3190 Probable component of ABC sugar transporter 4 5 >
a. Gene expression changes are displayed as discrete fold changes, converted from log (2) fold changes. Negative values correspond to downwards fold
change.
b. A > or a < denotes a significant upwards or downwards, below twofold, gene expression change respectively (P < 0.05). The presence of no fold change
number signifies an insignificant change in gene expression (P > 0.05).
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mucA strains independent of the actual production of algi-
nate were less virulent than wild-type strains (Fig. 2) in
agreement with the gene expression profile showing
reduced virulence factor expression in B38-2A-M and the
isogenic algD mutant strain (Table 3). The less pro-
nounced difference observed for the B38 strains is due to
rapid reversion to fast growing non-mucoid cells (> 95%
for B38-2A-M and about 40% for B38-2A-M algD).
However, even for the B38 strains the mucA mutation
resulted in reduced killing of the worms.
Among the many virulence factors suggested to be
expressed with reduced rates in the mucA strains (based
on the transcriptomic data set) we chose to investigate
further by phenotypic analysis the following activities:
motility, rhamnolipid production and quorum sensing
signal (the C4 Rhl signal) production. Table 4 shows that
compared with the isogenic non-mucoid strain the mucoid
variant B38-2A-M displayed a reduction in all types of
motility, rhamnolipid and Rhl quorum sensing signal syn-
thesis. Although B38-2A-M grows substantially slower
than its isogenic non-mucoid strain (doubling time 60 vs.
35 min) it is not the cause of reduced virulence as B38-
2A-M algD is almost equally slow growing. There was an
overall trend of reduction in motility for all investigated
mucoid isolates with minor deviations as, e.g. two pair of
strains almost retain full swimming motility, and also rham-
nolipid production differs between strains. This could indi-
cate that the effect of the mucA mutation is strain
background-dependent (e.g. isolate B7 seems more
virulent than most others). Nevertheless, the specific
virulence-associated phenotypes assayed here support
the overall virulence activity measured in the C. elegans
assay showing a reduced activity for the mucA strains,
which also confirms the transcriptomic data.
Discussion
Do the bacteria show indications of being on a path
towards a ‘chronic infection phenotype’, and if so which
underlying routes and mechanisms are involved?
The first simple answer to the question is that for two of
the patients (B12 and B38) genetic changes have led to
development of new bacterial phenotypes during the
course of colonization, and in both cases the derived
prominent phenotypes – antibiotic resistance and
mucoidy – are associated with the ‘chronic infection phe-
notype’. In fact, colonization in these two patients has
progressed to a chronic infection. In the former case (B12)
the mechanism behind the increased antibiotic resistance
of the bacteria is a mutation in nfxB leading to upregula-
tion of expression of the MexCD-OprJ efflux pump (Jalal
et al., 2000; Jeannot et al., 2008). In the latter case (B38)
the mechanism behind the bacterial mucoidy is upregula-
tion of the alginate biosynthesis enzymes encoded by the
alg operon, caused by a mutation in the mucA anti-sigma
factor. For the last patient (B6) no obvious phenotypic
changes occurring during the 2 year persistence of P.
aeruginosa seem related to the ‘chronic infection pheno-
type’, and persistence can therefore be explained by
either introduction of unidentified adaptive mutations or
simply the general adaptive repertoire of this organism.
Our data do not permit us to suggest any specific mecha-
nisms in this case.
The high resolution of our phenotypic analysis (DNA
arrays for transcriptional profiling) allows us, however, to
provide more detailed answers to the question. Thus, in
addition to the increased ciprofloxacin resistance medi-
ated by the mexCD-OprJ upregulation, the later B12 iso-
lates also show phenotypic changes reducing expression
of virulence factors (TTSS). Furthermore, all B12 isolates
Fig. 2. Survival of C. elegans propagated on isogenic non-mucoid
(mucA+), mucoid (mucA-) and algD- mucA- strains as an estimate
of virulence. Laboratory-derived (PDO300) and clinically derived
(B38, B7 and B11) strains were included. Non-mucoid (mucA+)
strains are highly virulent as they cause almost complete killing.
Error bars display standard error of the mean.
Table 4. Relative phenotypic levels of mucoid and algD strains com-
pared with isogenic non-mucoid strains.a,b
Strain Twitching Swimming Rhamnolipidc C4-AHLd
B38-2A-M 0 30 12 23
B38-2A-M algD 14 53e 26 35
PDO300 13 88 4 4
PDO300 algD 24 88 17 26
B3-M 0f 10 79 29g
B6-M 0f 23 12 Not done
B7-M 5 70 55 55
B7-M algD 30e 82 66 26
B11-M –h 33 –h 30g
a. Values are listed in percent and represent the phenotypic level of
mucoid or algD strains compared with their isogenic non-mucoid
strains.
b. All values significantly different compared with values of isogenic
non-mucoid strains using two-sample t-test, P < 0.05.
c. Rhamnolipid production was determined in supernatant after 24 h
incubation.
d. C4-AHL quorum sensing signal molecule was determined in
supernatant from cultures harvested at an OD600 of 1.
e. > 90% non-mucoid revertants present at the edge of motility zone.
f. Low twitching level in isogenic non-mucoid strain.
g. Minor clumping of isogenic non-mucoid strain at harvest.
h. Phenotype level is zero for both mucoid and non-mucoid strains.
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are twitching motility deficient and compared with PAO1
expression of genes (wbp) involved in O-antigen synthe-
sis were significantly downregulated, likely causing the
LPS modifications frequently found in CF infection (Gold-
berg and Pier, 1996). Increased expression of the atu
operon conferring improved growth on leucine has not
previously been reported but probably reflects another
less studied but potentially important means of adaptation
by metabolic optimization. Sputum of CF patients is
known to be rich in amino acids (Barth and Pitt, 1996),
and a 12-patient study showed that leucine is the fourth
most abundant amino acid in CF sputum present in
almost 1 mM concentrations on average (Palmer et al.,
2007). Pleiotropic effects of the upregulation of MexCD-
OprJ often include reduced virulence and growth rate
(Sanchez et al., 2002; Linares et al., 2005; Jeannot et al.,
2008), but in our investigations no growth rate differences
were observed for B12-4 and B12-7 relative to that of
B12-0. Nonetheless, it is clear that the mutations respon-
sible for the changed phenotypes of the B12 isolates –
whether pleiotropic or not – shift the colonizing bacteria in
direction of a ‘chronic infection phenotype’.
For the B38 isolates, the shift towards the ‘chronic
infection phenotype’ is even more apparent. With a single
mutation (mucA) the ‘chronic infection phenotype’ is
approached covering most of the characteristics, e.g. algi-
nate overproduction and reduction in virulence, motility
and growth rate. The transcription data of the B38 isolates
show that the mucA mutation has a substantial pleiotropic
effect on gene expression. Here we will focus most of our
discussion on gene expression changes that have been
confirmed by phenotypic analysis (cf. Supporting informa-
tion for complete data sets). Interestingly, it turned out that
several well-known virulence genes in P. aeruginosa
showed clear reduction in expression in the mucoid mucA
strain compared with an isogenic non-mucoid strain. Pre-
vious studies have investigated the pleiotropic effects of
mucA mutations or investigated the role of the relevant
regulators, e.g. AlgU and AlgR. In a transcriptome analy-
sis of PAO381 – a derivative of PAO1 – and its isogenic
mucA- strain very different results compared with this
study were obtained (Firoved and Deretic, 2003). Of the
27 differentially expressed genes published by Firoved
and Deretic only 3 genes were regulated in the same
direction, 9 in the opposite direction and the rest
unchanged in the B38 transcriptome analyses. Although
Firoved and Deretic (2003) applied a strict cut-off value
and only included genes with fold changes above 4 it
cannot explain the observed differences. Strain differ-
ences and/or the specific conditions of the experiments
may explain the observed differences.
Several other publications seem to corroborate the find-
ings of the mucoid phenotype observed in this study. Thus
it was found that a mucA mutation resulted in reduced
expression of TTSS-related genes, AlgU shown to repress
flagellum synthesis, and AlgR found to repress the rhl QS
system in biofilms (Wu et al., 2004; Tart et al., 2006;
Morici et al., 2007). However, differences have also been
observed as mucoid strains produced more hydrogen
cyanide than non-mucoid strains (Carterson et al., 2004)
using a different experimental setup than ours, which
could suggest that hcn regulation through AlgU is depen-
dent on growth conditions. Yet, in non-mucoid strains
AlgR was shown to be a hydrogen cyanide repressor
(Lizewski et al., 2004).
The reduced expression of virulence factors in the
mucA strains suggests that these variants have lost part
of their acute infection potential and gained potential for
chronic infections. There are several plant and animal
models for acute infections with P. aeruginosa, one of
which is the C. elegans killing assay (Tan et al., 1999;
Thomsen et al., 2006), which was chosen here for
assessments of the virulence activity of the mucoid/non-
mucoid strain pairs. Previous investigations have shown
that P. aeruginosa isolates from the environment or from
early stages of infection in CF children in most cases are
fully virulent resulting in rapid killing of the nematodes,
whereas isolates from older chronically infected patients
most often displayed reduced or no virulence (Jelsbak
et al., 2007). The results presented here show that mucA
strains in general display reduced acute virulence, as
measured in the C. elegans assay, thus confirming the in
vitro data.
The gene expression consequences of the mucA
mutations affecting the AlgU regulon could be further
selectively advantageous in the stressful environment of
the CF airways. In fact, a subset of genes putatively
involved in the osmotic stress response was shown here
to be upregulated in the mucA strain (expected to be
beneficial in the CF airway mucus). It was furthermore
found that a large fraction of cell wall stress-induced
genes belong to the AlgU regulon (Wood and Ohman,
2009). In vitro conversion to a mucoid phenotype is
known to occur during both oxidative and osmotic stress
conditions (Terry et al., 1991; Mathee et al., 1999). In
other Gram-negative bacteria the role of AlgU homo-
logues (sE) is also stress-related, e.g. by ensuring
homeostasis of lipopolysaccharide and outer membrane
porins (Rhodius et al., 2006). It was further proposed
(Rhodius et al., 2006) that the sE regulon in general may
constitute an adaptation system to facilitate survival in
vivo; this seems to be true for P. aeruginosa. The
linkage between alginate production, increased oxidative
and osmotic stress response and reduction of virulence
provides a powerful explanation to why this regulon is
repeatedly targeted for activation by MucA mutation in
the CF lung environment. Importantly, the effective alter-
ation of the MucA-AlgT regulatory circuitry constitutes
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the basis for the pleiotropic phenotypic switch by a
single mutational event.
At least five different mucoid lineages arose almost
simultaneously in patient B38 as evidenced by mucA
sequences and while it seems clear that only one lineage
persisted, the reason for this is less clear. The presence of
additional adaptation specific for this lineage is one expla-
nation whereas another could be the specific pleiotropic
effects of the mucA mutation in this lineage. Despite their
clonal relationship the five lineages displayed small phe-
notypic differences in the virulence properties tested here
(data not shown). If not because of other genetic differ-
ences among the lineages the latter could indicate that
different mucA mutations may cause different degrees of
pleiotropic effects based on varying interactions with the
AlgT or MucB proteins.
The appearance of mucA variants in samples from CF
patients is often very dominating for a period after the
occurrence of the mutation(s) in the bacterial airways
population, but subsequently non-mucoid clones appear
and constitute substantial sub-populations in the patients.
In most cases of chronically infected patients it has been
shown that by far most of these non-mucoid clones still
harbour mucA mutations (nearly always the same as the
mucoid counterparts) (Ciofu et al., 2001; Jelsbak et al.,
2007). In laboratory conditions most of such second-site
revertants carry mutations in the algU gene, but this is not
the normal cause of non-mucoid phenotypes in the CF
patients (Ciofu et al., 2008). Although it is still not clear
which mutations are responsible for the phenotypic rever-
sion of mucoidy in these cases, the findings suggest that
there is selection for maintenance of the mucA phenotype
combined with a wild-type allele of the algU gene, and it is
tempting to speculate that one reason for this is the appar-
ent beneficial pleiotropic effects described in this commu-
nication. Moreover it could indicate that the most
important pleiotropic effect of AlgU activation might not be
alginate overproduction, but rather one or a collection of
the other aforementioned pleiotropic effects.
The three cases of early colonization of human hosts
have shown that P. aeruginosa normally residing in
natural environments can move successfully to highly dif-
ferent and indeed stressful environmental settings includ-
ing the airways of humans and persist for hundreds or
even thousands of generations without a significant
number of genetic adaptive changes. The normal adap-
tive repertoire of wild-type strains has some limits,
however, and without fitness-increasing genetic alter-
ations the host defence or competition from other strains
will result in eventual eradication of the cells. In the event
that fitness-improving mutations do occur in the bacterial
genome, persistence may be extended. In the present
cases, of the three main characteristics of the CF lung
environment, host immune system, antibiotics and sub-
strate composition, the B12 isolates seem to possess
increased fitness towards all of these while fitness
increase in the B38 isolates seems to relate to the
immune system and, less pronounced, antibiotics. Mean-
while, the route towards ‘the chronic phenotype’ and
fitness increase seems to consist either of the additive
effects of several mutations or, for the mucoid variant, by
a mutation with profound pleiotropic effects. Identification
of pleiotropic adaptive mutations in regulatory genes is in
fact a recurrent finding in a number of experimental evo-
lution experiments with microbial populations in the labo-
ratory (Kolter, 1999; Zinser and Kolter, 1999; Elena and
Lenski, 2003; Bantinaki et al., 2007), documenting net
fitness increases despite highly complex resulting pheno-
types. Pseudomonas aeruginosa infections in CF airways
may help to further understand how organisms can move
between highly different natural environments helped by a
low number of mutations with high phenotypic impact.
Experimental procedures
Bacterial strains and growth conditions
Bacterial strains and clinical isolates used in this study are
listed in Table 5. The general isolation procedure and
identification of P. aeruginosa from sputum was performed
as previously described (Høiby and Frederiksen, 2000).
Sputum samples were obtained by expectoration or endo-
laryngeal suction, followed by Gram staining. Pseudomo-
nas aeruginosa was isolated on selective plates and
identified by conventional biochemical tests. Up to 84
isolates from each sample were selected and stored in
microtitre plates at -80°C including all colonies with a
distinct morphotype. The genotype of P. aeruginosa iso-
lates was identified by single-nucleotide polymorphism
(SNP) typing using AT biochips (Clondiag Chip Technolo-
gies, Germany) (Wiehlmann et al., 2007). Unless other-
wise noted bacteria were cultured in LB at 37°C.
Antimicrobial agents were used where appropriate at the
following concentrations: ampicillin at 100 mg ml-1, genta-
mycin sulfate at 30 mg ml-1 (P. aeruginosa) and 15 mg ml-1
(E. coli), carbenicillin at 200 mg ml-1. Estimation of growth
rate on leucine as carbon source was performed essen-
tially as previously described (Martin et al., 1973; Aguilar
et al., 2006) using M9 medium containing 0.6% wt/vol
L-leucine and supplemented with 0.005% L-isoleucine and
L-valine. Growth was performed shaking at 37°C in 250 ml
flasks containing 50 ml of medium.
CF patients
As part of a larger study we investigated P. aeruginosa
isolates from the majority of CF children attending the
Copenhagen CF clinic from 2005 and onwards having
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their first acquisition of P. aeruginosa during this period, or
for a few patients just before 2004. As part of the general
management structure at the CF Center, all patients were
monitored on a monthly basis by evaluation of their clini-
cal status, pulmonary function and microbiology of lower-
airway secretions. Detection of P. aeruginosa in sputum
resulted in treatment with antimicrobial eradication
therapy consisting of 3 weeks of oral ciproxin plus 3
months of inhaled colistin. Instead of applying the clinical
definitions of intermittent colonization and chronic infec-
tion (Høiby et al., 2005), we here distinguish between
cases of cured and persistent colonization of the patient
airways. Colonization with a specific genotype of P.
aeruginosa, which is absent from all consecutive samples
collected over a period of at least 1 year, is considered
cured, whereas continued colonization for more than a
year with the same genotype is considered a persistent
airway colonization. Analysis was performed on bacterial
isolates from three selected patients (B6, B12 and B38)
having persistent P. aeruginosa colonization. Two of the
patients (B12 and B38) had chronic P. aeruginosa infec-
tions according to the clinical definition based on antibody
titre level increases: for B12 the antibody titre level
passed 2 after 51 months while reaching 7 after 56
months, and for B38 a level of 2 was passed after 7
months while reaching 21 after 19 months. In contrast the
antibody titre level was 1 after 48 months for B6.
mucA allelic replacement
Isogenic non-mucoid strains were generated from mucoid
clinical isolates by allelic replacement of the mutated
mucA allele with a wild-type P. aeruginosa PA14 mucA
allele (the B38-1 mucA sequence is identical to the PA14
mucA sequence). Initially, a 1.8 kb fragment containing
the PA14 mucA allele was generated by PCR using
primers CCATGGTGCAAGAAGCCCGAGTCTAT and
GAATTCCAACTGGGTGAACTGGAAGC containing an
NcoI and EcoRI site respectively. The PCR fragment was
cloned into the EcoRI and NcoI site of plasmid
pEX18ApGW. A PCR fragment containing a gentamycin
resistance cassette was amplified from pPS856 using
primers CCATGGCGAATTAGCTTCAAAAGCGCTCTGA
and GGATCCCGAATTGGGGATCTTGAAGTTCCT and
Table 5. Strains and plasmid used in this study.
Strain or plasmid Description Source or reference
Strain
PAO1 Wild-type Holloway and Morgan (1986)
PA14 Wild-type Rahme and colleagues (1995)
PDO300 PAO1 mucA22 (DG430) Mathee and colleagues (1999)
PDO300 algD- algD-, non-mucoid strain derived from PDO300 This study
E. coli HB101 supE44 hsdS20 (rB- mB-) recA13 ara-14 proA2 lacY1 galK2 rpsL20 xyl-5 mtl-1
leuB6 thi-1
Kessler and colleagues (1992)
B3-M Mucoid isolate from sample 3 from patient B3 having mucA mutation DA368 This study
B3-NM* Non-mucoid strain derived from B3-M. mucA allele replaced This study
B6-0 Non-mucoid isolate from sample 0 from patient B6 This study
B6-4 Non-mucoid isolate from sample 4 from patient B6 This study
B6-M Mucoid isolate from sample 6 from patient B6 having mucA mutation C352T This study
B6-NM* Non-mucoid strain derived from B6-M. mucA allele replaced This study
B7-M Mucoid isolate from sample 3 from patient B7 having mucA mutation C424T This study
B7-NM* Non-mucoid strain derived from B7-M. mucA allele replaced This study
B7-M algD algD-, non-mucoid strain derived from B7-M This study
B11-M Mucoid isolate from sample 4 from patient B11 having mucA mutation T382C This study
B11-NM* Non-mucoid strain derived from B11-M. mucA allele replaced This study
B12-0 Non-mucoid isolate from sample 0 from patient B12 This study
B12-4 Non-mucoid isolate from sample 4 from patient B12 This study
B12-7 Non-mucoid isolate from sample 7 from patient B12 This study
B38-1-NM Non-mucoid isolate from sample 1 from patient B38 This study
B38-2A-M Mucoid isolate from sample 2 from patient B38 mucA mutation T349C This study
B38-2A-NM* Non-mucoid strain derived from B38-2A-M. mucA allele replaced This study
B38-2A-M algD- algD-, non-mucoid strain derived from B38-2A-M This study
B38-6A-M Mucoid isolate from sample 6 from patient B38 mucA mutation T349C This study
Plasmid
pRK600 CmR; oriColE1, RK2-Mob+, RK2-Tra+; helper plasmid for triparental matings de Lorenzo and Timmis (1994)
pDONR221 KmR; Gateway donor vector Rohwer and Edwards (2002)
pEX18ApGW ApR; Gateway destination vector Choi and Schweizer (2005)
pPS856 ApR, GmR; Gm cassette flanked with FRT sequences Hoang and colleagues (1998)
pFLP2 ApR; source for Flp recombinase Hoang and colleagues (1998)
pMHR1 ApR, GmR; Gm cassette from pPS856 and 1.8 kb algT-mucA-mucB fragment
from PA14
This study
pMHR2 ApR, GmR; from pEX18ApGW. Gm cassette and FRT sequences from pPS856
flanked with algD gene fragment from B38-2A-M
This study
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cloned in the NcoI and BamHI sites of pEX18ApGW con-
taining the PA14 mucA PCR fragment, creating pMHR1.
Plasmid pMHR1 was introduced into P. aeruginosa clinical
isolates by triparental conjugation employing helper strain
HB101/pRK600. Single recombinants were selected by
screening for gentamycin resistance and verifying carbe-
nicillin resistance, while sacB-mediated sucrose coun-
terselection was employed for plasmid excision leading to
allele replacement. To avoid selecting non-mucoid spon-
taneous revertants it was always verified that sucrose
counterselection generated both mucoid plasmid excised
and non-mucoid plasmid excised strains. Allellic replace-
ment was verified by mucA sequencing while potential
AlgU mutations were excluded by AlgU sequencing.
Generation of unmarked P. aeruginosa algD
deletion mutants
algD deletion mutants were generated as described by
Choi and Schweizer (2005). Briefly, a gentamycin cas-
sette flanked by B38-2A-M algD sequences were gener-
ated using primers up fw TTAACGGAAAGGCCATCAAG,
up rev CCCAAACCAAAGATGCTGAT, down fw TCGAC
CTGGTGAACAAGACC and down rev ATCAGCAGG
CTGAGGAACAC. The construct was inserted into
pEX18ApGW creating pMHR2 and the plasmid intro-
duced into mucoid strains by triparental mating using the
helper strain E. coli HB101/pRK600. Allelic exchange as
indicated by a Gmr sucroser Cbs phenotype was verified
by PCR using the primers, up fw and down rev. Genera-
tion of unmarked deletion mutants was achieved by trans-
forming electro-competent P. aeruginosa with pFLP2 and
deletion of the Gmr marker was verified by colony PCR
and sequencing.
DNA microarray sample processing
Transcriptomic profiles of clinical isolates were obtained
using the Affymetrix P. aeruginosa gene chip. Triplicate
experiments were performed for each strain. Bacteria
were grown at 37°C in 50 ml of LB medium in a baffled
250 ml Erlenmeyer flask shaking at 240 r.p.m. Cell
density starting conditions were 0.01 at OD600 inoculated
from an overnight culture grown in LB. Bacteria were
harvested in exponential phase at an OD600 of 0.5 and
immediately mixed with RNAprotect Bacteria Reagent
(Qiagen) and stored at -80°C. For mucoid strains preser-
vation of mucoidy was confirmed by plating the cultures
and scoring the colonies for mucoidy. RNA was extracted
with RNeasy mini kit (Qiagen) and transcribed to cDNA
using SuperScript III Reverse Transcriptase (Invitrogen).
Subsequent cDNA purification, fragmentation and label-
ling were performed based on prokaryotic sample and
array processing protocol from Affymetrix (Santa Clara,
CA). The labelled cDNA were then hybridized on Affyme-
trix P. aeruginosa gene chips and stained on the Gene-
Chip® Fluidics Station. The probe arrays were scanned
with the GeneChip® Scanner 3000.
Microarray data analysis
The raw data (Tables S1 and S2) were obtained using
the Affymetrix GeneChip® Operating System 1.4
(GCOS). Microarray data analysis was performed using
the BioConductor package for the R software environ-
ment (http://www.bioconductor.org). Normalization and
expression index calculation was done with the RMA
function while linear modelling was performed with the
LIMMA package and multiple strain-pair contrasts. A
P-value < 0.05 and absolute fold change > 2 was applied
as cut-off values for each contrast (strain comparison).
Transcription factor genes were selected using a P-value
threshold < 0.05 only. The fold change was calculated
using the difference of average (log2) expression
levels of all strain replicate group while the annotations
and functional classes were assigned according to the
Pseudomonas Genome Database V2 (http://www.
pseudomonas.com).
Gene sequencing
Sequencing of genes was performed by PCR using High
Fidelity Polymerase (Fermentas) and primers mucA fw
CTCTGCAGCCTTTGTTGCGAGAAG, mucA rev CTGC
CAAGCAAAAGCAACAGGGAGG, AlgU fw CCTGAGC
CCGATGCAATCCATTTTCG, AlgU rev GGACAGAGTT
TCCTGCAGGGCTTCAC, nfxB fw GCCTCCTGTCGCT
CTTCC, nfxB rev ACTGATCTTCCCGAGTGTCG, atuR fw
ATCCGGAAAAGGGGTACTCA and atuR rev CTGCACT
TCCTCCTGCTGA.
Acyl-homoserine lactone quantification
Acyl-homoserinelactone production was quantified by
high-pressure liquid chromatography and mass spectrom-
etry. ABT medium containing 0.2% glucose and 1.0%
cas-aminoacids was used as growth medium while
growth conditions were 37°C in 50 ml of medium in a
250 ml Erlenmeyer flask shaking at 240 r.p.m. Cell
density starting conditions were 0.01 at OD600 inoculated
from an ON culture grown in ABTGC. For mucoid strains
preservation of mucoidy was confirmed by plating culture.
Bacteria were harvested in late exponential phase at an
OD600 of about 1.0 and after centrifuging culture at
12 000 g for 5 min, 1.0 ml of supernatant transferred to an
auto-sampler vial along with 50 ml of 3 YY mM D5-C-4
internal standard (hydrogen’s in the acyl chain substituted
by deuterium) in acetonitrile (ACN) and frozen at -80°C.
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HPLC-MS/MS was performed on an Agilent (Torrance,
CA) 1100 HPLC system controlled by MassLynx V4.1.
Samples were separated on a Gemini C6-phenyl 3 mm,
2 mm ID, 50 mm column (Phenomenex, Torrance, CA),
using a flow rate of 0.300 ml min-1 at 25°C. A linear water-
ACN gradient was used, starting at 2% ACN, going to
40% ACN in 30 s, then 100% ACN in 4.5 min, the 1 min
with a flow of 0.500 ml min-1, before reverting to the start
conditions for 1 min and holding this for 5 min. Both sol-
vents contained 20 mM formic acid. The HPLC was a
coupled Quattro Ultima triple mass spectrometer (Waters,
Manchester, United Kingdom) with a Z-spray electrospray
ionization source using a flow rate of 700 l h-1 nitrogen at
350°C; hexapole 1 was held at 30 V, and the cone was
held at 25 V. Nitrogen was used as collision gas, and the
mass spectrometer operated in positive multiple-reaction
monitoring mode (dwell time 100 ms). Multiple-reaction
monitoring mode were: 0–4 min,(i) C-4 AHL retention time
(RT) 2.98 min m/z 172→102 @ 15eV (quantifier ion) and
172→71 @ 15eV (qualifier), (ii) open lactone-C-4 AHL RT
2.68 min 190→120 @ 25eV (quantifier) and 190→71 @
25eV (qualifier) and (iii) D5-C-4 (internal standard)
177→102 @ 15eV (same RT as C-4); 4–7 min, (iv) Oxo-
C12 AHL RT 5.08 298→102 @ 25V (quantifier) and
298→197 @ 25eV (qualifier) and (v) open lactone Oxo-
C12 AHL RT 4.67 min 298→102 @ 25eV (quantifier) and
298→197 @ 25eV (qualifier). Calibration was done using
D5-C-4 as internal standard (isotope dilution) against
standards in ACN. Data were processed in Quanlynx 4.1
(Waters) with s/n ratio of 10 (both transitions per com-
pound), giving detection limits in the 10–30 nM range.
Motility assay
Twitching and swimming motilities were assayed on agar
plates containing AB mimimal medium (Hansen et al.,
2007) supplemented with 7.4 mM thiamin, 0.5% glucose
and 0.5% casaminoacids; 0.3% and 1.5% agar were used
for swimming and twitching respectively. Plates were
inoculated with nearly equal amounts of biomass as start-
ing conditions based on OD600 measurement of ON
culture. The cells were inoculated onto the bottom of the
dish for twitching plates and inside the agar for swimming
plates. Twitching plates were incubated for 48 h at 37°C
while swimming plates were incubated for 24 h at 30°C
and subsequently maximum diameter was measured and
values background corrected by subtracting values of a
motility deficient strains (pilA, fliF). Preservation of
mucoidy was tested by streaking on LB plates from motil-
ity plates.
Rhamnolipid assay
The concentration of rhamnolipids in culture supernatants
was determined by the orcinol method as previously
described (Koch et al., 1991; Pamp and Tolker-Nielsen,
2007), with modifications. Briefly, P. aeruginosa strains
were grown at 37°C in LB for 24 h, and mucoid strains
were tested for preservation of mucoidy by streaking on
LB plates. A 0.5 ml of aliquot of culture supernatant was
extracted twice with 2 vols of diethyl ether. The ether
fractions were pooled, evaporated to dryness, and subse-
quently 1 ml of orcinol reagent was added and the sample
heated at 80°C for 30 min. Orcinol reagent was prepared
immediately prior to use and consisted of 7.5 vols of 60%
(vol/vol) sulfuric acid and 1 vol. of 1.6% (wt/vol) orcinol in
distilled water. After heating, the samples were allowed to
cool at room temperature for 15 min, and absorbance
(A421) was measured and compared with rhamnose
standards. Values were adjusted for differences in final
cell density (OD600).
Antibiotic minimum inhibitory concentration
Minimum inhibitory concentrations were estimated by
E-test according to the manufacturer’s guidelines (AB
Biodisk, Solna, Sweden) with minor modifications. Inocu-
lums were prepared from an ON culture diluted to an
OD600 of 0.5 of which 100 ml was inoculated and spread
with a Drigalski spatula on a predried LB plate. Subse-
quently E-test strips were carefully placed on the LB plate
and MIC values were read after 24 h of incubation.
C. elegans virulence assay
Virulence was assessed in C. elegans as described
(Thomsen et al., 2006). A total of 20 ml of overnight culture
of each strain was spread onto Nematode Growth Medium
(NGM) plates and incubated at 37°C over night. For each
strain, about 100 L4 hermaphrodites of the pha-1 (e2123ts)
mutant (Schnabel and Schnabel, 1990) were transferred
from NGM plates seeded with E. coli OP50 to the plates
seeded with P. aeruginosa strains and incubated at 25°C.
The plates were scored for live and dead worms every
24 h. Three independent trials were performed for each
strain. The E. coli and C. elegans strains used in this work
were provided by the Caenorhabditis Genetics Center
(University of Minnesota, Minneapolis).
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Evolution and diversification of Pseudomonas
aeruginosa in the paranasal sinuses of cystic
fibrosis children have implications for chronic
lung infection
Susse Kirkelund Hansen1,5, Martin Holm Rau1,5, Helle Krogh Johansen2, Oana Ciofu3,
Lars Jelsbak1, Lei Yang1, Anders Folkesson1, Hanne Østergaard Jarmer1, Kasper Aanæs4,
Christian von Buchwald4, Niels Høiby2,3 and Søren Molin1
1Department of Systems Biology, Technical University of Denmark, Lyngby, Denmark; 2Department of Clinical
Microbiology, University Hospital, Rigshospitalet, Copenhagen, Denmark; 3Institute for International Health,
Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark and 4Department of
Otorhinolaryngology, Head and Neck Surgery, Rigshospitalet and Faculty of Health Sciences Copenhagen,
Copenhagen, Denmark
The opportunistic pathogen Pseudomonas aeruginosa is a frequent colonizer of the airways of
patients suffering from cystic fibrosis (CF). Depending on early treatment regimens, the colonization
will, with high probability, develop into chronic infections sooner or later, and it is important to
establish under which conditions the switch to chronic infection takes place. In association with a
recently established sinus surgery treatment program for CF patients at the Copenhagen CF Center,
colonization of the paranasal sinuses with P. aeruginosa has been investigated, paralleled by
sampling of sputum from the same patients. On the basis of genotyping and phenotypic
characterization including transcription profiling, the diversity of the P. aeruginosa populations in
the sinuses and the lower airways was investigated and compared. The observations made from
several children show that the paranasal sinuses constitute an important niche for the colonizing
bacteria in many patients. The paranasal sinuses often harbor distinct bacterial subpopulations, and
in the early colonization phases there seems to be a migration from the sinuses to the lower airways,
suggesting that independent adaptation and evolution take place in the sinuses. Importantly, before
the onset of chronic lung infection, lineages with mutations conferring a large fitness benefit in CF
airways such as mucA and lasR as well as small colony variants and antibiotic-resistant clones are
part of the sinus populations. Thus, the paranasal sinuses potentially constitute a protected niche of
adapted clones of P. aeruginosa, which can intermittently seed the lungs and pave the way for
subsequent chronic lung infections.
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Introduction
Pseudomonas aeruginosa is an opportunistic patho-
gen capable of causing chronic infections in the
airways of cystic fibrosis (CF) patients, where it is
the predominant pathogen associated with morbid-
ity and mortality (Koch, 2002). Patients often
acquire intermittent colonization of the lungs from
early childhood, which eventually proceeds into
chronic lung infection where the same bacterial
lineage can persist for decades (Høiby et al, 2005;
Jelsbak et al., 2007). In this process, P. aeruginosa is
subjected to strong selection in the host environ-
ment leading to substantial genetic change and
diversification. Many characteristics of chronically
infecting strains are consistently selected in differ-
ent CF patients, suggesting that adaptation occurs
with conserved patterns of evolution (Nguyen and
Singh, 2006; Smith et al., 2006; Yang et al., 2011).
These characteristics include enhanced antibiotic
resistance, changes in nutrient utilization, over-
production of the mucoid exopolysaccharide algi-
nate, reduction in growth rate and loss of O-antigen,
motility, type III secretion and quorum sensing (Lam
et al., 1980; Hancock et al., 1983; Mahenthiralingam
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et al., 1994; Dacheux et al., 2001; D’Argenio et al.,
2007; Yang et al., 2008; Hoffman et al., 2010). In
addition, the initial infecting strains of P. aeruginosa
often diversify into subpopulations with distinct
colony morphologies (Wahba and Darrell, 1965;
Thomassen et al., 1979). Major selective factors in
the CF airways are believed to be the host immune
system, nutrient composition and antibiotic treat-
ments, and consequential adaptive changes of the
bacterial phenotypes can seriously affect disease
outcome and progression (Deretic et al., 1995;
Haussler et al., 1999; Parad et al., 1999; Hoffman
et al., 2009).
Initial colonizing strains primarily originate from
the environment, each event usually with a unique
genotype, displaying wild-type characteristics with
a non-mucoid and antibiotic-susceptible phenotype
(Burns et al., 2001). The early stages of lung disease
have therefore been recognized as windows of
opportunity to eradicate P. aeruginosa (Burns
et al., 2001), and clinical trials have shown that
early aggressive treatment is beneficial for the
patient and delays transition into a chronic infection
(Høiby et al., 2005; Taccetti et al., 2005). Following
eradication, a new acquisition is often with a
different genotype, but some studies have shown
that in approximately 25% of the cases re-coloniza-
tion occurs with the same genotype of P. aeruginosa
(Munck et al., 2001; Gibson et al., 2003; Doring
et al., 2006). Re-colonization could be either from a
persistent environmental source or from an unde-
tected reservoir in the patient upper airways such as
the paranasal sinuses (Jelsbak et al., 2007). Only few
reports have addressed the role of the upper
airways, and these studies suggest that the paranasal
sinuses can be a possible gateway and reservoir for
lung infection in CF patients (Taylor et al., 1992;
Dosanjh et al., 2000; Muhlebach et al., 2006; Mainz
et al., 2009). The mechanism may be aspiration
during sleep or when suffering from a viral infection
(Huxley et al., 1978). The mucous membrane lining
of the paranasal sinuses is similar to that of the
conductive bronchi and the mucociliary clearance of
the sinuses is impaired in CF patients by malfunc-
tion of the CF transmembrane regulator as is also the
case in the lower airways. Therefore, the physiolo-
gical properties and environment of the sinuses and
lungs are similar (Aanaes et al., 2011). The con-
sequences of bacterial colonization for the sinuses
are detention of thickened mucus, chronic inflam-
mation and sinonasal abnormalities that affect
almost all patients from an early age (Robertson
et al., 2008). The fair majority of CF patients acquire
a chronic bacterial sinusitis with varying degrees of
symptoms (Coste et al., 1995; Gysin et al., 2000;
Robertson et al., 2008). When colonization of the
sinuses occurs, the microbiota of the sinuses and
lower airways are quite similar, and identical
genotypes of P. aeruginosa (and other pathogens)
can be isolated from both sites (Dosanjh et al., 2000;
Muhlebach et al., 2006; Mainz et al., 2009). Little is
known about the dynamics of the interchange of
P. aeruginosa between upper and lower airways in
the early stages of lung disease, and the role of the
sinuses in the development of chronic lung infec-
tion needs further elucidation. Here we have
investigated populations of P. aeruginosa in the
combined airways of a number of children suffering
from CF, and based on genotypic and phenotypic
data, we conclude that the paranasal sinuses may
constitute an important niche for bacterial adapta-
tion from which subsequent persistent infections in
the lungs of the patients may be established.
Materials and methods
Bacterial strains, plasmids and culture conditions
Strains and plasmids used in this study are listed in
Table 1. P. aeruginosa and Escherichia coli were
routinely grown in Luria-Bertani (LB) medium or LB-
agar at 37 1C, unless noted. Antibiotics were used at
the following concentrations: 30mgml1 gentamycin,
200mgml1 carbenicillin and 100mgml1 ampicillin
for P. aeruginosa; and 15mgml1 gentamycin and
100mgml1 ampicillin for E. coli.
CF patients and clinical isolates
A total of 46 patients from the Copenhagen CF
Center, Rigshospitalet, were included in a long-
itudinal study where first and subsequent lung
colonizing isolates were stored from the beginning
of 2005 until conclusion in July 2009 (Supplemen-
tary Table S1). This group included the majority of
young CF patients who acquired their first
P. aeruginosa within the study period. Patients were
monitored on a monthly basis in the outpatient
clinic by evaluation of their clinical status, pulmon-
ary function and microbiology of lower airway
secretions that were obtained by expectoration,
endolaryngeal suction or bronchoalveolar lavage.
Identification of P. aeruginosa in lower airway
samples was carried out at the Department of
Clinical Microbiology, Rigshospitalet, as described
previously (Høiby and Frederiksen, 2000). The
genotype of P. aeruginosa was determined by
Table 1 Non-clinical strains and plasmids used in this study
Strain or
plasmid
Relevant characteristics Reference
P. aeruginosa
PAO1
Wild-type strain Holloway and
Morgan, (1986)
Plasmids
PMHRA rhlA::gfp(ASV) monitor
cassette, Gmr
Yang et al.
(2009)
PMHLAS lasB::gfp(ASV)—Plac::lasR
monitor cassette, Gmr
Hentzer et al.
(2002)
Gmr and Apr indicate gentamicin and ampicillin resistance, respectively.
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single-nucleotide polymorphism (SNP) typing using
the AT-Biochip (Clondiag, Jena, Germany) as de-
scribed by the manufacturer. Three months of oral
ciprofloxacin and inhaled colistin were used to treat
patients at first acquisition of P. aeruginosa as well
as patients with intermittent colonization. Intra-
venous treatment was started if recurrent isolate
during treatment, mucoid phenotype or increased
antibodies occurred. Chronic P. aeruginosa lung
infection was defined as the persistent presence of
P. aeruginosa in the sputum for 6 consecutive
months or less when persistence was combined
with the presence of two or more precipitating
antibodies against P. aeruginosa (Høiby, 1974, 1977).
Sample materials from the paranasal sinuses were
obtained by functional endoscopic sinus surgery in
the ENT Department at Rigshospitalet, Copenhagen.
The location and side (left or right) of each sinus
sample was noted. Identification and genotyping of
P. aeruginosa from the sinus samples was performed
as described for the lower airway samples.
Morphotype diversity
The morphotype diversity of P. aeruginosa in the
sinus samples was assessed using Pseudomonas
isolation agar (PIA; Difco, Lawrence, KS, USA)
plates containing ampicillin (100 mgml1). Sample
material was spread and plates incubated overnight
(ON) at 37 1C. Colonies were screened using a Zeiss
axioplan microscope equipped with a  2.5 plan
objective. The number of colonies screened from
each sinus surgery ranged from several hundred to
several thousand depending on the colony-forming
units of the samples. Several colonies of each
different morphotype were picked, clonally purified
on PIA amp plates and frozen at 80 1C after growth
ON in LB. The isolates were then re-cultivated on
PIA amp plates and the different colony morpho-
types were classified by comparing the shape of
single colonies grown ON simultaneously on the
same batch of plates (as the colony morphologies
vary with dryness of plate, crowdedness and other
factors). Morphotypes were distinguished based on
features such as colony size, color (dark or light),
translucent or opaque, surface roughness, surface
shape (mountain or flat), line pattern on top, sharp
edge or fuzzy edge and form/shape of colony (round,
oval and other). As only negligible intra-morphotype
differences were present in the tested phenotypes, a
representative of each colony morphotype was
chosen for further investigations. Morphotype diver-
sity of P. aeruginosa in the longitudinal lower airway
samples were assessed as described for the sinus
samples with a small modification: after spreading
the sample on PIA amp plates, 96 colonies were
picked (if possible) and frozen in a microtiter plate
at 80 1C. Isolates were re-cultivated to asses
morphotype diversity and a representative of each
colony morphotype was chosen for further investi-
gations. All unique morphotypes from one patient
was assigned a capital letter, which does not
correlate between patients, except morphotype M
(mucoid) and SCV (small colony variant). All colony
morphotypes isolated from the sinuses and lower
airways of patient B11, B13, B34, B22, B28 and B42
are listed in Supplementary Table S2.
Sequencing of mucA and lasR genes. A 687-bp
fragment covering the mucA region and an 1300-bp
fragment covering the lasR region plus 495 bp
upstream were amplified by standard polymerase
chain reaction. Primers used for polymerase chain
reaction amplification and sequencing of mucAwere
mucA1fwd (CTCTGCAGCCTTTGTTGCGAGAAG),
mucA1rev (CTGCCAAGCAAAAGCAACAGGGAGG),
and for lasR were lasRfwd3 (CTGGAAAAGTGGCTA
TGTCG) and lasRrev3 (TGCCCTTCCCTATATATCTGC).
Motility assays
All motility assays were performed using (soft) agar
plates with ABT minimal medium (Hentzer et al.,
2002) containing 0.5% glucose and 0.5% casamino
acids. Plates were inoculated from single colonies
using a sterile toothpick and incubated at 37 1C.
Swimming and swarming motility was assayed on
0.3% and 0.6% agar plates (wt vol1), respectively,
incubated for 24 h and twitching motility was
assayed on 1.3% agar plates (wt vol1) incubated for
48h. Maximum diameter of the motility zone was
recorded for minimum three replicates per strain.
Quorum sensing
Clinical strains were examined for a metallic
iridescent screen indicative of the presence of lasR
mutations as described previously (D’Argenio et al.,
2007). Confirmation of a lasR mutation was carried
out by polymerase chain reaction and sequencing.
Isolates were tested for the presence of C4-HSL
signal molecules using pMHRA containing an RlhR-
regulated rhlA::gfp(ASV) translational fusion (Yang
et al., 2009). 3-Oxo-C12-HSL signal molecules were
assayed using pMHLAS containing the lasB::
gfp(ASV)—Plac::lasR monitor cassette (Hentzer
et al., 2002). A lasI, rhlI double mutant of P.
aeruginosa (JP2) containing C4 or C12 monitor
plasmid was cross-streaked on LB-agar against a
clinical isolate in a T-shaped pattern as described
previously (Andersen et al., 2001). The plate was
incubated for 24h before it was examined for green
fluorescent protein fluorescence using an Axioplan
Epifluorescence Microscope (Carl Zeiss, Copenhagen,
Denmark).
Protease assay
Secreted protease production was assayed using the
method described in Brown and Foster (1970).
Single colonies of each strain were patched onto
LB-agar containing 10% skimmed milk and
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incubated at 37 1C for 24h and 48h. The diameter of
the clearing zones surrounding bacterial growth was
measured in triplicate experiments.
Biofilm formation
Biofilm formation was examined in 96-well
U-bottom polystyrene plates using crystal violet
staining (Pratt and Kolter, 1998). Briefly, ON
cultures of P. aeruginosa were diluted 20 times in
ABT minimal medium (Hentzer et al., 2002) con-
taining 0.5% glucose and 0.5% casamino acids.
A measure of 150 ml of diluted bacterial culture was
incubated in the microtiter plates for 24 h at 37 1C.
Staining was performed using a 0.02% crystal violet
solution for 20min and optical density measured at
595nm. Results are representative of two separate
experiments with a minimum of seven replicates in
total for each strain.
DNA microarray sample processing
Transcriptomic profiles of clinical isolates were
obtained using the Affymetrix P. aeruginosa gene
chip. Cells were grown in beef broth (State Serum
Institute, Copenhagen, Denmark) at 37 1C with
shaking at 170 r.p.m. Triplicate experiments were
performed for each strain. A 50ml volume of the
medium was inoculated with cells from an ON
culture to yield a start optical density of approx. 0.1
at 600nm. A measure of 4ml cells were harvested at
an optical density of approx. 1 at 600nm. RNA
isolation and purification was performed by RNA
Protect Bacteria Reagent and RNeasy Mini Kit
(Qiagen, Hilden, Germany). RQ1 RNAase-free
DNAse (Promega, Madison, WI, USA) was added
to remove the contaminating DNA. Processing of the
P. aeruginosa GeneChip was performed at the
Department of Clinical Biochemistry, Microarray
Core Unit, Rigshospitalet. In all, 10mg of purified
RNA was used to synthesize single-stranded
cDNA with SuperScript Choice system (Invitrogen,
Taastrup, Denmark) with a random primer. DNAse I
(Amersham Biosciences, Uppsala, Sweden) was
used for fragmentation of the DNA followed by
biotin labeling (GeneChip DNA Labeling Reagent;
Affymetrix Inc., Santa Clara, CA, USA) The labeled
cDNA was then hybridized on Affymetrix P. aerugi-
nosa gene chips and stained on the GeneChip
Fluidics Station. The probe arrays were scanned with
the GeneChip Scanner 3000. The Fluidics Station and
GeneArray Scanner were operated and managed with
the GeneChip Operation Software v.1.4.
Microarray data analysis
Microarray data analysis was performed using
bioconductor for the R software (http://www.
bioconductor.org). Normalization and expression
index calculation was carried out with the rma
function. A P-valueo0.05 and absolute fold change
X2 was applied as cutoff values. The fold changes of
expression between two strains were calculated as
the ratio of the average expression levels (of the three
replicates). The annotations and functional classes
were assigned according to the Pseudomonas Gen-
ome Database v.2 (http://www.pseudomonas.com).
Antibiotic resistance
Minimum inhibitory concentrations (MICs) were
estimated by E-test according to the manufacturer’s
guidelines (AB Biodisk, Solna, Sweden) with minor
modifications. ON cultures in LB were diluted with
LB to an optical density of 0.5 at 600nm. A measure
of 100 ml was spread with a Drigalski spatula on a
predried LB plate. Subsequently E-test strips were
carefully placed on the LB plate and MIC values
were read after 24 h of incubation at 37 1C.
A minimum of two replicates were performed for
each strain (if results were not consistent more
replicates were performed).
Results
In children suffering from CF, it was previously
found that early airway infections with P. aerugino-
sa can be effectively removed from the lungs by
antibiotic treatment, but often the same clones
reappeared after months of clearance and it was
suggested that subpopulations of the bacteria were
hiding in the sinuses (Jelsbak et al., 2007). The
primary hypothesis of this study therefore has been
that the paranasal sinuses of CF children constitute
a protected environment in which P. aeruginosamay
hide to avoid the antibiotics and the immune system
of the host, and from this niche subsequent seeding
of the bacteria to the lower airways can take place.
The hypothesis predicts that children with recurrent
intermittent colonization of the lower airways with
the same genotype of P. aeruginosa would also be
expected to have their sinuses colonized with the
same genotype. This hypothesis was tested in
several stages: First, by genotyping isolates from
the different airway compartments to establish
clonal relationships, second to assess the population
structure of P. aeruginosa in the airways, third to
characterize the developed phenotypes in the
different airway populations and finally to find
evidence for the direction of migration of the
evolved lineages between the airway compartments.
Airway colonization and P. aeruginosa genotyping
in intermittently colonized CF patients
In a large clinical study investigating the effect of
sinus surgery on disease progression, a number of
CF patients from the Copenhagen CF Center under-
went sinus surgery. The procedures were performed
as a standard computer-assisted functional endo-
scopic sinus surgery, where the maxillary sinuses
and the ethmoidal sinuses as a standard were
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targeted and opened widely. Multiple samples were
collected for cultivation including nasal secretions,
pus, mucosal tissue, polyps and bone. Colonization
and genotype profile patterns of P. aeruginosa in the
airways of 45 children enrolled in the Copenhagen
CF Center in the period from the beginning of 2005
until conclusion of the study in July 2009 have been
investigated. Results are listed for each patient
containing P. aeruginosa-positive sputum samples
within the study period labeled with sample date
and genotype (Supplementary Table S1). Genotypes
of P. aeruginosa were determined using the
AT-Biochip (Clondiag) method based on SNPs
(Wiehlmann et al., 2007). This identification meth-
od was further supported by performing pulsed field
gel electrophoresis of most clinical isolates, and in
all cases identical conclusions concerning clonal
relationships were obtained (not shown). The
genotypic analysis allowed us to investigate if (1)
each patient was colonized by a unique genotype of
P. aeruginosa, (2) if the patient carried more than
one genotype and (3) if the same genotype colonized
both upper and lower airways in the patient.
In concordance with previous reports (Burns
et al., 2001; Munck et al., 2001; Jelsbak et al.,
2007), the majority of the children had acquired
unique genotypes suggesting initial lung coloniza-
tion from environmental sources rather than trans-
mission between patients in our CF Center, the latter
being restricted owing to cohort isolation (Høiby and
Pedersen, 1989). However, eight specific genotypes
were isolated from more than one patient (indicating
transmission or common sources of colonization),
and 9 of 45 children had more than one genotype
isolated from their sputum. On the basis of the
colonization pattern and genotype profiles, the CF
patients could be divided into three groups:
(a) Patients with single or multiple events of short
colonization periods (o6 months) followed by
eradication. Each colonization event was with a
unique genotype. This group includes patients with
new colonization events within the last 6 months
before conclusion of study. (b) Intermittently colo-
nized patients with multiple recurrent colonization
events (usually separated by several months) with
the same genotype of P. aeruginosa and a low
number of precipitating antibodies (o2) indicating
the absence of chronic lung infection (Høiby, 1974,
1977). (c) Patients with a rapid development of
chronic lung infection with increasing numbers of
precipitating antibodies (X2). A total of 31 patients
(69%) belonged to group A with successful eradica-
tion after aggressive antibiotic treatments, and only
three patients (7%) progressed directly to chronic
infection (group C). In all, 11 patients (24%)
belonged to group B and it is a primary hypothesis
here, as suggested by several reports (Munck et al.,
2001, 2003; Jelsbak et al., 2007; Mainz et al., 2009)
that the bacteria were hiding in the paranasal
sinuses. At conclusion of the study, 6 of the 11
group B patients had developed chronic infection
after a period of intermittent colonization (Supple-
mentary Table S1).
Cultivation and identification of bacteria were
performed on sample materials from the six group B
patients (B11, B12, B22, B28, B34 and B42 (had
surgery twice)). We additionally included a young
CF patient (B13, had surgery twice) who had been
chronically infected for approximately 6 years.
Thus, a total of nine events of sinus surgery
performed on seven patients are referred to in this
study (Supplementary Table 2).
The P. aeruginosa genotype (determined as SNP
genotype from AT-Biochip assays supported by
pulsed field gel electrophoresis) was unique for
each patient, and the same specific genotype could
be found consistently in all P. aeruginosa-positive
sputum samples in each patient as well as in the
patient’s sinus samples (Table 2). Patient B13 is the
only exception as three genotypes were present in
the sputum samples, of which only two were
present in the sinus samples; however, the third
genotype was only isolated once from sputum. For
six of the seven patients (incl. B13) P. aeruginosa
was identified in the paranasal sinus samples. In
patient B12, only the left side of the nose was
cultured and no P. aeruginosa was found in the
cultured sinuses. In the other eight events, both left
and right side was cultured, an average of four sinus
cavities were cultured, each with several samples
and P. aeruginosa was found in all cultured sinus
samples.
Consequently, genotype identity exists between
the lower airways and the sinuses supporting the
hypothesis that the paranasal sinuses constitute a
colonized niche in the CF airways. The results
further suggest that the sinuses represent a protected
environment in which bacteria may survive even
after their eradication from the lungs (Low et al.,
2001). Despite the genotypic identity of the isolates
derived from each patient, it was noted, however,
that upon plating of individual clones, a clear
diversity was apparent among the obtained bacterial
colonies. It was therefore decided to investigate
further this apparent diversity of the bacterial
populations.
The paranasal sinuses harbor diverse bacterial
subpopulations
Colony morphology (morphotype) diversity of the
sinus isolates was assessed for each patient by
microscopy as described in Materials and methods.
Each morphotype could be stably maintained after
repeated growth, and the SNP genotype was deter-
mined for all variants. All available sputum samples
from the lower airways were similarly examined for
different morphotypes, and sinus and sputum
populations were carefully compared to determine
the number of identical morphotypes isolated until
the point of surgery (Table 2). A strain list of all
isolates (including morphotypes) is displayed in
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Supplementary Table S2, and the morphotype
diversity found in two of the patients (B22 and
B34) is shown in Figure 1.
Interestingly, substantial diversification of
P. aeruginosa was observed in the sinus cavities. In
two patients (B11 and B13), 10 or more morphotypes
were found and in average 6.7±2.9 (mean±s.d.)
morphotypes per patient were isolated from the
sinuses. For the lower airway samples, the observed
diversity was in average 5.3±1.2 (mean±s.d.)
morphotypes per patient. These numbers most
likely represent minimum estimates owing to the
partial sample material and limitations in screening
method. The overlap of morphotypes between the
sinuses and the lower airways was high; on an
average 3.2±1.2 (mean±s.d.) or 59% of the mor-
photypes found in the lower airways were also
cultivated from the paranasal sinuses. Patients B22
and B34 both had three morphotypes shared
between the sinuses and the lower airways
(Figure 1). Many of the lower airway morphotypes
that were not found in the sinuses belonged to the
very early isolates from the sputum. In addition, the
population in the left and right sinus cavities on
each side of the nose in most patients had evolved
into distinct morphotype populations (Table 2). In
one patient (B28), a few morphotypes were found in
both sides, but it is not known if this was a result of
cross-contamination during surgery, as in this case
the same instruments were used in the right and left
sinuses. Patient B13 who was chronically infected at
the time of the sinus surgery carried different
genotypes in each side of the sinuses, a result that
was confirmed at the second surgery 8 months later.
The genotype found in the left sinuses was the only
type recovered from the sputum samples until 2006,
after which only the genotype from the right sinuses
was identified in sputum (Supplementary Table S2).
The apparent diversity of the P. aeruginosa popula-
tions in the sinus samples from the investigated
group of patients strongly suggest that evolutionary
changes occur, and that some of the evolved
morphotypes may be similar to those documented
from lung samples. These observations made us
hypothesize that the bacteria colonizing the sinuses
evolve to become distinct lineages in the CF upper
airways, and that these lineages migrate to the lungs,
where they may establish and become persistent. In
the following sections, we will present data support-
ing this hypothesis.
Relationships between morphotype, phenotype and
genotype
The finding that the sinuses and the lower airways
are often colonized by identical P. aeruginosa
morphotypes suggests that the two compartments
harbor highly similar or identical lineages. If the
isolates indeed are identical, it would be evidence of
transfer between the sinuses and the lower airways.
Therefore, phenotypic and genetic profiles of all
isolates from patients B22 and B34 were compared.
Specifically, phenotypes known to change during
chronic infections in CF patients (Mahenthiralin-
gam et al., 1994; Demko et al., 1995; Smith et al.,
2006) such as motility, quorum sensing, secreted
virulence factors and biofilm formation were ana-
lyzed, and the lasR andmucA genes were sequenced
Table 2 Genotype and morphotype diversity of P. aeruginosa isolates from the sinuses and lower airways of group B patients
Patient
no.
Year
of
birth
Clinical
status of
P. aeruginosa
at sinus surgery
Period of
intermit./
chronic inf.
before sinus
surgery (years)a
P. aeruginosa
isolated
from the
sinuses
SNP genotype
found in both
lower airways
and sinusesb
No. of lower
airway
morphotypesc
No. of sinus
morphotypesd
No. of
identical
morphotypes
in both
Different
morphotypes
in the right and
left side of
the sinuses
B11 1993 Intermittent 2.6 Yes 6FA6 6 11 4 Yes
B22 1996 Intermittent 1.4 Yes 3C2A 7 6 3 Yes
B28 1994 Intermittent 1.9 Yes 2C1E 4 5 2 No
B34 1994 Intermit/
chronic inf.e
2.3 Yes F679 4 3 3 Yes
B42 1996 Intermittent 2.1a Yes
(both times)
F469 5 6 2 Yesf
B12 1998 Intermittent 3.25 No — ND — — —
B13 1996 Chronic infection 9.25a Yes
(both times)
239A and
EC5A
6g 9 5 Yes
Abbreviation: ND, not determined.
aThe duration of intermittent colonization/chronic infection from first colonization event until first sinus surgery or second sinus surgery in the
case of B42 and B13, which had first surgery 9 and 8 months before second, respectively.
bThe SNP genotype is given as hexadecimal code (Wiehlmann et al., 2007).
cThe total number of colony morphotypes was assessed for the lower airway samples collected until first sinus surgery or until second surgery in
the case of B42 and B13.
dColony morphotypes found in the samples from sinus surgery includes both first and second surgery for patient B42 and B13.
ePatient B34 was on the transition point from intermittent colonization to chronic infection (by definition) due to six consecutive samples just
1 month before surgery.
fFor patient B42, P. aeruginosa was only recovered from the left side of the sinuses at first surgery, but similar types were recovered from both
sides at second surgery, possibly a result of cross-contamination by surgical instruments.
gNote, only approx. one isolate per year from 2002 was available for B13 as this patient was included retrospectively.
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for certain isolates. In general, it was found that each
morphotype had a distinct phenotypic profile dis-
playing variable reduction or loss of the analyzed
traits (Table 3). In patient B22, all isolates from the
left sinuses had the same insertion mutation in the
lasR regulator gene, and all were quorum sensing
negative in contrast to the isolates from the right
sinuses. In patient B34, the isolates from the right
sinuses were mucoid owing to mutations in mucA
causing alginate overproduction, whereas the left
side isolates were non-mucoid and mucAþ .
In patient B22, morphotypes E, F and G were
found both in the sinuses and lower airways. The
two lower airway isolates, B22-7_F and B22-8_G,
were collected within the last 3 months before sinus
surgery, and they displayed phenotypic profiles
identical to the sinus isolates B22-sin_F and B22-
sin_G, respectively (motility and biofilm formation
values were within the standard deviation for each
morphotype) (Table 3). The IS insertion causing a
lasR mutation found in the entire left sinus popula-
tion was also identified in the lower airway isolate
B22-7_F, further suggesting a common origin. The
E morphotypes had identical profiles as well, except
for an 1.5-fold difference in biofilm formation
capacity.
In patient B34, the shared morphotypes were B, M
(mucoid) and SCV. All M isolates showed very
similar phenotypic profiles with minor differences,
which could in some part be due to instability of this
phenotype, as it was observed to revert during
experiments (DeVries and Ohman, 1994). However,
the last mucoid morphotype isolated from the lower
airways before surgery (B34-5_M) was not different
B22-1_A
B22-3_C
Isolates from the lower airways
B22-4_C
Mar '06 Mar '06 Jun '07May '07Jan '07
Aug '06
Aug '07 Oct '07 Apr '09
B22-3_D
B22-2_A B22-5_C B22-6_E B22-7_F B22-8_G B22-9_H*
From the left side
B22-sin_F B22-3_JB22-sin_I B22-sin_K B22-sin_G B22-sin_E
From the right side
Isolates from the sinuses Nov '07
B34-1_A B34-2_M B34-3_B B34-6_SCVB34-5_M
B34-4_B
B34-4_M
B34-7_M B34-8_C
May '06 Aug '06 Dec '06
Jun '07
Mar '08 Jan '09Aug '08 Mar '09
From the left side From the right side
Isolates from the lower airways
Isolates from the sinuses Sep '08
B34-sin_B B34-sin_SCV B34-sin_M
Surgery
Sep '08
Surgery
Nov '07
Figure 1 Colony morphotypes of sinus and lower airway isolates from patients B22 and B34. Diversity in colony morphotypes is seen in
and often shared between the paranasal sinuses and lower airways. (a) All morphotypes from patient B22. (*) A morphotype and
genotype identical to B22-9_H was isolated again in June 2009 (B22-10_H). (b) All morphotypes from patient B34. A representative of
each morphotype is displayed with sample date and isolate name.
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from the mucoid sinus isolate B34-sin_M with
respect to the tested phenotypes (within the
standard deviation), and only six genes were
differentially expressed at the transcriptomic level,
Po0.05 and X2-fold change (Supplementary Table
S3). The sinus and lower airway mucoid isolates all
had the same two mutations in the mucA gene
(T261C, 262 C insert), except the first mucoid
isolate, B34-2_M, which had a one base pair deletion
in mucA (585 DA), suggesting that this lineage
became outcompeted and possibly went extinct.
Both the B and SCV morphotype isolates from the
Table 3 Phenotypic profile of isolates from patients B22 and B34
Isolate Sample
date
Twitching
motilitya
Swimming
motilitya
Swarming
motilitya
QS
(C4)b
QS
(C12b
Proteasec Biofilm
formatione
lasRf
Low. airways
B22-1_A 13.03.06 3.0 (±0.10) 2.1 (±0.23) 0.4 (±0.06) + + +++ 1.70 (±0.19) WT
B22-2_A 20.03.06 3.0 (±0.25) 1.9 (±0.26) 0.5 (±0.12) + + +++ 2.05 (±0.26) WT
B22-3_C 22.08.06 2.6 (±0.10) 3.4 (±0.31) 0.6 (±0.15) +  + 0.47 (±0.08) 1.4 kb IS
insertion
B22-3_D 22.08.06 1.6 (±0.25) 3.2 (±0.21) 1.0 (±0.06) + + +++ 2.18 (±0.25) WT
B22-4_C 10.01.07 2.3 (±0.10) 3.2 (±0.17) 0.6 (±0.10) +  + 0.35 (±0.10) 1.4 kb IS
insertion
B22-5_C 24.04.07 2.2 (±0.12) 3.4 (±0.10) 0.5 (±0.06) +  + 0.35 (±0.12) 1.4 kb IS
insertion
B22-6_E 26.06.07 0.5 (±0.10) 2.0 (±0.15) 5.5 (±0.61) + + +++ 1.33 (±0.21) WT
B22-7_F 01.08.07 0.5 (±0.15) 3.5 (±0.31) 1.1 (±0.12) +  + 0.32 (±0.12) 1.4 kb IS
insertion
B22-8_G 29.10.07 0.7 (±0.16) 2.4 (±0.19) 5.7 (±1.10) + + +++ 0.84 (±0.13) WT
Sinus (left)
B22-sin_F 08.11.07 0.5 (±0.21) 3.7 (±0.15) 1.1 (±0.12) +  + 0.28 (±0.13) 1.4 kb IS
insertion
B22-sin_I 08.11.07 2.5 (±0.15) 3.1 (±0.56) 0.8 (±0.15) +  + 0.73 (±0.14) 1.4 kb IS
insertion
B22-sin_J 08.11.07 1.7 (±0.14) 3.4 (±0.35) 1.9 (±0.12) +  + 0.55 (±0.09) 1.4 kb IS
insertion
B22-sin_K 08.11.07 0.5 (±0.20) 2.9 (±0.10) 0.7 (±0.06) +  + 0.32 (±0.09) 1.4 kb IS
insertion
Sinus (right)
B22-sin_E 08.11.07 0.6 (±0.25) 2.2 (±0.25) 4.9 (±0.46) + + +++ 0.89 (±0.15) WT
B22-sin_G 08.11.07 0.6 (±0.20) 2.6 (±0.08) 5.5 (±2.12) + + +++ 0.80 (±0.13) WT
Low. airways mucAg
B34-1_A 08.05.06 3.8 (±0.31) 4.9 (±0.61) 1.9 (±0.32) + + +++ 0.58 (±0.09) WT
B34-2_M 29.08.06 0.3 (±0.06) 1.1 (±0.35) 0.3 (±0.10)    1.41 (±0.27) 585 DA
B34-3_B 18.12.06 0.5 (±0.15) 2.0 (±0.15) 0.9 (±0.06) + + +++ 0.52 (±0.10) WT
B34-4_B 11.06.07 0.5 (±0.25) 2.0 (±0.06) 0.8 (±0.31) + + +++ 0.53 (±0.13) WT
B34-4_M 11.06.07 0.4 (±0.10) 0.6 (±0.32) 0.3 (±0.06)    0.06 (±0.05) T261C, 262C
insert
B34-5_M 05.03.08 0.5 (±0.15) 0.7 (±0.20) 0.4 (±0.20)    0.10 (±0.08) T261C, 262C
insert
B34-6_SCV 12.08.08 0.5 (±0.10) — 0.4 (±0.06) + + d 2.99 (±0.17) WT
B34-7_M 05.01.09 0.5 (±0.10) 0.8 (±0.0) 0.7 (±0.38)    0.26 (±0.08) T261C, 262C
insert
B34-8_C 07.05.09 0.5 (±0.20) — 0.2 (±0.06) + + +++ 0.26 (±0.10) ND
Sinus (left)
B34-sin_B 18.09.08 0.5 (±0.10) 2.1 (±0.15) 0.6 (±0.06) + + ++ 0.64(±0.14) WT
B34-sin_SCV 18.09.08 0.4 (±0.10) — 0.4 (±0.06) + + d 2.92 (±0.18) WT
Sinus (right)
B34-sin_M 18.09.08 0.6 (±0.10) 0.8 (±0.10) 0.4 (±0.20)    0.09 (±0.07) T261C, 262C insert
Abbreviations: ND, not determined; WT, wild type.
aMotility zone diameters are presented as mean±s.d.tandard deviation of three replicates. , motility diameter is zero.
bPresence (+) or absence () of C4-HSL or 3-oxo-C12-HSL signal molecules.
cExtracellular protease level. Increasing number of +’s denotes increasing protease level, while  denotes no detectable protease level.
dSmall colony variants did produce detectable levels of proteases after prolonged incubation.
eBiofilm formation (OD595) presented as mean±s.d. of minimum seven replicates.
fThe lasR sequences in B22 isolates compared with PAO1 (WT). The IS element was inserted 4 bp upstream of the coding region in lasR.
gThe mucA sequence in B34 isolates compared with PAO1 (WT). All isolates from B34 had six additional nucleotides (GGGGAC) inserted
in position 360, which did not result in mucoid conversion.
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sinuses and lower airways (B34-4_B vs B34-sin_B
and B34-6_SCV vs B34-sin_SCV) displayed identical
phenotypic profiles (within the standard deviation).
Thus, the morphotypes found in both the sinuses
and lower airways of patients B22 and B34 were
highly similar or identical at a phenotypic and
genetic level documenting transfer between the two
compartments. Intra-morphotype diversity seemed
negligible as phenotypic profiling of several isolates
of the same morphotypes from B22 showed that they
were in general very similar, although small differ-
ences could occur (data not shown). The strong
correlation between morphotypes and phenotypes
shows that colony morphologies can be used
successfully to screen population diversity, a meth-
od that has also been applied in several other
studies (Rainey and Travisano, 1998; Boles et al.,
2005; Hansen et al., 2007). The data also suggest that
sinus and lower airway isolates from other patients
having identical colony morphologies may reflect
identical or at least closely related variants, suggest-
ing transfer between the two compartments for these
patients as well. Most importantly, however, the
phenotypic and genotypic characterization of sev-
eral isolates indicate that diversification of the sinus
bacterial population leads to the development of
lineages with the potential of establishing chronic
infections also in the lower airways of the patients.
Sinus isolates with increased antibiotic resistance from
patient B34
The presence of antibiotic-resistant strains in the
sinuses could implicate the sinuses as reservoirs for
colonization of the lower airways with pre-adapted
strains. Therefore, the level and mechanism of
antibiotic susceptibility was investigated for isolates
from patient B34 by determining MICs and global
gene expression analysis. In these isolates, suscept-
ibility to ciprofloxacin decreased during the infec-
tion (Figure 2). Isolate B34-2_M, the subsequent
mucoid (M) isolates and the SCV isolates were
moderately less susceptible than the initial B34-1_A
isolate, while B34-sin_MB type isolates were found
to be resistant. Notably, the highest levels of
resistance for any isolate type were always asso-
ciated with the sinus isolate of the respective type.
Isolates chosen for gene expression analysis
included the first isolate B34-1_A, the last B
morphotype before surgery (B34-4_B), the last
mucoid isolate before surgery (B34-5_M) and the
mucoid sinus isolate B34-sin_M (see Figure 1b for
morphotypes and Supplementary Table S3 for gene
expression changes). All isolates showed increased
expression of the mexCD-oprJ operon, 1.9–2.6-fold
for B34-4_B, 1.4–1.9-fold for B34-5_M and 5–10-fold
for B34-sin_M relative to the first isolate B34-1_A
(Supplementary Table S3). Overproduction of the
MexCD-OprJ efflux pump is known to reduce
susceptibility to antibiotics such as ciprofloxacin
(Poole, 2004). Both MIC and gene expression data
indicate that at least two or more separate events of
increased ciprofloxacin resistance occurred in the
B34 lineage. It is not certain in which part of the
airways the increase in resistance evolved, yet
interestingly the mucoid lower airway isolate
B34-7_M shows no further increase in ciprofloxacin
resistance in contrast to what was found for
B34-sin_M isolated at an earlier time point. It is
possible that the increased level of mexCD-oprJ
expression observed in B34-sin_M evolved in the
sinuses, and therefore that the increased resistance
was selected for in the sinuses. It should also be
noted from the transcriptomic data presented in
Supplementary Table S3 that genes known to
display reduced expression in isolates of P. aerugi-
nosa from chronically infected CF patients (Yang
et al., 2011), such as genes connected to motility,
type III secretion and other virulence factors, also
showed reduced expression in the B34 sinus
isolates, supporting the hypothesis that the sinus
populations evolve towards phenotypes associated
with chronic infections.
Parallel adaptive mutations in sinuses and lower
airways
Screening of sinus isolates from all patients revealed
the occurrence of mutations and phenotypes, which
are frequently observed in CF lung isolates. An
intriguing finding was mutations in mucA and lasR
and the isolation of SCVs, as these genetic changes
are known to promote disease progression in
relation to chronic lung infection (Deretic et al.,
1995; Haussler et al., 1999; Parad et al., 1999;
Hoffman et al., 2009). To determine the frequency
of these mutants in the sinuses, we screened the
phenotypes of all sinus morphotypes isolated in the
additional patients (Table 4). Colony morphology
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Figure 2 Ciprofloxacin resistance profile of sinus and lower
airways isolates of patient B34. The MIC of ciprofloxacin for
patient B34 isolates was determined by E-test. Isolates are
grouped into morphotype lineages with B34-1_A as a model
ancestor. An increase in resistance was observed for the mucoid
isolates, of which B34-sin_M has the highest level of resistance.
The B morphotype and SCV found in the left side of the sinuses
had increased resistance to the same level as the previously
isolated identical morphotypes from lower airways. Patient
isolates obtained after sinus surgery are not included. At least
two replicate experiments were performed for each strain.
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studies documented the presence of SCVs in the
sinus populations, but CF lung SCV isolates have
some additional characteristics besides the small
colony form (Haussler et al., 1999; Starkey et al.,
2009). Sinus SCV isolates were therefore further
analyzed for these specific phenotypes: clumping in
liquid culture, decreased motility, enhanced biofilm
formation and antibiotic resistance (Figure 3).
Susceptibility towards three antibiotics routinely
given to the patients, ciprofloxacin, tobramycin and
colistin, were tested. Two of the SCVs were less
susceptible to tobramycin when compared with the
initial isolate, whereas one strain in addition to
(B28-sin_SCV) displayed decreased susceptibility
to ciprofloxacin. No SCVs displayed increased
susceptibility to colistin. As the potential SCVs also
displayed clumping, decreased motility and
enhanced biofilm formation, it could be concluded
that four out of six patients possessed SCVs in the
sinus population. Morphotypes that did not produce
Table 4 Sinus isolates from several patients display mutations and phenotypes associated with poor lung disease prognosis
SCVa Loss of Las QS signalsb Mucoid (mucA) Reduced or loss of motilityc
No. of patientsd 4 2 2 6
Abbreviations: SCV, small colony variants.
aA morphotype was classified as a SCV when it displayed characteristics as previously described for SCVs: small colony morphology, clumping in
liquid culture and greatly enhanced biofilm formation (Haussler et al., 1999, 2004).
bOnly one of the two patients had lost production of 3-oxo-C12-HSL molecules owing to mutation in lasR.
cMinimum one sinus morphotype had lost or was significantly reduced in swimming and twitching motility.
dNo. of patients out of the six sinus colonized patients.
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Figure 3 SCVs from the paranasal sinuses display similar characteristics as SCVs from chronic lung infection. (a) Colony morphology of
first isolate and SCV from patients B34, B28, B42 and B11. SCVs were routinely grown on LB and not PIA amp plates owing to a higher
instability on the latter. On PIA amp plates, the morphology of SCVs resembled isolate B42-sin_SCV. (b) Motility was generally reduced
or lost in SCVs when compared with the first isolate. Swimming motility was also reduced in all SCVs; however, some activity still
remained (except for B34-sin_SCV). Motility zone diameters are presented as mean±s.d. for at least three replicates. White bars,
twitching motility; gray bars, swimming motility; black bars, swarming motility. (c) Biofilm formation abilities in microtiter plates were
significantly increased for all SCVs. Data are presented as mean±s.d. for seven replicates. (d) The antibiotic resistance profiles of the
SCVs were strain specific. Resistances to ciprofloxacin (black bars) and tobramycin (white bars) were determined by E-test. At least two
replicate experiments were performed for each strain.
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the Las-dependent signaling molecules were only
observed in two patients (B22 and B34). In addition
to patient B34, a mucoid variant was also present in
the sinuses of patient B11, whereas loss or severe
reduction in twitching and swimming motility was
observed for some sinus isolates from all six patients
(Table 3 and Supplementary Table S2). The finding
of multiple phenotypes associated with chronic CF
lung isolates among the sinus populations suggests
that these phenotypes are adaptive both in the lower
airways and in the sinus environment.
Transfer of P. aeruginosa between sinuses and lower
airways
The results presented above strongly suggest that
P. aeruginosa migrates between sinuses and lower
airways, although without addressing the direction-
ality. The fact that most patients have distinct
morphotype populations in each side of the sinuses
indicate little or no mixing of the two sinus
populations. If the sinuses were occasionally seeded
and invaded with different morphotypes that had
evolved in undetectable populations residing in the
lower airways (or oropharynx), one would expect to
find mixed and more similar populations in both
sides of the sinuses. Sinus surgery also seems to
affect the lower airway population as one patient
(B22) had no P. aeruginosa-positive sputum samples
for almost 1 year and 6 months after sinus surgery,
and the following colonization occurred with a new
(different) genotype, suggesting a complete eradica-
tion of the previous genotype. Patient B42 also did
not have recurrent colonizations after the second
surgery until conclusion of the study in July 2009,
and small reductions in lower airway colonization
frequencies were seen for a couple of the other
patients (Supplementary Table S1). These findings
suggest that the sinus populations are intermittently
seeding the lower airways, and that removal of these
may offer a temporary relief of sinus symptoms and
possibly lung colonization events (HK Johansen,
personal communication; Jones et al., 1993;
Nishioka et al., 1995).
On the basis of colony morphology and other
phenotypic characteristics, we have constructed a
model for a tentative development of the sinus
populations of P. aeruginosa in patient B22
(Figure 4). According to the phenotypic data, it
seems that two different phenotypic lineages were
found among the longitudinal lower airway sam-
ples, each lineage correlating with a specific
subpopulation from the right or left side of the
sinuses. The most likely scenario for the evolution-
ary trajectory of the B22 isolates (Figure 4) shows
that in one of the apparent lineages several pheno-
types were lost or reduced in a step-wise manner
over time, whereas the other lineage is almost
unchanged for the tested phenotypes. Probably the
two lineages branched even before the first isolate as
Swarming motility
Swarming
motility
WT
Mar '06 Aug '07Aug '06 Jun '07
Ev
ol
ut
io
n
Oct '07
Si
nu
s 
Su
rg
er
y The left sinus population
The right sinus population
Twitching motility
Swarming motility
Biofilm formation
Sinus population Nov '07
Twitching motility
Biofilm formation
Swarming motility
QS (lasR -)
QS (lasR -) QS (lasR -)
QS (lasR -) QS (lasR -)
Biofilm formation
Swarming
motility
Twitching motility Twitching motility Twitching motility
Biofilm 
formation
Segregation into
left and right side
of the sinuses
B22-6_E
B22-7_F
B22-8_G
B22-sin_F B22-sin_K B22-sin_IB22-3_J
B22-sin_GB22-sin_E
B22-5_C
B22-4_C
B22-3_C
B22-2_A
B22-1_A
Figure 4 Reconstruction model of the evolution of sinus populations in patient B22. On the basis of the phenotypic and genetic profile,
relatedness of isolated variants from patient B22 could be estimated. All isolates are of identical SNP genotype. The profiles of lung
isolates reveal that they likely represent previous stages in the evolution of variants from the sinus populations. The observed
evolutionary events of a very common left sinus morphotypes (B22-sin_F) could, for example, be followed in a step-like manner through
the longitudinal lower airway isolates. This was also the case in the right sinus population; however, only one major change was
observed. Swarming motility was already lost in the first lower airway isolate (B22-1_A), but not in all successive lower airway isolates,
suggesting that the first isolate from this patient does not fully represent the first colonizing strain (termed ‘WT’) and that segregation into
each side of the sinuses happened before the collection of first lower airway isolate. As the WT phenotype is unknown, first isolate
B22-1_Awas chosen as a reference strain for phenotypic comparison, except for swarming motility where B22-6_E was used as reference
strain. Each vertical step represents an evolutionary event that occurred at some point before the sample was collected (see timeline) and
all major phenotypic changes observed (relative to first isolate) at that point are shown. k, considerably reduced (470%) or lost
phenotype.
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none of the early evolutionary events are shared.
Indeed, the point of divergence of the lineages could
be the time of segregation into left and right sinus
cavities and hence the divergent phenotypes
between each side could reflect evolutionary events
actually occurring in the sinuses. The lower airway
isolates could consequently represent ‘snapshots’ of
the sinus populations at a given time in accordance
with the possibility that migration of P. aeruginosa in
the early colonization stages mainly occurs in a down-
ward direction from the sinuses towards the lungs.
Discussion
The initial hypothesis of this study was that the
paranasal sinuses of CF patients constitute an
alternative colonization site with reduced chances
of antibiotic- and immune response-mediated clear-
ance. This was supported by the findings that most
CF children carry P. aeruginosa populations in their
sinuses, and in all cases studied here the genotypes
of these were the same as those colonizing the lungs.
Surprisingly, it turned out that the sinus bacterial
populations diversify into mixed populations of
clonally related variants that migrate to the lungs
and establish colonization with pre-adapted
lineages, which eventually may result in chronic
infection. It is practically and ethically impossible to
prove a definite causal relationship between sinus
colonization and chronic lung infection, and that the
infection originates from the patients’ sinuses. How-
ever, our study provides arguments, which support
the proposition that the sinuses constitute a focus site
for early P. aeruginosa adaptive evolution directing the
colonization towards chronic lung infection.
Some intermittent colonization in CF patients end
after aggressive antibiotic therapy as P. aeruginosa
cannot be cultured from the sputum upon subse-
quent microbiological examination. The interpreta-
tion of this is that the bacteria are eradicated from
the combined airways of the treated patients, and
any later colonization events thus derive from new
environmental strains. Depending on the success of
the treatment regimen, this situation can continue
for many years, suggesting that the P. aeruginosa
population size and time of residence in the airways
do not allow adaptive mutations important for the
establishment of chronic infection to evolve. Other
intermittent colonization events, however, display a
different pattern with multiple recurrent coloniza-
tion events (usually separated by several months)
with the same genotype. In these patients, sinus
infections with P. aeruginosa may provide a source
for the occasional detection and low number of
P. aeruginosa in the sputum samples. Our results
show that the second-site colonization events in the
sinuses, often being more persistent than those in
the lungs, may provide extended opportunities for
evolution of the bacteria towards phenotypes, with
greatly increased potential of creating chronic lung
infections as well. Although it has long been known
that the microbiotas of the upper and lower airways
are similar in chronically infected CF patients, only
a small number of studies have investigated the
possibility of cross-infections between the paranasal
sinuses and the lungs (Dosanjh et al., 2000;
Muhlebach et al., 2006; Mainz et al., 2009). In a
large cohort study, almost half of the patients with a
history of chronic P. aeruginosa lung infection also
had an infection with the same genotype in the
upper airways (Mainz et al., 2009). Identical
genotypes in the sinus and bronchoalveolar lavage
(lung) samples have also been recovered from one
study of CF children with chronic sinusitis, and the
frequency of identical genotypes increased from 9%
of children up to 8 years old to 30% of children
more than 8 years old (Muhlebach et al., 2006).
In our study, the sinuses were found to display
substantial diversity in the P. aeruginosa popula-
tion, and in most cases the population had segre-
gated into two distinct populations on each side of
the nose. Although we cannot totally exclude that
specific subpopulations of bacteria from the lungs
are transmitted to individual sides of the sinuses
from time to time, it seems unlikely that a specific
population in the lower airways would always be
transferred to a specific sinus side, in particular
during the period of intermittent lung colonization,
during which antibiotic treatment effectively
removes the lung populations of P. aeruginosa.
Therefore, these results suggest that the direction
of migration is mainly downwards at the early stages
of infection. If it is assumed that recurrent inter-
mittent lung colonization with the same genotype is
associated with persistent sinus colonization, ours
and other studies show that around 25% of the CF
children may begin with a sinus colonization
(Munck et al., 2001; Gibson et al., 2003; Doring
et al., 2006), and more than half of all patients will
eventually be affected (Mainz et al., 2009).The study
further shows that phenotypic and genotypic
changes observed in sinus isolates of P. aeruginosa
are similar or identical to those often reported for
isolates from chronic lung infections in CF patients.
Several of the mutations and phenotypes that we
have observed among sinus isolates, evolved in
parallel in the different patients, including those
conferring loss of motility and quorum sensing
signals (virulence), alginate overproduction, anti-
biotic resistance and increased biofilm formation
(SCVs). (Cabral et al., 1987; Mahenthiralingam et al.,
1994; Haussler et al., 1999; Smith et al., 2006;
D’Argenio et al., 2007; Starkey et al., 2009; Hoffman
et al., 2010). Most of them are generally thought to
be beneficial also in the lung environment through
the development of resistance to host defenses and
antibiotics or to optimized utilization of available
nutrients. The effective removal of lung-associated
P. aeruginosa during intermittent colonization of
young CF patients and the consequential directional
dominance of migration from sinuses to lungs
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strongly support our proposition that the observed
diversity of the sinus-associated bacterial popula-
tions is predominantly caused by localized adaptive
evolution in the sinuses.
The suggested role of the paranasal sinuses as
persistent reservoirs for evolving bacterial popula-
tions may be associated with differences in the sinus
and lung environments. Although the physiological
properties and environment of the paranasal sinuses
and conductive bronchi (where the lung infection is
mainly residing) are likely to be comparable, as they
have similar mucous lining and the same defect in
CF transmembrane regulator, some differences in
the immune response seem to exist. Lung infection
with P. aeruginosa usually elicits stimulation of the
innate immune system (inflammation) and an
increase in precipitating antibodies against P. aeru-
ginosa (Høiby, 1977), but the CF children from this
study had colonization of the sinuses for long
periods without an elevated systemic (immuno-
globulin G) antibody response. Instead, it was
recently found that immunoglobulin antibodies
were prevalent and inflammation low, as also
indicated by low numbers of neutrophils associated
with the bacteria in the sinus samples (HK Johansen,
personal communication).
Another feature of the sinuses is the detention of
thickened mucus due to mucosal edema and closing
of the sinus ostia (connection to the nose). It is very
likely that the nutritional conditions in a partially or
fully concealed sinus cavity are different from the
lung environment where the sputum is produced
and replaced continuously. Airflow into the sinus
cavities can be reduced and lower oxygen tension in
the sinuses and anoxic conditions on the sinus
mucosa are seen in CF patients. These findings can
vary from one side to the other of the noses (Carenfelt
and Lundberg, 1977; Aanaes et al., 2011). Hence,
bacteria may be locally faced with nutrient limita-
tions and possibly starvation, in particular in some of
the smaller cavities such as the ethmoids.
Nutrient limitation including low oxygen tension
may be part of the conditions that facilitated the
generation of mucoid variants (Terry et al., 1991,
1992) in two of six sinus-colonized patients,
possibly in combination with other advantages such
as biofilm formation and protection from phagocy-
tosis facilitated by the alginate exopolysaccharide
(Cabral et al., 1987) and evasion of host defense via
downregulation of motility and virulence factors
(Rau et al., 2010). Nutrient availability may also
explain, in combination with antibiotic treatment,
the selection of the lasRmutant population found in
the left side of the sinuses of patient B22. Recent
findings have shown that lasR mutants exhibit a
dramatic metabolic shift with decreased oxygen and
increased nitrate utilization and in addition they
display increased resistance to antibiotics such as
ciprofloxacin and tobramycin (Hoffman et al., 2010).
Therefore, the lasR mutation is also likely to confer
increased fitness in the sinuses.
Partially obstructed sinus cavities lead to reduced
access of administered antibiotics, further resulting
in lower antibiotic load compared with the lower
airways. Sublethal antibiotic concentrations could
provide opportunities both for survival as well as
sufficient time for evolving increased antibiotic
resistance. Altogether, the environment of the
sinuses seems to differ from that of the lower
airways in several important aspects: The immune
response is apparently much weaker in the sinuses,
the antibiotic bioavailability is low, antibiotics may
be less effective owing to the physiological state of
the bacteria in the sinuses and the environmental
conditions in the sinuses may stimulate the occur-
rence of antibiotic-resistant mutants. In essence,
what is important for the clearance of intermittently
colonizing P. aeruginosa in the CF lungs is only
partially functional in the sinuses, providing oppor-
tunities for the bacteria to adapt through evolution
of resistance mechanisms with severe impacts on
subsequent treatment possibilities in relation to
bacteria migrating from the sinuses to the lungs.
Our study suggests that the paranasal sinuses can
be an evolutionary ‘nest’ in early colonizations,
where the bacteria are diversifying, evolving anti-
biotic resistance and other phenotypes associated
with adaptation to the CF airways in general. From
there the population is intermittently colonizing the
lungs and may ultimately cause a chronic lung
infection. On the basis of our findings, we suggest
that the paranasal sinuses could have an important
role for some CF patients in the development of
chronic lung infection, and that chronicity in such
cases is in fact established before it is usually
diagnosed in the clinic. A precise localization and
diagnosis of the CF airway colonizations and
infections are therefore crucial to target treatments.
Early diagnosis and successful treatment of
P. aeruginosa colonizations in the paranasal sinuses
could be an important therapeutic approach to
prevent or delay transition to chronic lung infection
and ultimately prolong the life of the patients.
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Abstract 
Adaptation of bacterial pathogens to a permanently host-associated lifestyle by means of 
deletion or acquisition of genetic material is usually examined through comparison of present-
day isolates to a distant theoretical ancestor. This limits the resolution of the adaptation 
process. We conducted a retrospective study of the dissemination of the P. aeruginosa DK2 
clone type among patients suffering from cystic fibrosis, sequencing the genomes of 45 
isolates collected from 16 individuals over 35 years. Analysis of the genomes provides a high-
resolution examination of the dynamics and mechanisms of the change in genetic content 
during the early stage of host adaptation by this P. aeruginosa strain as it adapts to the cystic 
fibrosis (CF) lung of several patients. Considerable genome reduction is detected 
predominantly through the deletion of large genomic regions, and up to 8 % of the genome is 
deleted in one isolate. Compared to in vitro estimates the resulting average deletion rates are 
12 to 36 fold higher. Deletions occur through both illegitimate and homologous 
recombination, but they are not IS element mediated as previously reported for early stage 
host adaptation. Uptake of novel DNA sequences during infection is limited as only one 
prophage region was putatively inserted in one isolate, confirming that the main mechanism 
of early host adaptation is loss of function instead of gain of function. Finally, we also 
describe the complete genome of this highly adapted pathogenic strain of P. aeruginosa to 
strengthen the genetic basis, which serves to help our understanding of microbial evolution in 
a natural environment. 
 
Introduction 
Entry of a bacterium into a new environment provides an opportunity for expanding the 
possible niches it can inhabit. The inherent fitness of the bacterium towards the new 
environment as well as improvement of fitness by genetic adaptation will decide if entry is 
also followed by successful persistence.  Modification of the genetic makeup of the organism 
may be the result of multiple mechanisms. For example, already present DNA can be changed 
by single nucleotide polymorphisms, small insertions and deletions and genome 
rearrangements. Also, larger genetic elements can be entirely lost or novel DNA may be 
gained by the processes of transformation, conjugation and transduction.  
Depending on the environment certain mechanisms might be more prevalent than others. 
Acquisition of novel DNA can e.g. be important for adaptation towards environments 
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containing toxic compounds as is antibiotic resistance adaptation and acquisition of virulence 
enhancing elements for host infection (Hacker and Kaper, 2000; Aguilar-Barajas et al., 2010; 
Campos-García, 2010). On the other hand adaptation towards permanent association with a 
host may be characterized by reductive evolution through extensive gene loss affecting 
functions that are no longer essential.  
Studies of genome reduction are normally carried out either on present isolates compared to a 
theoretical ancestor or using in vitro evolutionary experiments. The former method is limited 
by a low resolution of the succession of events as the most recent common ancestor is usually 
millions of years older than the present day species that are investigated. In vitro evolution 
experiments allow for high resolution of the genomic change but the necessary time-scales are 
difficult to obtain and extrapolating directly from in vitro to in vivo should be done with 
caution.  
Based on these two types of studies late stage reductive evolution is known to occur by 
pseudogene formation and subsequent gradual loss of small genomic regions, whereas the 
process of reduction in the early stages is less clear with reports emphasizing either gene-by-
gene non-functionalization (Silva et al., 2001; Dagan et al., 2006) or the loss of large 
contiguous regions (Moran and Mira, 2001; Nilsson et al., 2005).  
For the lack of useful model organisms for in vivo monitoring of adaptation to a distinctly 
different environment, Pseudomonas aeruginosa infection of cystic fibrosis patients provides 
a useful alternative as well as an opportunity for studying the initial stages of host adaptation 
and the associated mechanisms of evolution. P. aeruginosa is a highly versatile bacterium 
present in water and soil habitats but also capable of acute infection in a range of hosts from 
amoeba and plants to humans (Rahme et al., 2000; Pukatzki et al., 2002). Its vast array of 
functionalities also enables colonization of the lungs of cystic fibrosis (CF) patients, a 
colonization which is rapidly followed by genetic adaptation to be able to successfully persist 
in the new CF lung environment (Smith et al., 2006; Rau et al., 2010). 
A specific lineage of P. aeruginosa, DK2, with a history of infecting a large number of CF 
patients over at least 35 years was recently described by (Yang et al., 2011b), providing an 
opportunity for studying the early stages of adaptation to a host environment. The initial study 
correlated the phenotypic change with a SNP-based phylogeny based on genome sequences of 
12 P. aeruginosa DK2 isolates collected from six individuals over 35 years. Here, we describe 
the complete genome of this highly adapted pathogenic strain of P. aeruginosa. In addition, 
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by sequencing the genomes of additional 33 DK2 clones sampled from 16 CF patients we 
have investigated the dynamics in the overall genomic content of the DK2 lineage, and 
focused on the role of genome reduction, acquisition of new DNA, and movement of mobile 
genetic elements in long-term adaptation to the new environment offered by its human hosts,  
 
Materials and Methods 
Bacterial strains and genome sequencing 
Forty-five isolates of the P. aeruginosa DK2 clone type were sampled over 35 years from 16 
CF patients attending the Copenhagen Cystic Fibrosis Clinic at the University Hospital. 
Isolation and identification of P. aeruginosa from sputum was done as previously described 
(Hoiby and Frederiksen, 2000). Sequencing of all isolates, except CF510-2006, was 
performed as earlier described (Yang et al., 2011b) on Illumina’s GAIIx or Hiseq2000 
platforms generating 75 base single-end reads using a multiplexed protocol to an average 
coverage depth of 11-99 fold (except CF333-1991 which was 454-sequenced only cf. Yang 
PNAS). 
Assembly and annotation of the P. aeruginosa DK2 reference genome 
The initial study of the P. aeruginosa DK2 clone type was based on a draft genome sequence 
of isolate CF333-2007 that was represented in 87 contigs assembled from 524,464 reads with 
an average length of 232 nucleotides generated from 454 pyrosequencing (Yang et al., 
2011b). Isolate CF333-2007 was also sequenced on an Illumina GAII platform which 
generated 5,791,129 75-bp reads to complement the 454 generated reads and to increase the 
overall read coverage. By combining the two data sets, and by using knowledge of gene 
synteny in the genomes of other strains of P. aeruginosa genomes, we were able to complete 
the genome of CF333-2007 over several rounds of improvement:  
First, the Illumina reads were de novo assembled with the assistance of genome sequences of 
P. aeruginosa PAO1, PA14, LESB58 and CF510-2006, respectively, using the Columbus 
module of Velvet version 1.0.16 (Zerbino and Birney, 2008). Each reference assisted de novo 
assembly was used to extend and close gaps between the 87 original contigs using Minimus2 
(Sommer et al., 2007), resulting in 49 new contigs. 
We then manually inspected the 49 contigs and found all gaps to be caused by repetitive 
regions due to the following previously described reasons (Nagarajan et al., 2010; Cerdeira et 
al., 2011); (1) copies of repeats collapsed onto one another into a single contig, (2) 
misassembly caused by collapse of tandem repeats, and (3) incorrectly assembled chimeric 
contigs (false positive re-arrangements). For example, reads from the four nearly identical 
ribosomal RNA operons co-assembled into a single contig. Although this resulted in gaps in 
the de novo draft genome, we closed these gaps by first ordering the de novo contigs based on 
other available P. aeruginosa genome sequences followed by local re-assembly of the reads 
flanking the gaps. In the same way, gaps caused by tandem units of nearly identical repeats 
could be resolved by local re-assembly where only exact match reads were used, and chimeric 
contigs leaving orphan contig ends were broken up and re-assembled. A single gap consisting 
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of 10 identical repeat units could not be resolved in silico, but was instead confirmed by PCR. 
In addition, the in silico gap closure were validated by PCR spanning 13 other gaps, including 
the gaps flanking the ribosomal RNA operons. 
Finally, the Illumina reads was iteratively mapped back against the closed genome to correct 
small sequence errors which would be identified as mutations. Pileups of the reads mapped by 
Novoalign (Novocraft Technologies) (Krawitz et al., 2010) were produced by SAMtools 
release 0.1.7 (Li et al., 2009), and single nucleotide polymorphisms (SNPs) called by the 
varFilter algorithm in SAMtools (samtools.pl varFilter -­‐d 3 -­‐D 10000 (–N 10) and SNP 
quality scores ≥50) were corrected in the genome sequence. In total 531 nucleotides were 
corrected. All putative indels were manually inspected, and 37 assigned to be true were 
corrected. 
The final genome sequence was annotated using the NCBI Prokaryotic Genomes Automatic 
Annotation Pipeline (http://www.ncbi.nlm.nih.gov/genomes/static/Pipeline.html) and 
deposited at GenBank (accession no. CP003149). 
The accessory genome of P. aeruginosa DK2 was defined as genomic regions not present in 
at least two other fully sequenced P. aeruginosa genomes (strains PAO1, PA14, LESB, PA7). 
Alignment through MUMmer3 was used to locate accessory regions. Remaining regions were 
designated as core regions. 
Genome sequencing and phylogenetic analysis of isolate CF510-2006 
Clone CF510-2006 was isolated from a CF patient in 2006 with an acute P. aeruginosa 
infection. Initial molecular genotyping using ArrayTube microarrays showed that the isolate 
was genetically related to the DK2 lineage. However, the phenotype characteristics of the 
isolate were incompatible with contemporary DK2 strains present in chronically infected 
patients which strongly suggest that the CF510-2006 isolate has little or no history of growth 
in the CF environment prior to its isolation. The sequencing of the  CF510-2006 genome was 
done by AGOWA (Berlin, Germany). First, 454 pyrosequencing reads were generated to an 
approximate genomic read-coverage of 50 fold that was assembled into 1,205 contigs. 
Second, Sanger sequence reads from end-sequencing and primer walking of a fosmid genome 
library were used to close the majority of gaps to obtain a final genome containing 6,683,163 
bp assembled into 71 contigs, which we annotated using the NCBI Prokaryotic Genomes 
Automatic Annotation Pipeline and deposited at GenBank (accession no. AJHI00000000). 
The genome of CF510-2006 was analysed with respect to the set of 363 SNPs that was 
previously identified to reconstruct the phylogenetic relationship of the P. aeruginosa DK2 
lineage (Yang et al., 2011b). Of these 363 informative positions we found 358 in the CF510-
2006 genome to be identical to the previously predicted most recent common ancestor 
(MRCA) of the DK2 lineage. The MRCA was predicted based on the assumption that its 
sequence at the informative SNP sites would be identical to the homolog sequences found in 
P. aeruginosa reference strains PAO1, PA14, LESB58, and PA7 (Winsor et al., 2011).  
Analysis of genome reduction in multiple clones of the DK2 lineage 
To enable the identification of deletions larger than 1 kbp the genome sequence of a DK2 
clone we used the CF510-2006 sequence. llumina reads from all isolates were mapped onto 
the genome of CF510-2006 using Novoalign (Novocraft Technologies) (Krawitz et al., 2010) 
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and further processed by SAMtools release 0.1.7. A custom script was employed to identify 
candidate regions larger than 1 kbp that was not present (i.e. lost) in the sequenced isolate as 
compared to CF510-2006. Subsequently the candidate regions were manually inspected and 
exact deletion coordinates were verified by retrieving reads bridging the two regions adjacent 
to each deletion end. The genome sequence of isolate CF333-1991, which was assembled 
from 454 pyrosequencing reads, was aligned to the CF510-2006 genome using MUMmer3 
(Kurtz et al., 2004) and deleted regions extracted from the alignment. 
Some deletions spanned several contigs in CF510-2006 with unassembled sequence in 
between. For such cases, the  corresponding contiguous sequence was identified in CF333-
2007 and used instead based on the assumption that synteny would be preserved between the 
two isolates.  
Mobile genetic elements 
Genomic islands in P. aeruginosa DK2 were detected by comparative genomics and 
prediction approaches. The first approach involved alignment to reference P. aeruginosa 
strains PAO1, PA14 and LESB genomes using MUMmer3 (Kurtz et al., 2004). Regions in 
PADK2 above 8 kbp and not present in two or more reference strains were designated as a 
genomic island. Additional genomic islands above 8 kbp were predicted using Islandviewer 
(Langille and Brinkman, 2009). Prophage regions in PADK2 were predicted using Prophinder 
(Lima-Mendez et al., 2008) using a normalized score of 0.5 as a cutoff and Prophage Finder 
(Bose and Barber, 2006) using number of hits and predicted phage components as selection 
criteria. IS elements were located in the DK2 genome using ISsaga (Varani et al., 2011) 
(http://www-is.biotoul.fr). The expansion or loss of these known IS elements during infection 
for Illumina sequenced isolates was tracked by detecting all flanking regions to each IS 
element in reads for each isolate. A change in location of an IS element or its duplication was 
then detected as a change or increase in flanking regions while the loss of an IS element was 
detected as a loss of a flanking region. The presence of CRISPRs in the DK2 genome was 
detected using CRISPRfinder (Grissa et al., 2007).  
Deletion rates 
Deletion rates per year were assessed for the most recently sampled isolate for each patient. 
The size in bp of deleted regions occurring since isolate CF30-1979 was divided by number of 
years from 1979 up until isolation year. The year 1979 and isolate CF30-1979 was chosen as 
reference time-point since CF30-1979 was isolated this year and based on SNP analysis 
(Yang et al. 2011b) it is very closely related to the ancestor of all isolates from 1979 and 
onwards.  
Deletion rates per generation were calculated using  a previously described  estimation of in 
vivo doubling times of the DK2 lineage (Yang et al., 2008; Yang et al., 2011b). These 
doubling times were used to estimate the number of generations from 1979 to the isolation 
year of the most recent isolate from each patient, and deletion rates per generation. was then 
calculated using the number of generations from 1979 and the quantity of genome reduction 
that occurred after CF30-1979. 
Uptake of novel DNA 
7 
 
The genomes of Illumina sequenced isolates were de novo assembled using Velvet (version 
1.0.17) (Zerbino and Birney, 2008) with the Columbus module providing reference assisted 
assembly. First, reads were mapped onto contigs of CF510-2006 using Novoalign (Novocraft 
Technologies) (Krawitz et al., 2010)and the mapping data was used during Velvet read 
assembly with CF510-2006 as reference. Coverage cutoff of 5 and minimum contig length of 
100 bp were used as parameters for velvetg while k-mer length of 35 was used for velveth. De 
novo assembled genomes were aligned to the genome of CF510-2006 using MUMmer3 
(Kurtz et al., 2004)to locate novel sequence in each isolate. Any novel sequence compared to 
CF510-2006 was subsequently aligned to CF114-1973, to verify if the sequence was present 
in the least evolved isolate.  
 
 
Results 
Isolates of the DK2 clone type have been extensively collected at the Copenhagen CF center 
at Rigshospitalet, Denmark, over a long time period ranging from 1973 and onwards. By 
sequencing the genomes of 45 DK2 isolates sampled from 16 individuals over a period of 35 
years we have conducted a retrospective study of the dissemination of the P. aeruginosa DK2 
clone type among CF patients attending the Copenhagen CF center (Figure 1).  
 
Figure	  1:	  Overview	  the	  patient	  origin	  and	  sampling	  time	  of	  the	  P.	  aeruginosa	  DK2	  isolates	  used	  in	  
this	  study.	  Bacterial	  isolates	  are	  represented	  by	  grey	  circles	  and	  their	  location	  in	  the	  phylogentic	  
tree	  in	  Figure	  3	  is	  indicated	  by	  capital	  letters.	  If	  multiple	  isolates	  are	  sampled	  the	  same	  year	  from	  a	  
patient,	  they	  are	  represented	  by	  stacked	  circles	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A previous study of DK2 strains by Yang et al. (2011b) dealt with the evolutionary 
relationship of isolates from six patients as determined by genome-wide SNP analysis based 
on a draft genome scaffold. To enable a more detailed investigation of the genetic content of 
this highly successful invader of the airways of CF patients, we completed and annotated the 
genomic features of clone CF333-2007, which has been sampled in 2007 from patient CF333 
chronically infected with the DK2 strain for more than 16 years.  
 
P. aeruginosa DK2 genome features 
The entire genome sequence of P. aeruginosa DK2 clone CF333-2007 was completed using a 
combination of Illumina and 454 reads together with a previously proposed hybrid de novo 
assembly strategy (Nagarajan et al., 2010; Cerdeira et al., 2011). The CF333-2007 genome of 
P. aeruginosa DK2 (which we label PADK2) has a size of 6,402,658 bp comprising 5884 
genes, which corresponds to a coding density of 89.3 % (Figure 2). These numbers are similar 
to those of other assembled P. aeruginosa genomes as is the GC content of 66.3 %. A large 
fraction of the genome is homologues to the other completed P. aeruginosa genomes of 
strains PAO1, LESB58, PA14 and PA7 (92.5 %, 93.4 %, 93.2 %, 86.6 %, respectively) 
(Winsor et al., 2011), whereas 216 kbp containing 195 genes were found to be unique to the 
DK2 strain relative to the other four strains.  
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Figure 2: Genome map of P. aeruginosa DK2. First and second outer circles denotes CDS (blue) 
and rDNA (red); The third circle shows the location of genomic islands; the subsequent three 
rings display blast comparisons of the DK2 genome to P. aeruginosa PAO1 (red), PA14 (green), 
LESB (blue); the next ring depicts the GC content of the PADK2 genome. 
 
The majority of the unique DNA (55 %) was contained in three genomic islands related to 
heavy metal resistance (GI4, GI7 and GI12, respectively) indicating a former habitat of 
environmental origin with the presence of heavy metals. In total there are 12 genomic islands 
(GIs) in the PADK2 genome constituting roughly 489 kbp (Table 1).  
 
 
Table	  1:	  Genomic	  islands	  present	  in	  the	  P.	  aeruginosa	  DK2	  genome.	  
5 Mbp
1 Mbp
2 Mbp
3 Mbp
4 Mbp
6 Mbp
Pseudomonas aeruginosa
DK2
GI# Start# End# Size# Function#
GI1# 667531# 680249# 12719# Prophage#
GI2# 1836969# 1862655# 25687# LPS/OCantigen#biosynthesis#
GI3# 2296150# 2341644# 45494#
#
GI4# 2495033# 2601031# 105998# Copper#resistance#
GI5# 2794504# 2804831# 10328# CRISPR#region#
GI6# 2828700# 2863808# 35108# Pyoverdin#biosynthesis#
GI7# 3056897# 3144981# 88084# Prophage,#chromate/copper/silver#resistance#
GI8# 3275228# 3286591# 11363#
#
GI9# 3708420# 3723852# 15432# Type#III#secretion#
GI10# 4214902# 4228275# 13373# NonCribosomoal#peptide#synthetase#modules#
GI11# 5097794# 5188335# 90541# Type#IVb#pilus#
GI12# 6054401# 6091531# 37131# Arsenic#resistance,#nucleoside#metabolism#!
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The genome also contains two relatively small prophage regions, approximately 8 kbp and 16 
kbp each as well as eight different insertion sequence (IS) element types belonging to five 
different IS families. One IS element, IS222, is previously characterized while the other seven 
(ISPa36 – ISPa42) are new and added to the IS Finder Database (Siguier et al., 2006). Three 
IS elements belong to the TN3 family and all carry passenger genes (3, 6 and 14), while the 
other IS elements carry no passenger genes. Two CRISPR loci are present in the genome. One 
consists of two CRISPR regions flanking CRISPR associated (cas) genes, while the other 
locus is devoid of cas genes. Apart from the spacers within the CRISPR regions, the former 
locus is identical to a CRISPR-cas system in P. aeruginosa strain PA14, where it has a 
different functionality than typical systems as it does not confer phage resistance but rather is 
mediating phage regulation of biofilm formation (Zegans et al., 2009; Cady et al., 2011).  
 
Reductive evolution is prevalent in the DK2 lineage 
Bacterial long-term adaptation to a host environment often includes reductive evolution in 
which non-essential functions are lost over time. We located all contiguous genome 
reductions of ≥1 kbp among 44 DK2 isolates sampled from chronically infected CF patients, 
and in a maximum-parsimonious phylogenetic manner we reconstructed the sequence of 
reductive events that was most likely to explain the observed genome reductions (Figure 3).  
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Figure	  3:	  Maximum-­‐parsimonious	  phylogenetic	  tree	  reconstructing	  the	  sequence	  of	  large	  deletion	  
events	   within	   the	   DK2	   lineage.	   The	   tree	   is	   based	   on	   the	   genome	   sequences	   of	   45	   DK2	   isolates	  
which	   according	   to	   their	   genetic	   content	   locates	   in	   the	   nodes	   of	   the	   tree	   designated	   by	   capital	  
letters.	   Refer	   to	   Table	   2	   or	   Figure	   1	   for	   the	   location	   of	   each	   isolate.	   The	   size	   of	   each	   node	  
represents	  the	  total	  size	  (kbp)	  of	  genomic	  regions	  that	  have	  been	  deleted	  since	  the	  previous	  node.	  
If	  more	  than	  one	  deletion	  has	  occurred,	  the	  circle	  is	  divided,	  and	  each	  subdivision	  corresponds	  to	  
the	  size	  of	  each	  deletion.	  The	  total	  quantity	  deleted	  regions	  in	  a	  isolate	  represented	  by	  node	  J	  can	  
for	   instance	  be	  found	  by	  summing	  all	  the	  deletion	  events	  along	  the	  path	  from	  the	  root	  to	  node	  J	  
(52+1.8+80=133.8	   kbp).	   The	   root,	   represents	   the	   most	   recent	   common	   ancestor	   (MRCA)	   of	   all	  
isolates.	  
 
The phylogenetic reconstruction displayed a high consistency (0.93) allowing for an accurate 
depiction of the evolutionary relationship among the clones. It predicted the clones to share a 
common ancestor located at the node between the branch point of the four earliest isolates 
sampled in 1973 (CF114-1973, CF105-1973, CF43-1973 and CF66-1973). The ancestor had a 
predicted approximate genome size of 6,535,548 bp. In total, 968 kbp (15 %) of the genome 
were found to be deleted in at least one of the descendant DK2 clones sampled from 
chronically infected CF patients. Consequently, 968 kbp (~ 968 genes) of the ancestral P. 
aeruginosa DK2 genome is non-essential for survival in the human hosts. 
 
Root
A
B
C
D
E
G
H
I
J
K
L
N
M
O
F
472
40
66
52
28
100 67
1.8
2.8 80
148
91
26
20
3.5
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Table	  2:	  Location	  of	  isolates	  on	  the	  nodes	  in	  the	  phylogenetic	  tree	  in	  Figure	  2.	  
 
The extent of reductive evolution varies significantly between isolates, but every isolate 
displays reduced genomic content compared to the predicted ancestor. The level of genomic 
reduction is most extensive in CF240-2002 with a total reduction of at least 525 kbp since 
infection initiation corresponding to a loss of 8 % of the entire genome. The majority of the 
reduction observed in CF240-2002 is specific to this isolate lineage only (472 kbp), the largest 
event being the loss of 146 kbp spanning mainly core genomic regions as well as minor 
accessory regions. The large deletions in CF240-2002 are caused by six separate events while 
most other reductions in individual isolates are the cause of only one event. The high number 
of large deletions in CF240-2002 could be stochastic, however, the genome of CF240-2002 
contains missense mutations in two exonuclease genes, sbcB and sbcC, involved in 
recombination. In E. coli, mutation of sbcB enhances illegitimate recombination and increases 
the rate of deletion (Allgood and Silhavy, 1991), hence, the increased number of deletion 
events and the large quantity of lost regions in CF240-2002 could have a deterministic origin.  
In total 27 reductive events above 1 kbp are observed during the infection period with an 
average loss of 44.5 kbp per event (median 26.6 kbp). The lost genomic regions constitute 
both core regions and accessory regions of various functions (Table 3). Overall, 56 % of the 
lost regions belong to the core genome while 44 % belong to the accessory genome, a 
significant over-representation considering the overall percentage of the accessory genome is 
8.5 %.  
A:# CF114(1973# D:# CF173(2005# I:# CF240(2002# J:# CF333(2005#
B:# CF43(1973# E:# CF243(2002# J:# CF66(1992# J:# CF333(2007a#
B:# CF105(1973# F:# CF243(1986# J:# CF66(2002# J:# CF333(2007b#
C:# CF66(1973# G:# CF222(2001# J:# CF180(2002# J:# CF333(2007c#
C:# CF30(1979# G:# CF223(2002# J:# CF248(2002# K:# CF333(2003a#
C:# CF173(1984a# G:# CF311(2002# J:# CF333(1991# K:# CF333(2003c#
C:# CF173(1984b# H:# CF173(1992# J:# CF333(1992a# K:# CF333(2004b#
C:# CF173(1984c# H:# CF173(1994# J:# CF333(1992b# L:# CF206(2002#
C:# CF173(1991# H:# CF173(1995# J:# CF333(1994# M:# CF66(2008#
C:# CF224(2002# H:# CF173(1997# J:# CF333(1997# N:# CF333(2004c#
D:# CF173(2002# H:# CF173(1999# J:# CF333(2004a# O:# CF333(2003b#!
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a Column defines whether deleted sequence belongs to core or accessory genome. If both types are present within the 
sequence both are noted with the major type listed first. 
 
Table	  3:	  Description	  of	  deleted	  regions.	  
 
Deletion rates are high compared to in vitro estimates 
Based on the knowledge of lost sequences and time points of strain isolation it is possible to 
obtain an estimation of the deletion rate during the reductive evolution. All DK2 clones 
sampled from chronic infections after 1973 share the same ancestor as recognized by 
proposed key-adaptive mutations in three global regulators (mucA, lasR and rpoN) and SNP-
based phylogenetic analyses (Yang et al., 2011b). The latter suggested clone CF30-1979, 
which is the earliest clone to possess all three key-adaptive mutations, to closely resemble this 
common ancestor of all isolates sampled from chronic infections from 1979 and onwards 
(Yang et al., 2011b). In agreement with this, our analysis of genome reduction predicted 
CF30-1979 to represent an ancestor of all subsequently sampled clones (Figure 3 and Table 
2). Therefore all deletions present in clo anes isolated after CF30-1979 most likely occurred 
Node% Length% acc./core%a% Function%
A% 1,160% acc.% %
A% 5,287% core% exopolysaccharide%(pslAB)%
A% 24,134% acc.% chromate%transport,%arsenic%resistance,%copper%resistance%
A% 35,534% core% %
B% 2,795% acc.% %
C% 1,455% core% exopolysaccharide%(pslFG)%
C% 50,834% acc.% phage%
D% 1,957% core% homoprotocatechuate%metabolism%(hpc)%
D% 26,610% acc.% RND%efflux%pump,%silver%efflux%pump%
E% 4,332% core% %
E% 4,754% acc.% %
E% 91,043% acc.% PAGIR5%
F% 67,272% core% homoprotocatechuate%metabolism%(hpc)%
G% 1,775% core% %
H% 40,295% core% homoprotocatechuate%metabolism%(hpc)%
I% 7,156% core% homoprotocatechuate%metabolism%(hpc)%
I% 38,588% acc.% %
I% 60,758% core% virulence%(pqsL,%phzM/A1),%biofilm%(bfiRS),%efflux%(mexGRI)%
I% 91,043% acc.% PAGIR5%
I% 128,817% core/(acc.)% Iron%uptake%(pyoverdin)%
I% 145,995% core/(acc.)% exopolysaccharide%(pslARI)%
J% 80,345% core% homoprotocatechuate%metabolism%(hpc)%
K% 148,735% core/(acc.)% adhesion%(cupA1R5),%cobalt/zinc%cadmium%resistance,%virulence%
(katalase,%ExoY%toxin,%hydrogen%cyanide)%
L% 91,043% acc.% PAGIR5%
M% 26,104% core% denitrification%
N% 20,141% acc./(core)% iron%uptake%(pyoverdin)%
O% 3,532% core%
%!
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after the year 1979 which therefore can be used as a reference point. The lineages share 
evolutionary trajectory over several time periods and the deletions of each lineage are 
therefore not independent measures however the results will nonetheles provide a good 
indication of the deletion rate. Averaging the reduction rate per year for only the latest isolate 
for each patient (12 isolates) gives an overall deletion rate of 3,723 bp per year. Estimating 
the deletion rate for the CF240-2002 sub-lineage gives a deletion rate of 22,637 bp per year. 
Using previous estimates of in vivo doubling times, it is also possible to estimate the number 
of generations from 1979 to each endpoint isolate (Yang et al., 2008; Yang et al., 2011b). A 
deletion rate of 3,723 bp per year then corresponds to 0.62 bp per generation which is 12 to 36 
fold higher than previously reported in vitro deletion rates of 0.05 and 0.017 bp per generation 
for Salmonella enterica grown in rich medium (Nilsson et al., 2005). Although the extensive 
reduction observed in CF240-2002 significantly contributes to the high deletion rate, 
exclusion of this isolate from the calculations still result in a high rate of deletion (0.41 bp per 
generation). For bacteria usually 20 bp of homologous sequence is required for homologous 
recombination (Ehrlich et al., 1993). Out of the 27 large deletions found here, seven of these 
contain homologous regions above 20 bp in length in the deletion end-point regions. The 
homology of three of these are long and spans more than 100 bp. The remaining 20 deletions 
caused by illegitimate recombination have an average and median length of deletion endpoint 
identity of 5.5 bp with 10 of the deletions having homologous regions below 5 bp. 
 
Parallel reductive evolution 
Two genomic regions have been lost in parallel for more than two sub-lineages during the 
infection period indicating a selective pressure against encoded functions in the region. In 
addition to this there are seven examples of overlap between two lost regions. One of the two 
parallel reductions is the fivefold parallel loss of genes encoding enzymes for 
homoprotocatechuate (hpc) catabolism, a sub-pathway in tyrosine catabolism. Although some 
of the five observed reductions also include the loss of large genomic regions surrounding hpc 
catabolism genes (up to 79kbp) all five reductions include genes for this pathway making it 
the likely selective target of deletion.  
The second example of parallel reductive evolution is the threefold loss of a region highly 
similar to the pathogenicity island PAGI-5, although the region in the DK2 isolates do not 
contain the main region of virulence genes (NR-II) identified in PAGI-5. This GI spans 90 
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kbp and the three-fold independent loss therefore constitutes a large fraction of the accessory 
genome reductions (50 %). Two genomic islands closely related to PAGI-5 are pKLC102 and 
PAPI-1 both of which are mobilizable at respective frequencies of 10 % and 0.16 % (Qiu et 
al., 2006; Klockgether et al., 2007). Since PAGI-5 shares similar integration and transfer gene 
modules as PAPI-1 and pKLC102 it could possess similar mobilization frequencies. 
Accordingly the threefold independent loss of PAGI-5 homologue need not signify the GI has 
no fitness contribution, contrary the preservation of PAGI-5 in other lineages could indicate 
otherwise. We also note that deletion of different parts of the psl gene cluster occurred on 
three occasions (Table 3) which suggest selective pressure for loss of Psl exopolysaccharide 
production. 
 
Acquisition of novel DNA 
For rapid adaptation, acquisition of novel DNA can play a crucial role. However, during 
evolution of the DK2 lineage in the CF airways, acquisition of novel genetic elements, e.g. 
viruses or plasmids, seem to be less important in changing the genomic content. De novo 
assemblies of all genomes were performed to detect genetic elements not already present in 
the original infecting clone. Only 54 kbp of novel DNA sequence was found in CF114-1973 
with half of it being homologous to phage D3 sequence indicating the insertion of a related 
prophage. However, since CF114-1973 is the first of the early 1973 clones to have diverged, 
the sequence could have been present also in the ancestor and merely lost in a lineage leading 
to all other isolates. No novel sequence could be found in other isolates. 
The above is the only putative example of prophage insertion in the genomes of any DK2 
strains during infection indicating a low level of temperate phage attack or high level of phage 
resistance in the DK2 population. Contrary, a GI containing two prophage regions was lost in 
the branch leading to CF66-1973 and all strains isolated subsequent to 1973. The spacers in 
the two CRISPR loci present in the DK2 lineage also remain unchanged for the duration of 
infection indicating further the absence of temperate phage attack or simply that the systems 
are not functional. The identical system described by Cady et al. for strain PA14 was 
functional although 105 SNPs (within 8140 bp) differentiate it from the strain DK2 system. 
 
Limited IS element expansion during infection 
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The P. aeruginosa DK2 genome contains eight different IS element types of which all exist in 
the 1973 isolates and have consequently not been acquired during infection. However one 
type, IS222, existed in 7 copies in the genome of CF333-2007 while only in 5 copies in 
CF114-1973 which based on SNP analysis is the least evolved isolate. The increase in copy 
number of this IS element occurred on branch C and it is therefore present in CF66-1973 and 
all subsequent isolates. Apart from this only two other multiplication events of IS222 occurs 
in CF43-1973 and in an ancestor to the CF66 isolates, leading to the presence of an extra copy 
in CF66-1992, CF66-2002 and CF66-2008. 
 
 
Discussion 
The early stages of P. aeruginosa adaptation to the cystic fibrosis airways is characterized by 
the loss of large genomic regions. Whether the deletions are caused by drift or selection is 
unknown, but large deletions of core genome could facilitate the loss of beneficial genes 
making the bacteria susceptible to Muller’s ratchet. Although the largest proportion of 
reductions reside in the core genome there is a significant overrepresentation of reductive 
evolution in the accessory genome. This might also be expected as accessory functions often 
ensures proliferation in certain niches and here we e.g. see the loss of some of the genes 
encoding heavy metal resistance in certain isolates. Probably many of the accessory functions 
in the genome are neutral at best and therefore more prone to loss by drift or even selection 
against their functions.  
The time scale in other studies of naturally evolved human pathogens compared to a known or 
theoretical ancestor are usually of a different magnitude spanning millions of years. 
Burkholderia mallei provides such an example with 1.4 Mbp lost over 3.5 million years (Song 
et al., 2010) and Mycobacterium leprae another with 408 out of 2977 genes deleted over 66 
million years (Gomez-Valero et al., 2007). In these cases there is no information on the 
deletion dynamics. Consequently, due to a lack of intermediary strains rough estimates of in 
vivo deletion rates and dynamics have not been reported until now.  
In vitro deletion rates have been reported for Salmonella enterica grown in rich medium 
rendering several biosynthesis functions superfluous (Nilsson et al., 2005). The observed 
deletion rates for the DK2 lineage is however 12 to 36 fold higher than those reported for the 
S. enterica evolutionary experiment. The S. enterica genome is around 4.8 Mbp while the P. 
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aeruginosa DK2 genome is 6.4 Mbp, which could suggest that P. aeruginosa has a larger 
potential for genome reduction. In addition, P. aeruginosa is a versatile organism with a 
diverse metabolic repertoire, for which there is no need in the more confined human airways 
environment.  
  
The CF lung contains a multitude of microbial species suggesting that this environment could 
constitute a rich source of new genomic material. However, during the infection period of the 
DK2 strain lineage only little or no novel DNA was acquired in the lineage. Only part of a 
prophage region was possibly acquired in CF114-1973. The prophage region was not present 
in other isolates suggesting either that it entered in the branch leading to CF114-73 or was 
present in the shared ancestor but subsequently lost before the isolation of other 1973 strains. 
The overall lack of genetic expansion could e.g. be due to the lack of beneficial novel DNA in 
the lung or reduced potential for uptake and acceptance of novel DNA in the isolates. Several 
receptors for DNA uptake, e.g. pili, flagella and LPS are either lost, reduced or altered during 
infection (Yang et al., 2011b; Yang et al., 2011a) likely diminishing the rate of DNA uptake. 
Since the DK2 lineage emerges as a highly successful colonizer of the CF lung it stands to 
reason that lateral acquisition of DNA is in no way essential for P. aeruginosa adaptation to 
the CF lung and probably plays a limited role in this. This is in contrast to the gut microbiota 
where lateral transfer of virulence and resistance determinants has been proposed to provide at 
mechanisms for opportunistic pathogens to emerge. 
 
Transposable elements can impact evolution of an organism by inserting in new locations 
altering gene functionality or catalyzing deletions by providing opportunity for homologous 
recombination. In the infecting lineage only one transposable element, IS222, seems capable 
of movement and the limited increase in copy number from 5 to 7 for most isolates, only 
affecting two genes, demonstrates its low significance in generating direct mutations 
compared to the high number of SNPs occurring in the genome over time (Yang et al., 
2011b). This is in contrast to recent in vitro experiments revealing an important contribution 
of IS elements to mutation generation (Barrick et al., 2009; Gaffe et al., 2011). In the early 
stages of reductive evolution it has been suggested that extensive proliferation of IS elements 
occurs based on the high densities of these in fairly recent host-restricted species such as B. 
mallei, Bordetella pertussis, Shigella flexneri and Salmonella enterica Typhi (Parkhill et al., 
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2003; Moran and Plague, 2004; Song et al., 2010). In B. mallei and B. pertussis there seems to 
be a link between the location of IS elements and large deletions and inversions, suggesting 
that IS elements function as catalysts for reductive evolution, and this mechanism was 
therefore proposed to be a key component in the early stage. However, at the very earliest 
point in adaptation of P. aeruginosa to the CF airways the proliferation of IS222 is still too 
limited for catalysis of reductions, which creates a potential for only very large (usually 
deleterious) reductions. Although the smallest distance between IS222 in later isolates is only 
6 kbp the second-smallest is close to 340 kbp. Possibly, with a higher density of IS222 or the 
presence of another IS element with faster duplication the rate of reduction would be 
increased. Even though IS elements were estimated to be involved in nearly all large deletions 
in B. mallei we see here in the earliest of stages substantial genome reduction of up to 8 % of 
the genome without any involvement of IS elements.  
 
Instead of IS mediated genome reduction we observe mechanisms of homologous 
recombination and more frequently, illegitimate recombination. Likely this proportion is due 
to the abundance of non-homologous regions over homologous regions. Nilsson et al. (2005) 
also found mainly non-homologous end regions of reductions during S. enterica in vitro 
reductive evolution (6 regions) while one end region contained 40 bp with high identity when 
investigating the early stages of in vitro reductive evolution. These provide two examples of 
the earliest stage of host adaptation and both present reductive evolution through mainly 
illegitimate recombination.  
The adaptation of the DK2 lineage to the CF lung environment provides for the first time 
insight into the early stages of adaptation of a bacterial pathogen to its human host. This early 
stage is exemplified by substantial reductive evolution predominantly through deletions of 
large genomic regions. Genomic change through uptake of novel DNA is on the other hand 
very limited which is likely a reflection of gain of function being less important during 
transition to a permanent host association. The movement of mobile genetic elements is 
likewise scarce as IS element multiplication is low. Accordingly, IS elements are not involved 
in the process of genome reduction observed here. In spite of this high deletion rates are 
readily occurring through mechanisms of deletion mainly consisting of illegitimate 
recombination and to a lesser extent homologous recombination. Consequently, the 
involvement of IS elements is dispensable even for extensive genome reduction. Deletion 
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rates are most likely determined by several factors, one of them being the genome reduction 
potential. This could explain the high deletion rate of the DK2 lineage as a significant portion 
of the coding capacity of P. aeruginosa should be geared towards its normal environmental 
habitats and therefore dispensable in the host environment. 
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